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Human corneal regenerative capacity is not enough to heal deep injuries that 
causes scars, such abrasions result in the formation of the irregular extracellular 
matrix that leads to scar and often results in corneal transparency and vision 
reduction. Because of the limited number of corneal donors for transplantation, there 
has been an increased interest in cell therapy. Adipose-derived stem cells (ASCs) 
showed a promising choice for they are environmentally responsive in wound repair. 
ASCs can secrete paracrine factors and extracellular molecules that have 
immunomodulatory, angiogenic, trophic, anti-fibrotic, and antimicrobial activity. This 
thesis explores the formation of bandages; such bandages are formed of sodium 
alginate. Alginates are present in nature and extracted from brown seaweed. 
Generally, this material is safe, cost-effective, and wildly used in biomedical 
applications due to its biocompatibility and ease of handling. Hypothermic 
temperatures are also explored in here for bandage storage. Hence, this project 
hypothesized the formation of hypothermically stored ASCs bandages and their 
beneficial effect on corneal injuries. ASCs bandages were found to improve in 
vitro corneal scratch wounds, while storage at 15°C presented a favorable condition 
to store the bandages to vastly enhance their therapeutic potential. This storage is 
suggested to be a hypoxia-induced environment that augments cells ability to 
produce paracrine factors. Thus, hypoxia-induced ASCs bandages showed a 
promising therapeutic ability in healing corneal injures. Gene assessment and 
protein array revealed the production of several paracrine factors including HGF, 
TSG-6, IL-8, MCP1, TSP-1 that aid in wound healing. In vivo, hypoxia-induced ASCs 
bandages were transferred to adult male mice corneas following a chemical burn, 
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 1 
Chapter 1. Introduction 
 
1.1 The cornea  
The cornea is a small tissue located at the outermost part of the eye. It is the 
barrier between the eye and the external environment. Due to collagen amount, 
thickness varies, 551 - 565 µm centrally and 612 – 640 µm peripherally (Fares et al., 
2012, Feizi et al., 2014). Cornea is the most sensitive part of the body (due to the 
high density of nerves contained within the eye), avascular (thus immune-privileged), 
and transparent acting as the primary lens of the visual system responsible for 
refracting light onto the retina (Figure 1.1) (Jager et al., 1995, Meek et al., 2003).  
Corneal healing following wounding remains a challenge, with millions of 
people suffering from injuries, trauma, and diseases that could lead to unbearable 
pain (Fea et al., 2008). The wound healing process is largely dependent on the cells 
contained within the cornea; their migration, proliferation, and ability to produce 
growth factors to influence other cells is key in restoring tissue integrity. Whilst there 
are various methods used for correcting/protecting the eyesight such as spectacles, 
contact lenses, LASIK (laser-assisted in-situ keratomileusis), LASEK (laser epithelial 
keratomileusis), PRK (photorefractive keratectomy), and Wavefront-guided LASIK, 
damage to the cornea remains a global concern. One method employed to treat 
irreversible damage to the cornea is corneal transplantation (keratoplasty). This 
method, however, which has been undertaken for over a century, has significant 
limitations, including reliance on donor availability and compatibility, thus, it does not 
currently meet the worldwide demand for treatment. It is suggested that 12.7 million 
people are on the waiting lists for transplantation, with only 1 in 70 individuals 
receiving transplants due to the shortage of donor tissue (Gain et al., 2016). They 
further report that 53% of the world’s inhabitants did not have access to corneal 
transplantation. Even in countries where transplantation routinely performed, it is 
becoming increasingly difficult for eye banks worldwide to meet the growing demand 
for transplantable tissue, which is in part due to population aging. Thus, cell-based 





Figure 1.1 – The eye. Represents the major ocular structure; there are three layers 
of the eye; the fibrous tunic that comprises of sclera and cornea. The vascular tunic 
that comprises of the choroid, ciliary body, and iris. And the nervous tunic that 
comprises of the retina. The cornea is the window from which we observe the world. 
It is the transparent outermost layer of the optical system that is responsible for 
refracting the light into the retina and separates the eye from the surrounding 
environment. https://www.lasikrapidcity.com/cornea-rapid-city/.  
 
 
1.2 Corneal significance and structure  
The corneal structure consists of two main areas; the limbus that is the niche 
for corneal epithelial (Cotsarelis et al., 1989) and stromal stem cells (Funderburgh et 
al., 2016) (Figure 1.1A), and the central part that consists of uniquely distinctive 
cellular layers (Figure 1.1B). From the outer surface they are epithelium layer, 
Bowman’s membrane, Stromal layer, Dua’s layer, Descemet’s membrane, and the 
endothelial monolayer. Each of these layers has a specific role essential in 
maintaining corneal function for normal vision and intraocular protection of its 
contents (Lu et al., 2016).  
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Figure 1.2 – Corneal structure. (A) The limbus is the niche that contains corneal 
stem cells, located between the cornea and the sclera. (B) A schematic diagram 
representing the corneal layers in a cross-section. The outer surface contains the 
epithelial layer based on the basement membrane atop Bowman’s membrane. In the 
middle, there is stroma that is occupied by keratocytes, collagen fibrils, and 
proteoglycans. Followed by Descemet’s membrane and endothelial monolayer 


























1.3 The epithelium  
The Epithelium contains 5-7 multi-cellular sheets that cover the front of the 
cornea and is considered the first line of defense. It contains three layers of non-
keratinized cells connected by strong tight junctions (DelMonte and Kim, 2011). 
These layers are the superficial squamous, suprabasal, and basal layers. The 
epithelial cells are in a constant healing state, where the squamous cells routinely 
shed into the tear film. These cells immediately replaced by cells migrating anteriorly 
from the basal layer and centrally from the limbus (Figure 1.3). The outer superficial 
layer cells contain microplicae and microvilli that allow tight junction interaction with 
the tear film and metabolites transport to protect the eye from harm (Klyce, 1972). 
The superbasal layer contains wing-shaped cells that migrate and differentiate 
superficially into squamous cells. The single layer basal cells are responsible for 
generating superbasal cells and mediate cell migration upon injury (Pajoohesh-Ganji 
and Stepp, 2005). The superficial epithelial cells are in constant renewal that is 
mediated by the limbal cells, in the limbus area located between the cornea and 
sclera tight junction. Limbal epithelial stem cells (LESCs) have similar characteristics 
to somatic stem cells, in terms of size (Romano et al.,2003) and nuclear-cytoplasm 
ratio (Barrandon and Green, 1987). LESCs lack cytokeratins 3 and CK12 markers, 
which are expressed by differentiated epithelial cells (Aranguren et al., 2011, 
Lauweryns et al., 1993). Limbal cells are slow cycling cells and produce transient 
amplifying cells (TAC) that differentiate following cell division to epithelial cells 
(Auran et al., 1995, Lehrer et al., 1998). This ability allows them to reduce DNA 
replication-errors, while upon injury they become extremely proliferative (Lavker and 
Sun, 2003). TAC would then differentiate to post mitotic cells (PMC) and then 
terminal differentiated cells (TDC) upon reaching corneal epithelial superficial layer 
(Li et al., 2007). One method used to detect LESCs is by labeling them with a DNA 
precursor, such as bromodeoxyuridine (BrdU) or thymidine, followed by a chase 
phase to detect the label in the slow cycling TAC (Bickenbach and Chism, 1998, 
Cotsarelis et al., 1989). This allows for the detection of LESCs in the limbus (Watt, 
1998). LESCs divide asymmetrically, where one daughter cell remains in the stem 
cell niche to maintain their number and another daughter cell become TAC, which 
will go into differentiation. Recently Gouveia (Gouveia et al., 2019) described the 
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presence of low elastic modulus within the limbal zone that directs cells to retain an 
undifferentiated state via mechanotransduction processes. In contrast to LESCs, 
epithelial cells are not considered slow-cycling cells, they have a low proliferative 
ability; express CK3 and are extremely prone to involuntary debridement with 
pigment protection (Lehrer et al., 1998). Gouveia et al. suggest this phenotype is a 
consequence of the limbal epithelial cells migrating centripetally to a stiffer central 
environment. 
 
Figure 1.3 – A schematic of the limbal stem cell niche. Limbal stem cells (SC) 
located at the basal layer. In the basal layer, early transit amplifying cells (eTAC) 
differentiate into later TAC (ITAC), upon migrating into the suprabasal layer they 
differentiate into post-mitotic cells (PMC) and then into terminally differentiated cells 
(TDC) upon reaching the corneal superficial layer. The limbal stroma contains unique 
softer tissue with mesenchymal cells (MC), upon cells differentiation and migration 

































1.3.1 Bowman’s membrane  
The Bowman’s membrane (BM) is an acellular, smooth, non-regenerating 
layer located between the epithelial and the stromal layer. This membrane is 
approximately 8 to 14µm in thickness and is composed of collagen fibrils randomly 
arranged within the extracellular matrix (ECM) (Last et al., 2012). These collagen 
fibrils are connecting to the stroma posteriorly and the basement membrane of the 
epithelial layer anteriorly (Gordon et al., 1994). It is suggested that the limbus 
compliance state is due to that fact that it lacks BM, which then effects 
mechanotransduction as the epithelial cells are mainly driven from the limbus by the 
elasticity gradient across the cornea (Foster et al., 2014, Gouveia et al., 2019). The 
exact role of the BM is still unknown; however, it is suggested to be superfluous to 
the corneal function, considering the absence of this layer in patents who underwent 
PRK surgery. BM may act as a biological barrier to pathological infection and 
defensive barrier to subepithelial nerve plexus (Wilson and Hong, 2000). Since BM is 
an acellular layer and viruses need cells for transmitting and spreading, it is highly 
acceptable that BM likely to function as a biological barrier. BM may also provide 
resistance to trauma, however, it cannot be regenerated once damaged, thus forms 
a scar (Lagali et al., 2009, DelMonte and Kim, 2011).  
 
1.3.2 The stroma  
The stromal layer is a mesenchymal tissue that comprises 90% of corneal 
volume where it remains transparent by maintaining the corneal thickness and 
structure. The stroma consists of keratocytes, collagen fibrils, and proteoglycans that 
maintains structure. Collagen fibrils consist predominately of collagen molecules type 
I, type V and type VI arranged in a pack known as lamellae (Fini and Stramer, 2005). 
Proteoglycans along with collagen arrangement allow the transmission of light 
(Chakravarti et al., 1998, Connon et al., 2003, Liu et al., 2003). Keratocytes are 
dormant cells of neural crest origin distributed thinly between the collagen lamellae 
(Muller et al., 1995). Their key function is to maintain the corneal transparency 
through the secretion of alpha crystalline proteins that can increase cellular tolerance 
to stress and prevent denatured proteins precipitation (Jester et al., 1999a, 
Augusteyn, 2004). Keratocytes also restore the stroma upon injury by differentiation 
into a fibroblastic phenotype that can migrate and proliferate at the injury site. The 
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replication of keratocytes leads them to lose their morphological characteristics and 
become differentiated fibroblasts both in vivo and in vitro. Fibroblasts were found to 
secret non-transparent extracellular matrix (ECM) proteins (Funderburgh, 2005). 
They also produce matrix metalloproteases (MMPs) that are responsible for stromal 
remodeling throughout wound healing. Authors stated that these fibroblasts cultured 
in vitro could exhibit similar properties to primary keratocytes when cultured with low-
mitogen or serum-free media (Gouveia and Connon, 2013). The ECM contains 
collagen types I and V, MMPs, and glycosaminoglycans (GAGs), where keratin 
sulfate is the predominant GAG. Dermatan sulfate is the predominant GAG 
anteriorly, whereas keratin sulfate found posteriorly and is much more hydrophilic 
(Muller et al., 2001).  
 
1.3.3 Dua’s layer 
According to a study by Harminder Singh Dua’s group, a sixth layer found in 
the cornea located between the stroma and Descemet’s membrane (Dua et al., 
2013). Dua’s layer is strongly impermeable to air and 15µm in thickness. Many 
researchers believed that this layer is part of the stroma (McKee et al., 2014). A 
recent clinical study found this layer in a 74-year-old patient with persistent corneal 
edema (Dua and Said, 2016). The authors suggested that Dua’s layer is formed of 
collagen I and VI. Its exact function, however, is still unknown.  
 
1.3.4 Descemet’s membrane 
Descemet’s membrane is in constant regeneration via the endothelium cells 
to form a thick basement membrane between the endothelium layer and the stromal 
layer (Gipson and Joyce, 2000). Descemet’s membrane is composed of collagen IV 
and VII (Gandhi and Jain, 2015). This membrane is softly attached to the stroma, 
thus can be easily removed (Anwar and Teichmann, 2002). The main function of 
Descemet’s membrane is its ability to exchange fluids and nutrients between the 
cornea and the rest of the eye.  
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1.3.5 The endothelium layer 
The endothelium is composed of a single layer of squamous epithelial cells. 
This layer is essential for the corneal hydration via controlling water content in the 
stroma. This ability directed by the ion transport system (endothelium pump), that is 
vital for transparency (Waring et al., 1982). Endothelial cells are not able to 
regenerate, thus a reduction or damage to this layer leads the remaining endothelial 
cells to stretch to maintain their function. This stretching, however, leads to a loss in 
morphology, thus affecting their deturgescence ability (Stiemke et al., 1991).  
 
1.4 Corneal wound healing  
1.4.1 Corneal epithelium wound healing 
Many wounds can affect the cornea, such as chemical burns, laceration, or 
abrasion. These injuries can either be simple to heal where no scar may form i.e. 
surface abrasions that cause blur in vision or deep abrasion and lacerations that 
could form scar tissue and lead to blindness. Once an injury occurs it activates the 
extracellular matrix (ECM) proteins and growth factors (GFs) that would induce the 
healthy cells to migrate, proliferate, and adhere (Figure 1.4). The healing procedure 
includes (i) an increase in the metabolic activity and actin filament polymerisation 
and reorganisation of the basal layer (Anderson, 1977). The cells at the wound 
edges start separating and thickening while the wound site is cleared from damaged 
and dead cells (Brewitt, 2009, Kuwabara et al., 1976, Crosson et al., 1986, Ljubimov 
and Saghizadeh, 2015). Polymorphonuclear (PMN) leukocytes a type of white blood 
cell that travels through the tear film to the wound, to form a temporary monolayer, 
that will disappear upon epithelial cell migration (Kuo, 2004, Robb and Kuwabara, 
1962, Pfister, 1975); (ii) Cells begin flattening, spreading and migrating as a sheet 
from the wound edges, enveloping the exposed surface until it is closed (Kuwabara 
et al., 1976). Energy is essential for the cells to start migrating; therefore, there is an 
increase in the glycogen metabolism and production of proteins and glycoproteins, to 
serve as an energy source (Gipson and Kiorpes, 1982). A key player in the migration 
process is the actin filaments rearrangement and the appearance of lamellipodia and 
filopodia (Buck, 1985, Dua and Forrester, 1987, Dua et al., 1993); (iii) The basal 
epithelial cells at the limbus start proliferating, migrating, and dividing to produce 
TAC to become differentiated cell while moving towards the wound site, to restore 
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the structure and intercellular junction of the epithelium (Cotsarelis et al., 1989); (iv) 
cell adhesion, where newly regenerated epithelial cells restore the layer to its original 
state and form anchoring and cells-to-cell contact.  
 
 
Figure 1.4 – Corneal epithelial wound healing. Upon injury, various cytokines and 
growth factors released to mediate wound healing. Stromal keratocytes produce 
hepatocytes growth factor (HGF) and keratinocytes growth factor (KGF). Epithelial 
cells secret Interleukin-1 (IL1) and platelet-derived growth factor (PDGF) to start 
stromal injury response. Transforming growth factor β (TGFβ) and epidermal growth 
factor (EGF) takes part in epithelial and stromal wound repair (Wright et al., 2012). 
 
1.4.2 Corneal stromal wound healing 
Deep injuries that affect the stroma initiate healing responses of both 
epithelial and stromal cells (Figure 1.5). The injury repair starts with Interleukin-1 
alpha (IL-1α) secretion by the wounded epithelium (Wilson et al., 2003). This triggers 
some of the surrounding keratocytes to undergo apoptosis (Wilson et al., 2003), 
while others activate to proliferate and secrete matrix metalloproteinases (MMPs). 
The epithelial cells secrete transforming GFs (TGFβ2) into the stroma, to direct 
keratocyte subpopulations to transform into myofibroblasts that secrets ECM (Jester 
et al., 1999a). The quiescent keratocytes switch to fibroblastic phenotype, which is 
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capable of fibrous production and tissue remodeling (Fini and Stramer, 2005). This 
phenotypic change is hypothesised to be due to the high level of glucose entering 
the stroma, which in normal cases is prevented by epithelial cells (Foster et al., 
2015). Keratocytes only activate when there is a change in the surrounding 
environment. This ability credited to their production source, the cranial neural crest 
cells. The cells at the wound site undergo apoptosis and the neighboring cells 
become active fibroblasts 6 hours post wounding (Wilson et al., 1996), which signals 
the rest of the cells to start migrating to the injury site and release MMPs (Malecaze 
et al., 1997). TGFβ2 inhibited when the basement membrane closes, and the 
number of activated myofibroblasts diminishes. The fibroblasts continue to remodel 
the ECM by secreting IL-1α until the stromal layer is back to functioning normally.  
 
Figure 1.5 – Represents the stromal layer wound healing. (A) Upon injury, epithelial 
cells release IL-1α to the stroma that induces the keratocytes at the injury site to 
undergo cell death, whilst adjacent keratocytes undergo proliferation to secrete 
MMPs and become active. Since the basement membrane is open, the epithelial 
cells secret TGFβ2 to induce keratocytes subpopulation to become myofibroblasts 
and secret ECM. (B) The wound healing and the re-formation of the basement 
membrane stop TGFβ2 release and absence of myofibroblasts phenotype. 
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Meanwhile, the active keratocytes keep secreting autocrine IL-1α and ECM 
remodeling (West-Mays and Dwivedi, 2006). 
 
1.5 Corneal injuries and disorders   
1.5.1 Corneal abrasions  
Corneal abrasions are the induction of a scratch on the transparent cornea, 
which causes discomfort, teary eye, and susceptibility to infection. Abrasions can be 
caused by much day-to-day activity, such as paper, debris, sports equipment, etc. 
The treatment is dependent on the severity of the scratch and the cause 
(Saghizadeh et al., 2017). Minor scratches can be treated with eye drops that keep 
the eye moist to allow for the cornea to naturally heal. Other injuries may require 
antibiotics, steroids, and painkillers. Severe injuries can leave a scar that affects 
vision. If errors arise in the cells' natural healing process, scars can occur. The best 
method used until now with a 90% success rate for corneal healing is a corneal 
transplant. The limitation affecting this therapy is the donor supply, and in some 
cases, rejection may occur. 
 
1.5.2 Chemical burns  
Chemical burns are one of the most common causes of corneal injuries. The 
severity of the burn can vary from minor burns that affect the corneal surface to more 
severe burns that penetrate deep into the corneal layers causing inflammation, haze, 
vascularization, and epithelial damage (Singh et al., 2013, Vaidyanathan et al., 
2019). Treatment depends on the severity, where alkali burns are the most 
dangerous compared to acidic burns (Bizrah et al., 2019b, Bizrah et al., 2019a). 
Current research is employing different methods of cell and gene therapies. Stem 
cells hold great promise in the fact they are naturally occurring undifferentiated cells. 
These cells reside in many types of tissues in the quiescent form. Stem cells activate 
when there is an external signal produced by the injured cells. Natural scaffolds can 
be used to maintain the cells, which allow for the cells to be immobilized and 




1.5.3 Keratoconus  
Keratoconus (KC) is a bilateral and asymmetrical corneal disorder 
characterized by thinning of the corneal stroma, which results in corneal protrusion 
that leads to myopic shift and astigmatism (Romero-Jimenez et al., 2010, Zadnik et 
al., 1996, Zadnik et al., 2002). It is considered a multifactorial disorder caused by 
environmental and genetic factors (Bawazeer et al., 2000, Wachtmeister et al., 2009, 
Fabre et al., 2009). Although KC considered a non-inflammatory disease, 
inflammatory factors including IL and MMPs have a role in its development 
(Balasubramanian et al., 2012, Lema et al., 2009, Kaiserman and Sella, 2019). KC 
treatment depends on the severity of the disease, ranging from spectacles and 
contact lenses to keratoplasty in severe cases.  
 
1.5.4 Limbal stem cell diseases  
Limbal stem cell deficiency (LSCD) alters the function of stem cells at the 
limbus, which leads to failure in the limbal barrier, causing a malfunction in corneal 
epithelial healing and reduction in corneal transparency (Ahmad et al., 2010). To 
address this problem, several investigations were made, including the transfer of 
healthy LSCs, either limbal autograft or limbal allograft (Pellegrini et al., 1997, 
Koizumi et al., 2002). However, there is a risk in both these methods where the 
healthy eye may develop pathogenesis LSCD caused by medical treatment or 
examination due to the size of the insert that must be taken and inserted (Liang et 
al., 2009). To overcome this problem, LESCs have been isolated and used to 
reconstruct the damaged cornea (Figueiredo et al., 2004, Fernandez-Buenaga et al., 
2018). Although novel therapies are emerging such as Holoclar® (Pellegrini et al., 
2018), conjunctival limbal autograft (CLAU) (Kheirkhah et al., 2008), cultivated limbal 
epithelial transplantation (CLET) (Sacchetti et al., 2018), simple limbal epithelial 
transplant (SLET) (Sangwan et al., 2012), and amnion-assisted conjunctival 
epithelial redirection (ACER) (Dua et al., 2017), they have limitations (Dong et al., 
2018, Shanbhag et al., 2019). 
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1.6 Mesenchymal stem cells and their therapeutic potential   
Adult mesenchymal stem cells (MSCs) can be extracted from various tissues, 
including brain (Gonzalez-Perez, 2012, Siebzehnrubl et al., 2011), lung (Summer et 
al., 2007), spleen (Hoogduijn et al., 2007), heart (Messina et al., 2004), bone marrow 
(Peister et al., 2004) and adipose tissue (Bunnell et al., 2008). MSCs are multipotent 
stromal stem cells with the ability to differentiate into adipocytes, osteocytes, 
myocytes, and chondrocytes in vitro (Prockop, 1997, Yang et al., 2018). MSCs are 
spindle-shaped fibroblast-like cells, that can be used as a therapeutic agent or a 
delivery vehicle for therapeutic genes. Their ability to repair the damaged tissues has 
been shown in many diseases including cartilage repair(Satue et al., 2019), bone 
tissue engineering (Lin et al., 2017), diabetes (Pileggi, 2012), liver diseases 
(Tsuchiya et al., 2019), and ischemic heart disease (Klopsch et al., 2018). The 
International Society of Cellular Therapy stated the minimal criteria for defining 
MSCs in vitro are their adherence to plastic substrates, their ability to expand and 
differentiate and the surface markers they express (Table 1.1) (Dominici et al., 
2006). A rich source of MSCs is the adipose tissue, via liposuction, where each year 
countless liposuction surgeries performed that yield a large range of lipoaspirate 
tissue (Alstrup et al., 2019, Schneider et al., 2017). Compared with MSCs, 1g of fat 
contains 500 times more stem cells compared to 1g of bone marrow MSCs. Hence, 
ASCs hold great experimental potential.  
 
Table 1.1 – Markers used to characterize and isolate MSCs in culture as positive or 
negative expression. These markers depend on the source of MSCs (Data compiled 


















MSCs characteristics that make them a suitable therapeutic agent are their 
ease of isolation, in culture expansion, plasticity to plastic, paracrine production, 
regulation of inflammatory and immune responses, immunosuppressive, 
migration/reaction to site of injury, ethical concerns and usage in allogeneic 
transplantation (Chu et al., 2019, Si et al., 2019). Several factors work together to 
initiate wound healing, i.e., GFs and ECM proteins. A growing body of literature has 
shown the importance of MSCs in wound healing and their involvement in all phases 
of wound response (Figure 1.6). In the inflammation phase, MSCs decrease 
interferon-y (IFN-y) and pro-inflammatory cytokines (TNF-a), whilst increasing anti-
inflammatory cytokines IL-4 and IL-10 (Aggarwal and Pittenger, 2005, Newman et 
al., 2009, Singer and Caplan, 2011). They have an anti-microbial ability where they 
secret IL-37 and immune factors that control phagocytosis and bacterial removal 
(Krasnodembskaya et al., 2010, Mei et al., 2010). The improvement and healing of 
tissue are regulated with MSCs paracrine factors production and differentiation 
(Saeedi et al., 2019). Research showed the main mechanism responsible for wound 
healing by MSCs is their paracrine signaling, and the differentiation is only 
secondary to that (Gnecchi et al., 2008, Duran et al., 2013, Regmi et al., 2019). 
These GFs productions were proven by examination of MSC-conditioned 
medium (MSC-CM), which showed MSCs to release cytokines, GFs and 
chemokines, i.e. bFGF, VEGF, EGF, PGDF, TGF-B and KGF for tissue repair (Chen 
et al., 2014, Chen et al., 2008, Jun et al., 2014, Sagaradze et al., 2019). In vitro, 
MSC-CM showed to behave as chemo-attractant for epidermal keratinocytes, 
macrophages, endothelial cells, and fibroblasts (Gurtner et al., 2008, Hocking and 
Gibran, 2010, Hwang et al., 2018). It has been shown that MSCs or their CM could 
enhance wound healing by enhancing the dermal fibroblasts and secreting mitogens 
to stimulate keratinocytes, endothelial cells, and fibroblasts proliferation in vitro 
(Smith et al., 2010, Rodriguez-Menocal et al., 2012). From the presented data, 
MSCs are shown to release GFs that stimulate cell migration and proliferation in 
response to wounds via HGF and VEGF secretion, whilst maintaining a balanced 
level of TGF-β3 and TGF-β1 (Colwell et al., 2005, Cha and Falanga, 2007, Lau et 
al., 2009).  
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Figure 1.6 – The role of mesenchymal stem cells in wound healing phases. 
Abbreviations: interleukin, IL; hepatocyte growth factor, HGF; matrix 
metalloproteinase MMP; keratinocyte growth factor, KGF; platelet-derived growth 
factor, tissue inhibitor of metalloproteinase, TIMP; PDGF; transforming growth factor, 
TGF; vascular endothelial growth factor, VEGF; tumor necrosis factor, TNF (Maxson 
et al., 2012). 
 
1.6.1 Mesenchymal stem cells in corneal treatment    
The systemic administration and migration of MSCs are directed by the 
presence of intracellular signals, proteases, chemokines, adhesion molecules, and 
chemokines receptors (Chavakis et al., 2008, Wu and Zhao, 2012, Fernandes-
Cunha et al., 2019, Tao et al., 2019). In vivo studies demonstrated the benefits of 
using MSCs in treating corneal wounds. The ability MSCs have on local engraftment 
was proven by the use of alkali burn on rabbit corneas, where it promoted cells 
proliferating, differentiation, and speed of healing (Ye et al., 2006). Systemically 
directed MSCs without engraftment were also found to reduce the corneal 
inflammatory injury via secreting TNF-a (Roddy et al., 2011). Subconjunctival or IV 
administration of MSCs following corneal injury was found to reduce aSMA, IL-1ß, 
and TNF-a expression whilst reducing corneal opacity, thus showing the superior 
efficacy of MSCs (Shukla et al., 2019). One study on a rabbit model investigated the 
alkali-induced oxidative wounding of the cornea using MSCs derived from rabbit 
bone marrow (Cejkova et al., 2013). By either seeding MSCs on a nanofiber 
scaffolds or applying MSCs directly to the cornea and suturing the eyelid for two 
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days. The results showed the superiority of MSCs seeded on nanofibers by 
decreasing MMPs and TNF-a production that lead to increasing of corneal thickness. 
A similar study showed the nanofiber to be effective in the treatment of alkali-induced 
wounds (Cejka et al., 2016, Treacy et al., 2014).  
A great amount of research is being conducted into the use of MSCs in KC 
treatment (Mansoor et al., 2019). MSCs ability to release growth factors in response 
to the environment is one of the key therapeutic features of these cells. It has been 
shown that MSCs release HGF, TGF-ß1, PDGF, etc. These factors although not fully 
understood, were found to promote cell migration, proliferation, and extracellular 
matrix protein production (Jiang et al., 2017). ASCs were tested in a pilot clinical trial 
of advanced KC patients, which resulted in vision improvement, production of 
collagen which improved corneal thickness (Alio Del Barrio et al., 2017). In another 
clinical trial, KC patients showed improved corneal transparency when using MSCs 
in treatment (Alio et al., 2019). These studies however need further validation and 
longer follow up. 
 
1.6.2 Multipotent adult stem cells in therapy  
Multipotent adult progenitor cells (MAPCs) were discovered in 2001 at the 
University of Minnesota by Catherine Verfaillie (Verfaillie, 2005). Verfaillie described 
MAPCs as progenitor cells isolated from the bone marrow of adult patients. The cells 
were biologically and antigenically different from MSCs (Jiang et al., 2002, Khan and 
Newsome, 2019). Unlike MSCs, MAPCs are primitive cell population, able to expand 
and double in culture whilst retaining their differentiation potential up-to 80 passages 
to adipogenic, chondrogenic, osteogenic, hepatic, hematopoietic, myogenic, 
neuronal, epithelial and endothelial lineages. MAPCs were also shown to present 
favorable characteristics that are perceived in embryonic stem cells (ESC), however, 
unlike ESC, MAPCs have no ethical concerns since they are isolated from adult 
patients with their consent. Therefore, MAPCs present an encouraging source for 
cell-based therapy, which have been tested in many diseases in vivo, such as acute 
myocardial infarction (Penn et al., 2012), bone repair and myelodysplasia (Martens 
et al., 2017, Roobrouck et al., 2017, Plessers et al., 2016), ischemic stroke (Hess et 
al., 2017), and graft vs host disease (Maziarz et al., 2015). It has been shown that 
MAPCs have immunomodulatory effects and are able to release a cocktail of growth 
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factors in response to the wound (Ravanidis et al., 2015, Reading et al., 2013, Carty 
et al., 2018). These, however, have not been tested on the ocular surface or the 
cornea, hence, it is expected MAPCs to have a positive effect on corneal recovery. 
This effect is postulated to be driven by MSC’s ability to produce growth factors, 
including tumor necrosis factor-inducible gene 6 (TSG-6), HGF, and TGF-ß1, among 
other factors.  
 
1.7 Biomaterials for the production of stem cell bandages   
Biomaterials can either be synthetic-based or natural-based materials (Figure 
1.7). Naturally derived materials have frequently been used to substitute lost tissues, 
i.e., prosthetics. In comparison, synthetic-based polymers, metal alloys, and 
ceramics have presented improved performance and reproducible properties (Ratner 
and Bryant, 2004, Huebsch and Mooney, 2009). Biomaterials are defined as induced 
materials to border biological organisms to replace, increase, or treat whichever 
tissue, function, or organ in the body (Williams, 2009). Naturally derived biomaterials 
are gaining much attention recently for their unique inherent biocompatibility.  
Cell encapsulation within the 3D environment is one of the approaches for the 
development of stem cell therapy. It is essential that the encapsulation environment 
is biocompatible with the cells. Ideally, the environment would be similar to the cells 
in vivo original tissue, for the cells to present the same behaviour in vitro and when 
transferred to a patient (Nicodemus and Bryant, 2008, Kachouie et al., 2010). 
Therefore, for the stem cell bandages approach, choosing the right biomaterial is a 
key to cell encapsulation and transplantation. A biomaterial should (i) maintain cell 
survival from days to weeks, (ii) prevents cells aggregation, (iii) aid integration into 
the host, (vi) control differentiation, whilst (v) allowing nutrients to reach the cells, 






Figure 1.7 – Types of synthetic and natural-based biomaterials 
 
1.7.1 Sodium alginate properties    
 Sodium alginate is a natural non-toxic water-soluble biopolymer, extracted 
from brown seaweed with a molecular formula of C6H7NaO6 and molecular weight of 
216.12g/mol. Alginate is considered one of the safest biomaterials that have been 
used, it is inexpensive and is available in large quantities. Alginate is considered to 
be a mucoadhesive biocompatible substance that can help maintain and support the 
vitality and growth of tissues in vitro (Gombotz, 1998). Simple cross-linking with 
cations can make alginate solidify. Their structure is similar to ECM of living cells; 
this allows them to be used widely for clinical applications as delivery vehicles 
(Ashimova et al., 2019). Alginate hydrogels are linear anionic polysaccharide that 
consists of repeated units of β-D-mannuronic acid (M) and α-L-guluronic acid (G) 
positioned in a homo-polymeric block (Figure 1.8). Alginate properties are dependent 
on the G and M residues sequence composition, which is highly dependent on the 
algae source, and in turn, the G/M ratio of the alginate determines the quality of the 
microcapsules (Tonnesen and Karlsen, 2002). Alginate hydrogels are mostly 
prepared as a result of the chemical and physical polymer chains crosslinking. The 
physicochemical characteristics of the hydrogels depend on the monomers 
crosslinking contents, distribution, density, molecular weight, as well as the presence 



















microenvironment, prevents bacterial infection, and enables wound regeneration 
(Hay et al., 2013, Bochenek et al., 2018). It can be used for a controlled release of 
drug molecules ranging from small chemicals to large proteins depending on the 
cross-linking method and type (Kong et al., 2004b). Moreover, the administration of 
alginate into the body can either be orally or by injection. Therefore, the use of 
alginate in cell transfer and transplantation to deliver cells to the injury site is a 




Figure 1.8 – Alginate hydrogels structure. It is composed of two Uronic acids, the 
Mannuronic acid (M), and the Guluronic acid (G). Three types of polymer segments 
formed, the M only blocks, the G only blocks and the M&G blocks. The difference in 
the M/G ratio and the block configuration results in different alginate functionality and 
properties in gelling and strength. This is dependent on the seaweeds species, 
location, season, and part. (http://www.kimica-
alginate.com/alginate/chemical_structure.html).   
 
The gelation of alginate hydrogels occurs upon the ionic cross-linking with the 
cations, the interaction of the sodium ions originates from the G blocks with the 
divalent ions such as calcium and magnesium ions (Ca2+, Mg2+) to produce an “egg-
box” structure (Grant et al., 1973, Zimmermann et al., 1992). The gel three-
dimensional network can form upon the interaction of every chain with various other 
chains; these types of gels can contain water up to 95% and can be treated with heat 
without melting (Kong et al., 2004a). Alginate gels that contain a large number of G 
residues are strong, stable, and more porous than the ones with M blocks. It has 
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been stated in previous researches that the higher the G content of the alginate the 
stronger the prevention of solute transport, and in reverse, the higher the M content 
in the gel the weaker and more elastic it becomes (Zhao et al., 2010). 
 
1.7.2 Alginate encapsulation in therapy   
Transplanting cells is an attractive method to promote healing of the ocular 
surface, especially when the host cells can respond to the released signals. In a 
study, MSCs have been encapsulated in alginate-PLL for extended periods where it 
showed stable cell proliferation and viability; spread cells, with stem cells properties 
(Goren et al., 2010). This study showed the alginate-encapsulated cells did not affect 
MSCs properties. Another investigation on the storage of alginate encapsulated 
MSCs in hypothermic conditions, where it resulted in no change in cell function 
following 3 days of storage (Swioklo et al., 2016). Therefore, encapsulating MSCs in 
alginate hydrogels show a promising method of cell therapy, which can improve the 
biocompatibility and long-term transportation of stem cells bandages. 
Alginate has been investigated as a biomaterial for biological use due to its 
proven biocompatibility, low cost, speed of gelation when crosslinked with calcium 
ions, and low toxicity (Sun and Tan, 2013, Augst et al., 2006). Alginate as bandages 
was found to prevent wound dehydration, reduce infection, and initiate wound 
recovery (Aderibigbe and Buyana, 2018). Alginate therapy tested for the treatment of 
gastroesophageal reflux disease where it showed improvements in the symptoms 
(Leiman et al., 2017, Bor et al., 2019). Alginate can be administered orally or injected 
into the body without causing side effects, thus, it is important in many 
pharmaceutical applications (Bidarra et al., 2014). Cell therapy is looking into 
delivering functional cells into the injury site to replace or induce the production of 
paracrine factors (Kim, 2013). Alginate as a wound dressing material maintains a 
moist environment, reduce bacterial infection, and induce wound healing. Alginate 
has also been tested in tumor therapy, where authors loaded arsenic trioxide to 
alginate that resulted in toxicity reduction (Lian et al., 2019).  Depending on the 
cross-linker used, alginates can be controlled in releasing drug dosage inside the 
wound, which makes them appealing for pharmaceutical applications (Lee and 
Mooney, 2012). For this, alginate hydrogels can be used to deliver cells into the 
injury site to induce the resident cells in regenerating the tissue. (Grøndahl et al., 
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2020) Alginate hydrogels have been used in cultivating corneal endothelial and 
limbal stem cells, where it suggested that alginate can aid in corneal regeneration 
(Wright et al., 2012, Liang et al., 2011). It has also been found that alginate 
maintains ASCs viability and functional ability during short-term hypothermic storage 
(Swioklo and Connon, 2016, Swioklo et al., 2016). This ability of alginate is a key 
feature in the formation of stem cells bandages (Varaprasad et al., 2020). As such, 
alginate showed prominence in wound dressing.  
 
1.8 Hypothermic storage effect on viable cell recovery  
 To develop stem cell therapy the final product must be tested and approved by 
the regulatory authorities. The absence of contamination is a key step in the 
formation of the final product (Galvez et al., 2014, Coopman and Medcalf, 2014). 
Sterility testing is another aspect that must be tested when storage is involved (Use, 
2017). Transporting therapeutic cells from the laboratory to the patient is an 
important consideration for successful therapy (Petrenko et al., 2019). Hydrogels 
able to maintain cells hydrated state resist physiological damage while preventing 
cell release into the wound bed. Transporting the bioactive material require storage 
at a specific temperature. An important aspect is that the storage must not harm the 
cell, i.e. reduce cells function and viability. Thus, it is vital to test different storage 
temperatures to find a suitable storage condition.  
 
1.9 Cell therapy delivery and limitations  
An important aspect of cell therapy is the delivery of therapeutic cells to the 
injury site without losing their viability and functionality. Current delivery systems, 
such as systemic and intradermal injections have limitations of cell loss (Li et al., 
2015, Lukomska et al., 2019). During cell migration to the injury site most cells will 
be trapped in the spleen, kidneys, and lungs while injecting a large number of cells 
could solve this issue, it could result in low engraftment efficacy due to fast diffusion. 
Another method is to transfer cells directly to the injury site; however, this method 
can cause differentiation to the transferred cells which leads to loss of function. 
Therefore, trapping cells within a functional material presents a solution, where the 
cells maintain their phenotype, viability, and most importantly, are able to release 
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therapeutic factors from within the scaffold. It has been found that sodium alginate, a 
material used in wound dressing (Wang et al., 2016), protein, and cell immobilization 
(Schmitt et al., 2015) are able to trap MSCs while maintaining their viability. Cell 
storage is also one of the important aspects to consider in transferring therapeutic 
cells to the clinic, which should maintain cell viability and function during storage and 
transfer to induce wound recovery. Previous studies from Prof. Connon’s lab has 
found that entrapping MSCs within sodium alginate maintains their viability and 
functional recovery following hypothermic storage for a period ranging from days to 
weeks (Chen et al., 2013, Swioklo et al., 2016). They also show that MSCs in 
suspension had the highest recovery rate following storage at 15°C compared to 
cells stored in the same condition without alginate. Therefore, alginate presents a 
safe, low-cost method of preserving cells for up-to several weeks without losing their 
viability or function, which gives enough time to transport the cells from the 
manufacturing site to the clinic. 
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1.10  Research aim and hypothesis  
We are interested in the formation of bioactive, biocompatible, and cost-
effective stem cell-based bandages capable of stimulating the wound repair process. 
Hence, the main aim of this project is the formation of stem cells bandages. These 
bandages formed using sodium alginate to encapsulate adipose-derived stem cells 
(ASCs) to speed the migration/healing of human corneal wounds. To address this, 
we chose ASCs as the main therapeutic cells. ASCs can be extracted in large 
numbers, hold no ethical concerns, and showed to produced paracrine factors that 
aid in wound healing (Si et al., 2019, Yang et al., 2010). we also chose sodium 
alginate as the main carrier material. Alginates are present in nature and extracted 
from brown seaweed, calcium alginates are used in enzyme immobilizing, 
food/cosmetic manufacture and in wound dressing. Generally, this material is safe, 
cost-effective and widely used in biomedical due to its biocompatibility, and ease of 
handling (Lee and Mooney, 2012). Within the thesis, we used a standard scratch 
assay to assess the effect of stem cell bandages in a co-culture. The therapeutic 
effects of ASCs bandages formed in sodium alginate investigated on corneal stromal 
cells and corneal keratoconus. Their effect was tested following hypothermic 
storage. Moreover, we evaluated the conditioned media produced from the 
bandages in scratch healing. Following which, conditioned media tested for soluble 
protein concentration using Bradford assay, ASCs production of paracrine factors 
were tested using qPCR and an XL cytokine array kit (such as HGF, TGF, and 
VEGF) and corneal cells tested for collagen production using Sirius red staining. On 
the other hand, MAPC bandages were used and compared to ASCs in wound 
healing. Lastly, an animal study using corneal chemical burn was performed as a 
proof of concept of ASCs bandages. ASCs bandages improved corneal stromal and 
keratoconus cells scratch wound healing via the production of paracrine factors. 
ASCs' ability to influence a secondary population was shown whilst within the 
bandage. ASCs were found to produce paracrine factors (i.e HGF, EGF, TGF-ß) 
following hypothermic storage. ASCs bandages also improved in vivo corneal 
chemical wound healing whilst reducing immune cell infiltration. Thus, shown the 






Chapter 2. Materials and methods  
 
2.1 Cell culture and isolation 
2.1.1 Isolation of human corneal stromal cells 
The corneal ring is referred to as the transparent cornea with the conjunctiva 
cut in a ring shape from the eye for research. Human Corneal rings were collected 
from healthy cadaver donors as grafting procedures by-products, kindly provided by 
Prof. Francisco Figueiredo (Royal Victoria Infirmary, Newcastle Upon Tyne, UK). The 
rings obtained following an informed approval according to Newcastle University and 
Newcastle Upon Tyne Hospital Trust Research Ethics Committees guidelines. The 
rings were collected and delivered to the lab within 30 days post mortem, 
(male/female, with age range +/- 70 years old). The corneas were stored and 
maintained in a medium with nutrients to keep the cornea fresh in glass flasks. Upon 
receipt, the corneal ring flasks were maintained at room temperature until further 
use.  
Corneal explants were minced using sterile blade and forceps in a DMEM: F12 
digestion medium. Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12 
(DMEM: F12) (ThermoFisher Scientific, Cramlington, UK) is a high glucose medium 
contains GlutaMaxTM -1 with phenol red. The basal media is supplemented with 5% 
Fetal Bovine Serum (FBS) (ThermoFisher Scientific, UK) and 1% penicillin-
streptomycin (ThermoFisher Scientific, UK). This media composition is the basic 
corneal stromal cell extraction and expansion media termed ‘5% media’ in all of the 
subsequent experiments.  
 For the extraction of corneal stromal cells (i.e. corneal fibroblasts) (CSF) 
(Diagram 2.2), the minced explants were incubated with digestion media containing 
2mg/mL (450units/mL) collagenase type I (ThermoFisher Scientific, UK) powder 
dissolved in 10mL of the 5% media and sterilised via filtering in a sterile Sartorius™ 
Minisart™ syringe filters, with 0.2μm pore size and 26mm diameter (Sigma-Aldrich, 
St. Louis, Missouri, UK). The explants were transferred into a 15mL centrifuge 
conical tube (Sigma-Aldrich, UK) along with the digestion media, and placed inside 
the incubator set at 37°C and under constant rotation for 5 hours.  
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Collagenase type I is a key enzyme in digesting corneal tissues to allow for 
CSF extraction. Whilst the rotation of the tissues in the falcon-tube prevents the 
explants from settling at the bottom of the tube, which otherwise may block the 
enzyme infiltration and in turn stops CSF extraction. 5 hours following incubation, the 
medium that now contains CSF along with the enzyme-digested explant were filtered 
via sterile EASYstrainerTM cell strainer with 40μm pore size (Sigma-Aldrich, UK) into 
a 50mL centrifuge conical tube (Sigma-Aldrich, UK). Cell strainer only allows for cells 
to pass throw the filter and so separate cells suspension from the minced corneal 
explant. The cell suspension was diluted with 0.25% trypsin-EDTA solution (Sigma-
Aldrich, UK) in a 1:1 ratio that was also passed through the strainer, to increase the 
retrieval of cells that did not pass through the strainer. Trypsin functions to cleave C-
terminal peptides of lysine and arginine residues while EDTA acts as a chelating 
agent to prevent any blockage of the trypsin activation via chelation of magnesium 
and calcium ions. Therefore, this enzyme will dissociate cells aggregation in the 
medium and prevent their clumping. A cell pellet was obtained after 5 minutes 
centrifugation at 1500xg and resuspended with 1mL 5% media. Cells in suspension 
were then transferred into a vented cell culture flask with a surface area of 75cm2 
(Sigma-Aldrich, UK), assigned passage number 0, and incubated at 37°C. in CSF 
basal media. The media was changed 3 times a week to remove dead cells and cell 
waste and add fresh nutrients. Upon confluency (typically at 70%), the cells were 
further passaged (as described in section 2.2.2) and used for subsequent 
experiments. 
 
2.1.2 Human keratoconus fibroblasts culture 
Human keratoconus cell (KC) cultures were received from Dr. Dimitrios 
Karamichos (University of Oklahoma Health Sciences Centre, Oklahoma City, USA).  
These primary cell cultures were previously isolated from patients (n = 4) with 
Keratoconus disorders with Dr. Karamichos’ lab as previously described 
(Karamichos et al., 2012). Cells were received in cryovials containing 1 x 106 
cells/mL at which point they were defrosted and subsequently expanded in DMEM: 
F12 medium supplemented with 10% FBS and 1% penicillin-streptomycin. The 
primary culture of KC cell lines was used up to passage 5 in the subsequent 
experiments.   
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2.1.3 Human adipose-derived stem cells culture 
StemProTM human adipose-derived stem cells (ASCs) (Invitrogen, 
ThermoFisher, UK) were commercially purchased. The cells were isolated from 
lipoaspirate tissues of healthy donors. The primary cell cultures were expanded for 
one passage and cryopreserved in 20% DMSO and MesenPRO medium. 
MesenPRO RSTM Medium (ThermoFisher, UK) is a specific medium for human 
mesenchymal stem cell growth. The basal medium is formulated with a reduced 
serum of 2% and supplemented with MesenPRO RSTM growth supplement 
(ThermoFisher, UK) manufacturer defined, 2% antibiotic-antimycotic (100X) 
(ThermoFisher, UK) and 1% GlutaMAX (100X) (ThermoFisher, UK). The antibiotic-
antimycotic solution prevents bacterial and fungal formation and so prevents cell 
culture contamination. GlutaMAX improves cell growth and viability and reduces 
toxic ammonia accumulation. The supplied ASCs were tested for viability, sterility, 
mycoplasma contamination, human pathogen contamination, and purity by the 
supplier. In the lab, the cells were tested for their differentiation potential in vitro to 
adipocytes, osteoblasts, and chondrocytes.  
The primary cell line of ASCs used in the following experiments originates from 
lipoaspirate surgery of a 43 years old female, the abdomen of a 45 years old female, 
and the abdomen of a 63 years old male donors. Each of the donor’s cells was 
provided with a certificate of analysis (including viability, sterility, mycoplasma, a 
human pathogen, and purity tests) and confirmed to be ASCs, and they meet the 
requirements for research. The cells were shipped in cryovials in a sealed container, 
each vial contained 1 x 106 cells in 1mL MesenPRO medium. Upon receiving the 
vials, the cells were expanded to produce a working stock cell, then split and frozen 
in separate vials, where each vial contains 1 x 106 cells/mL and stored in liquid 
nitrogen until needed.  
 
2.1.4 Human dermal fibroblast culture  
Human dermal fibroblasts (hDF) were purchased from Gibco (Invitrogen, UK). 
Cells were received in cryovials containing 1 x 106 cells/mL at which point they were 
defrosted and subsequently expanded in DMEM: F12 medium supplemented with 
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10% FBS and 1% penicillin-streptomycin. The cell cultures of hDF cell lines were 
used up to passage 5 in the subsequent experiments.   
 
2.1.5 Human multipotent adult progenitor cells culture 
Human multipotent adult progenitor cells (MAPCs) are a primitive cell 
population isolated from adult patients, they can expand up-to 80 passages without 
losing their phenotype. They were found to present favourable characteristics that 
are shown in embryonic stem cells, with no ethical concern, which makes them 
favourable in cell therapy.  MAPCs were received in association with ReGenesys 
(Heverlee, Belgium). The cells were stored in cryovials containing 10 x 106 cells/mL 
with Xeno-free media. Xeno-free media (XFM) (XF MAPC medium, GeGenesys, 
Belgium) is animal free-origin medium supplemented specifically for MAPCs survival 
and growth in culture by the collaborator. The primary cell line received were labelled 
as passage 1 and expanded in CellBIND tissue culture plastic (Sigma-Aldrich, UK) 
as recommended by the supplier. MAPCs cultures were used up to passage 2 in the 
subsequent experiments. 
 
2.2 Cell cultures detachment 
Cell dissociations were performed as follows; media that was original with the 
cells were removed, and cells washed with sterile phosphate-buffered saline (PBS) 
(ThermoFisher, UK). PBS is a balanced salt formulated without magnesium, calcium, 
or phenol red, therefore, it is effective in removing chelators from cell cultures. PBS 
is mainly used for washing cells prior to detachment, they are supplied as tablets and 
each tablet is dissolved in 500mL ultrapure distilled water followed by autoclaving. 
Following PBS wash and removal, TrypLETM Express Enzyme (1X) (ThermoFisher, 
UK) was added to cover the cells layer and incubated for a maximum of 10 minutes 
at 37°C at which point the individual cells rounded up and started floating. TrypLETM 
Express is a recombinant enzyme, animal-origin free, highly purified, with EDTA as a 
chelating agent that mainly cleaves C-terminal peptide bonds of lysine and arginine. 
5% of media was then added to wash the remaining cells with gentle pipetting until 
all cells were in suspensions. The cell suspension was then transferred into a 15mL 
conical tube and centrifuged for 5 minutes at 1500xg. The supernatant was then 
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discarded and the cell pellet was resuspended in 1mL media and cultured in a 
vented cell culture flask and assigned an increased passage number (i.e. p1, p2) to 
prepare for further studies. 
 
2.3 Cell counting and viability assessment  
Countess II FL Automated Cell Counter (ThermoFisher, UK) was used to give 
accurate and quick results of cells number. Cell Counting Chamber Slides Kit 
(ThermoFisher, UK) was used to count the cells. The kit contains 2mL Trypan Blue 
solution 0.4%, which usually used to determine cell viability employing the dye 
exclusion test. This test centered on the concept that lives cells do not allow the dye 
to penetrate inside and only dead cells will be dyed. The kit also contains counting 
chamber slides, which designed specially to work with the Countessâ. To count cell 
number 10µL of cells resuspension was mixed with 10µL of trypan blue dye and 
transferred inside the slide chamber for counting. The Countessâ gives results of the 
total number of cells, viable cells, dead cells, and their percentages. For the 
expansion and growth of cell cultures in culture flasks, corneal CSF and KC were 
seeded in a density of 6 x 103 cells/cm2 and ASCs seeded in a density of 8 x 103 
cells/cm2, while MAPCs seeded in a density of 2 x 103 cells/ cm2, all of which were 
suggested by previous work. 
 
2.4 Corneal cells plating in serum-free media in preparation for subsequent 
experiments  
Corneal cells plating took place after reaching 80 - 90% confluency, during 
passages 1 - 4. CSF and KC cultures were plated in a Multidish Nunclon 6-well plate 
132 x 88mm (ThermoFisher, UK). CSF and KC were seeded in a density of 2.5 x 105 
cells/well and cultured in 5% media for 24 hours, followed by 72-hour incubation with 
standard media (serum-free DMEM: F12 supplemented with 1 x 10-3 M L-Ascorbic 
acid (Sigma-Aldrich, UK), 1:100 Insulin-Transferrin-Selenium (ITS-G) (Invitrogen, 
UK) and 1% penicillin/streptomycin). Serum-free media (SFM) induce CSF to their 
inactive format, termed ‘CSC’.  
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2.5 ASCs plating in a transwell 
To measure ASCs' effect on a secondary population, ASCs were plated on a 
transwell and cultured with CSC in a 6 well plate. Two different methods were used 
to handle ASCs, (i) 5x 105 cells were plated directly on a transwell and incubated for 
two hours at 37°C and 5% CO2 to allow cell attachment. (ii) 1 x 106 cells were 
stored in suspension at 4°C and 15°C for 72 hours in cryovials with 1 mL SFM. 
Following recovery from storage, the cells were resuspended, counted, and 
incubated on a transwell membrane at 37°C for 2 hours to allow cell attachment. 
Following this, membranes were washed gently and used for a scratch assay 
experiments. 
 
2.6 Preparation of stem cells bandages  
Stem cell bandage formation took place after reaching >90% confluency, 
utilising cell culture passages 3 – 5. Cells were detached using TrypLE enzyme and 
counted using Live/Deadâ Viability/Cytotoxicity Assay (ThermoFisher, UK). 
Live/Dead assay is a mixture of two types of fluorescence dyes, calcein AM stains 
live cells green while ethidium homodimer (EthD-1) stains dead cells red. These 
probes recognise cell membrane integrity and intracellular esterase activity, and so, 
calcein AM can be retained inside live cells whereas EthD-1 is retained inside dead 
cells. Live/dead stain is mixed with the cells in suspension at a 1:1 ratio and 
incubated for 15 minutes at 37°C humidified incubator. The mixture is then counted 
using Countess II FL Automated cell counter to determine the number of cells 
required to be encapsulated. A 2.4% (w/v) calcium alginate (NovaMatrix, FMC, 
Norway) working solution was used to encapsulate cells.  
A cell suspension containing 1 x 106 cells in SFM was suspended in a 1:1 ratio 
with calcium alginate solution in a total volume of 0.5mL. The mixture, containing 
calcium alginate ± cells were cast within filter paper moulds (defined below) to form 
the initial encapsulation (Diagram 2.1 A). The alginate ± cells mixture was 
crosslinked with 102mM calcium chloride (Sigma-Aldrich, UK) to form and stabilise 
the bandages. The filter paper moulds (1mm thickness, 24mm diameter) were 
stacked in a doughnut shape and soaked with 0.5mL CaCl2 for two minutes. 
Following initial gelling, the bandage was then transferred to 4ml CaCl2 for a further 
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6 minutes incubation followed by a brief wash with sterile PBS, which resulted in the 
formation of stable alginate bandage ± cells that were transferred for subsequent 
experimental use.  
Following bandage formation, the stabilised bandages were transferred into a 
transparent 6-well insert 0.4µm pore diameter (Greiner Bio-One LTD) and placed 
inside a 6-well plate (Diagram 2.1 B). The plate was then sealed with parafilm 
(Sigma-Aldrich, UK) and placed into a non-ventilated incubator or fridge that 
precisely controlled the external temperature facilitating the storage of cells at a fixed 
temperature of 4°C or 15°C, for three days. The bandages were submerged in a 
3.5mL SFM medium to prevent dryness and allow the diffusion of growth factors 
from the bandage into the surrounding medium.  
The bandages + cells were released via incubation with 3mL of 100mM 
trisodium citrate (Sigma-Aldrich, UK) at room temperature to rapidly dissolve the gel 
(Diagram 2.1 C). PBS was added to the mixture to make-up a final volume of 10mL 
before centrifuging at 1500xg for 5 minutes. Cells pellet was then resuspended with 
0.2mL medium before counting with live/dead stain.  
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Diagram 2.1 – Formation of stem cell bandages. Cells encapsulation, storage, and 
release procedure. (A) Filter paper moulds were stacked in a ring-like shape and 
socked with CaCl2 to cast the already prepared mixture of alginate ± cells for 2 
minutes initial gelation before transferring to a 4mL CaCl2 to stabilise the bandage. 
(B) The stabilised bandage is placed inside a transparent 6-well insert, 0.4µm pore 
diameter and placed inside a 6-well plate and sealed before placing the plate in 
temperature controlling container, to prevent a hasty temperature drop that would 
otherwise kill the cells, the container is then placed in a fridge set at 4°C or incubator 
set at 15°C for 72 hours. (C) The bandages + cells were incubated with citrate at 
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room temperature until dissolved before diluting the mixture with PBS and 
centrifuging for 5 minutes at 1500xg to pellet the cells, cells pellet is then 
resuspended with 0.2mL media before counting with live/dead stain. 
 
2.7 Light microscopy imaging  
Following ASCs release, cells were counted and plated in a 24 wells plate 
(Greiner Bio-One, Austria) at a density of 5000 cells/cm2 with MesenPRO medium 
for 24 hours. Cell morphology assessed using a light microscope (Leica 
Microsystems, Wetzlar, Germany) imaging system at 10x objective magnification. 
Cells phenotype was assessed after storage and release from encapsulation and 
compared to the normal cell culture morphology. 
 
2.8 Flow cytometry  
ASCs were assessed for their immune-surface markers before and after cell 
culture experiments, using positive and negative markers of mesenchymal stem 
cells. Positive surface markers included CD90, CD73, HLA ABC, and negative 
markers include CD45, CD14, and HLA DR (BD Biosciences, Becton Dickinson, 
Franklin Lakes, New Jersey, USA) (Table 2.1).  
Flow cytometry (Diagram 2.2), employs cell sorting procedure, all cells that 
pass through the nozzle get sorted in a single line in the beam. Cells that pass 
through the beam scatter the light forward (FSC) and a side (SSC) scatter light that 
is detected by the detectors. While cells labeled with fluorescent antibodies emit 
fluorescence light to be detected by the detectors. The detectors detect and analyze 
the cells as they go through the beam. The forward scatter relates to the cell size, 
while the side scatter relates to the cell density i.e. membrane size and cytoplasmic 
granules number. Therefore, when using this technique, cells can be sorted and 
diluted in enough media to be in a single cell and not clumped or aggregated.  
Sample preparation for direct immunofluorescence staining was as follows; 
cells were harvested and counted for a total of 120,000 cells in 0.1mL PBS in a 
microcentrifuge tube. Cells were incubated with 10µL markers mix of CD90 FITC & 
CD72 PE, CD45 FITC & CD14 PE, HLA-ABC & HLA-DR, IgG2a PE, IgG1 FITC & 
IgG1 PE in the dark at room temperature for 20 minutes. The microcentrifuge tubes 
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were centrifuged at 1500xg for 5 minutes, discarded supernatant leaving 10-20µL 
and resuspended with 0.1mL PBS, followed by filtration using 30µM cell filters into a 
FACS tube (Flow Cytometry Core Facility, Newcastle University, UK) to remove cell 
aggregation or clumps. Lastly, 0.2mL of PBS was added through the filter to increase 
the volume of cells suspension and to ascertain total cell collection - no cells left in 
the filter - for the following cell reading.  
Flow cytometry BD LSRFortessa™ (BD Biosciences, Wokingham, Berkshire, 
UK) was used to detect cell markers and results were plotted and processed using 
BD FACSDIVA software. In the software, the worksheet was adjusted as follows, 
‘Folder’, ‘Experiment’, ‘Specement’, and ‘Tube’ files were made to save the results. 
In the global worksheet, 2 windows of ‘Dot plot’ Histograms were made to assess the 
forward and side scatters before reading the samples. The Histograms were 
adjusted to read the FITC filter (2-488/530/30-A) and PE filter (2-488/585/42-A). 
Polygon Gates were placed on the FSC-SSC dot plot. Contour Plot was also chosen 
to show cell density, and a Dot Plot for florescent reading was used with a quadrant 
gate. ‘Acquire’ was chosen after placing the sample tube, and the reading was saved 
after 15 seconds for all samples. The following parameters were used for the sample 
readings; voltage FSC 250 and SSC 250, high flow rate 120µL/minute, 10,000 
events to record and 100,000 events to display, and negative isotype controls were 
used to assess the antibody signal, where values of 1.4% were considered optimal.   
 
 
Table 2.1 – Flow cytometry antibody markers used to label adipose-derived 
mesenchymal stem cells. 
 
Antibody Marker type Isotype control
CD 90 FITC Positive IgG1 FITC+IgG1 PE
CD 73 PE Positive IgG1 FITC+IgG1 PE
CD 45 FITC Negative IgG1 FITC+IgG1 PE
CD 14 PE Negative IgG2a PE
HLA ABC FITC Positive IgG1 FITC+IgG1 PE




Diagram 2.2 – Flow cytometry principle. Cell suspension go through nozzle and cells 
get sorted in a single line before light reflects on them, and the labeled cells emit 
fluorescence, whilst forward and side scatters detected from all cells that pass 
through reflecting cell size and density respectively.  
 
2.9 Generation of conditioned media 
We sought to test the Conditioned media (CM) produced by the ASCs to 
assess whether the bandages prevented the cells from releasing paracrine factors or 
if storage temperature had any effect on the number of paracrine factors produced. 
CM that contains all possible secreted factors by ASCs such as exosomes, 
microvesicles, growth factors, and cytokines were collected. CM collected the 
following storage at 4°C and 15°C. The collected CM was centrifuged to remove 
debris and stored at -80°C until use to give an analysis of the level of growth factors 
and cytokines released during storage. ASCs were cultured in a reduced serum 
media until encapsulation, where they were washed a few times with PBS and 
encapsulated in SFM media followed by 3 days storage, thus, we expect no serum 
contamination to have affected our cultures. 
Nozzle
Sheath fluid
Sample labeled with antibodies 
Hydrodynamic Focusing
The cells pass in a single line
Laser light source
Fluorescence emitted from 
labeled cells is detected 
Forward and side scattered light 
is detected from every cells
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2.10 Cell lysis within scaffold  
Cell lysis is the breakage of the cell membrane and the release of cell 
components to the environment. One common method used for cell lysis is freeze-
thawing, which involves freezing cells (in the absence of a cryo-protectant) followed 
by thawing cells at room temperature. This method elicits the cells to swell due to ice 
crystal formation during freezing, which then contracts during thawing, thus, cells will 
break releasing their components into the media (lysate). Following encapsulated 
ASCs storage at 4°C and 15°C, the encapsulated cells were placed at -80°C for two 
hours, to allow for cell lysis within alginate and the release on their components into 
the media for the formation of lysate. Followed by 30 minutes thawing at room 
temperature to allow the bandage to return to room temperature before use in 
scratch-wound. During thawing, the medium incubated with the bandage contains 
the released components of the lysed cells, which is referred to as cell lysate. In the 
following experiments, cells lysis used ± their lysate. 
 
2.11 Mechanical-wound assay 
In vitro scratch assay is the simplest and most economical method to 
investigate cell migration and/or proliferation in response to a physical 
assault/wound. This mechanical wound assay is one of the most common method of 
measuring cells behaviour in vitro. The assay includes the introduction of a physical 
wound to cells confluent monolayer. Mechanical cell scratching offers a simple, cost-
effective method with a variety of approaches used to create scratches such as 
pipette tips. The methods used in the following experiments was created using the 
fine end of a sterile 1mL pipette tip (diameter 1.15mm). The scratches were 
performed on a cell monolayer grown in a 6-well plate (surface area of 9.6cm2) in a 
straight line as shown in Diagram 2.3 c. To standardise scratch formation, we (i) 
used a blue tip to induce the scratch, (ii) used the same area to image the scratch, 
which is the middle of the well, and (iii) measured the same area size using ImageJ 
software.   
Images of the scratches were taken using Iprasense lens-free microscopy (Cap 
Alpha, Avenue de l’Europe, 34830 CLAPIERS, France) 6-well cytonote. The 
cytonote is designed to take time-lapse images of the cells inside the incubator using 
 37 
a holographic reconstruction algorithm. Iprasense holographic microscopy is a live 
cell imaging system that can be used inside the incubator. It has a wide field of view 
(29.4mm2), with LED 650nm light source and a CMSO 10 Mpix sensor, which makes 
it the preferred imaging system for our experiments (Diagram 2.3). Following image 
taken, images were analysed using ImageJ (version 1.49u) software using the 
Polygon selection tool, the cell-free area was chosen and from the Analyze tab, 
plugin Measure used to give a reading of the scratch area in µm. The area values 
were then transferred to a spreadsheet and graphs plotted using Prism 6.0 software. 
Images at the time (t) = 0, 20, 30, and 40-hours post scratch were analysed using 
ImageJ and presented after adjusting the Colour Balance and adding the scale bar 




Diagram 2.3 – Iprasense lens-free microscopy. (A) Lens-free microscopy acquisition 
system, RGB LED and pinhole placed roughly 5cm above the sample where they 
provide illumination. (B) 6-well plate cytonote used to take time-lapse images inside 
the incubator via a holographic reconstruction algorithm, the microscope uses CMOS 
image sensor with image area of 29.4mm2 (6.4 mm x 4.5 mm). (C) The microscope 
allows for the imaging and analyzing of the cells monolayer behavior upon wounding. 
Images (A and B) are taken from the manufacturer guide.  
 
RGB LEDs + pinhole




2.12 Assessment of corneal cells collagen production 
Following scratch healing, human CSC was stained with Picro-Sirius Red 
(Sigma-Aldrich, UK) a polyazo dye that is used to determine collagen production, by 
staining collagen fibers in red, and subsequently dissolved in picric acid to keep the 
solution stable. The stain was used as previously described by Dapson et al (Dapson 
et al., 2011), briefly; following three days post-scratch, the plates were gently 
washed with warm PBS before fixing with 70% ice-cold EtOH (absolute ethanol, 
VWR, Lutterworth, Leicestershire, UK) for 10 minutes, followed by overnight 
incubation at 4°C with Sirius red stain and gentle agitation to allow for equilibrium 
staining of the cells. Plates were washed with double distilled water before adding 
1M sodium hydroxide (NaOH) (ThermoFisher, UK) with gentle agitation to allow cells 
dissociation from the plate, 100µl were aliquoted into 96-well plate and absorbance 
measured at 490nm. The collagen results were plotted against a Rat Tail Collagen I 
(First Link Ltd, UK) standard curve made at different concentrations.   
 
2.13 Total protein analysis 
Bradford protein assay is a quick analytical procedure used to measure the 
amount of protein in a sample. The assay is a colorimetric protein assay that 
measures the shift in absorbance of the Coomassie Brilliant Blue G-250 dye. The 
colour range from blue (anionic), green (neutral) to red (cationic) depends on the 
amount of protein present in the sample. Quick Start™ Bradford Protein Assay (Bio-
Rad Laboratories Ltd, Watford, Hertfordshire, UK) was used to measure the protein 
concertation in conditioned media samples.  
The protein content within the conditioned media was concentrated prior to 
mixing with the 1x dye via adding 4x volume of ice-cold 70% EtOH (VWR, UK) 
stored at -20°C to the conditioned media (i.e. 800µl of EtOH was added to 200µl of 
conditioned media) and allowed to incubate overnight at -20°C, followed by 10 
minutes centrifugation at 10,000xG at 4°C, the protein pellet was allowed to dry at 
room temperature before resuspending with PBS. According to the manufacturer, 5µl 
of the concentrated protein was then mixed with 250µl 1x dye and incubated for 20 
minutes at room temperature, the mixture was then aliquoted to 96-wells plate and 
absorbance was then taken at 595nm using VariosKan LUX Multimode Microplate 
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Reader (ThermoFisher, UK) (Diagram 2.4). The results were plotted against a 
standard curve made of bovine serum albumin (BSA) protein standard provided by 
the manufacturer. BSA is a purified protein used as a reference protein to give a 
relative protein value.   
 
 
Diagram 2.4 – Bradford protein assay principle. Mixing of the 1x dye with the sample 
in a ratio recommended by the manufacturer (Left), followed by 20 minutes 
incubation at room temperature before aliquoting 100µl into 96-wells plate (Right). 
Absorbance measured at 595nm.    
 
2.14 Enzyme-linked immunosorbent assay 
Enzyme-linked immunosorbent assay (ELISA) can detect the antigen present in 
the sample. To detected the enzyme activity, the immobilised antigen is complexed 
to an enzyme-linked antibody. With a specific antigen-antibody interaction, the 
enzyme can be measured. ELISA used to quantify hepatocyte growth factor (HGF), 
vascular endothelial growth factor (VEGF), and interleukin-1 beta (IL-1ß). Human 
HGF ELISA kit (ThermoFisher Scientific) used to quantify the presence of HGF, 
VEGF, and IL-1ß in conditioned media collected from the encapsulated ASCs 
following 15°C storage following the manufacturer guidelines. Data were plotted and 
normalised against a standard curve made with each sample. Absorbance measured 
at 450nm using VariosKan LUX Multimode Microplate Reader.  
 
Mixing of sample with Bradford dye
20 minutes incubation 
Absorbance taken at 595 nm
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2.15 Real-time polymerase chain reaction 
2.15.1 Primer design 
Decorin and Vimentin cDNA transcripts were obtained from the Ensemble 
genome browser, the specific primers were then designed using the Primer3 (v0.4.0) 
tool, and Primer-BLAST was then used to cross-reference the primer specificity. 
These design tools were used as follow:  
The Ensemble genome browser is an online database that offers the search of 
genes of interest from all species. For the purpose of this thesis, the human genome 
database was used in choosing the appropriate cDNA. Searching for specific genes 
will result in multiple choices, choosing one of them will show a tab that contains the 
description of this gene, from the ‘Sequence tap’, clicking on ‘cDNA’ shows the 
different transcript ID of the gene. Clicking on the ‘CCDS’ tab, Nucleotide Sequence 
of the transcript gene is shown in a FASTA format, copying a specific sequence 
length (20 ~ 30 base pair) is desirable and pasting that in ‘Primer3’ tool to design the 
primer.  
Primer3 tool is an online database that allows the paste of the nucleotide 
sequence to pick primers. This tool must be set on specific settings to allow for 
optimal primer choice. ‘Pick left primer’ and ‘pick right primer’ were set to the 
following selections: product size 80 – 200bp, maximal 3’ stability is 9, maximal 
repeat mispriming is 12, pair maximal repeat mispriming is 24.00, maximal template 
mispriming is 12.00, pair maximal template mispriming is 24.00, minimum primer 
size is 18bp, optimum primer size is 20bp, maximum primer size is 27bp, minimum 
primer melting temperature (Tm) 57°C, optimum Tm is 60°C, maximum Tm is 63°C, 
while the maximum difference allowed between primers Tm is 2°C, minimum primer 
GC% is 35%, optimum GC% is 60%, maximum GC% is 80%, maximum self-
complementarity is 8 and maximum 3’ self-complementarity is 3. ‘Pick primers’ was 
then selected which showed the sequences of the primer that best resemble the 
properties chosen. The optimal primer sequence pair was then copied and pasted 
into the ‘Primer-BLAST’ tool for primer specificity.   
Primer-BLAST: after finding the optimal 5’->3’ forward and reverse primer 
sequence, they were then pasted onto Primer-BLAST and clicked on ‘Get primers’ to 
give details of the primers. Primer details include length, Tm, GC%, and Self 
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complementarity, once optimal details of the forward and reverse primer sequences 
were found, the primer RNA oligonucleotides were ordered from Eurofins Genomics 
(Ebersberg, Germany). Upon receiving the primers, they were solubilised in 0.1 µm-
filtered RNase-free water (Sigma Aldrich, UK) to 100µM stock concentration. For 
real-time PCR primers were further diluted via mixing the forward and reverse 
primers in a 1:1 ratio. To ensure minimal risk of ribonuclease (RNase) contamination, 
RNase-free filter pipette tips were used.  
Decorin, vimentin, a-smooth muscle actin, aldehyde dehydrogenase 3, and 
lumican primers were used for keratocytes gene expression analysis (Table 2.2). 
Hepatocyte growth factor, insulin-like growth factor, hypoxia-inducible factor-1A, 
vascular endothelial growth factor, REX1, tumor necrosis factor-inducible gene 6 
protein, and a-smooth muscle actin primers were to measure the gene expression 
following scratch healing (Table 2.3). GAPDH housekeeping gene was used in all 
real-time PCR runs.  
 
Table 2.2 – Description of primers used in real-time PCR for keratocytes gene 
expression analysis. 



























Table 2.3 – Description of primers used in real-time PCR for ASC gene expression 
analysis. 
 
2.15.2  Sample preparation and RNA extraction  
Sample preparation: human CSC and keratoconus cultures were harvested 
following scratch-wound healing. Three wells of the 6-wells plate were pooled 
together for every condition to harvest enough cells for RNA extraction. The 
harvested cells, counted in the range of 5 x 105 ~ 1 x 106 proceeded with RNA 
extraction. Human ASCs were also harvested following storage and use in scratch-
healing.  
RNA extraction: RNeasy® Mini Kit (QIAGEN, Manchester, UK) was used for 
RNA purification from cell cultures as directed by the manufacturer. Briefly; the 
harvested cell pellets were resuspended with 350µL RLT Buffer for sample 
disruption and homogenizing before transferring suspension to the RNeasy Mini spin 
column with an equal amount of 70% EtOH and centrifuging at 8000xg for 15 
seconds. The flow-through was discarded and 700µl Buffer RW1 was added to the 































the column followed by 15 second and 2 minutes centrifugation respectively. At 
which point, the RNeasy spin column was placed in a new 1.5mL microtube and 50µl 
RNase-free water was added to the column membrane to yield the RNA. The 
extracted RNA was either used for cDNA synthesis or stored at -80°C until needed.  
 
2.15.3 cDNA synthesis  
RNA samples, extracted in section 2.9.B were thawed on ice and measured for 
RNA concentration and purity using NanoDrop 2000 spectrophotometer 
(ThermoFisher, UK). The samples were measured by the 260nm and 280nm 
(A260/280) absorption ratio before diluting RNA samples to 0.1mg/µl concentration 
using RNase-free water and stored on ice. cDNA synthesis was performed using the 
RT2 First Strand Kit (QIAGEN, UK). All the reagents were thawed on ice before 
mixing 2µl of genomic DNA elimination GE buffer with 8ul RNA sample and water 
mix and incubated for 5 minutes at 42°C in TC-Plus thermal cycler (Techne, 
Staffordshire, UK) then immediately returned to the ice. A Reverse-Transcription 
mastermix containing 4µl 5x buffer BC3, 1µl P2 control, 2µl RE3 reverse 
transcriptase mix, and 3µl RNase-free water was mixed with the genomic cDNA and 
returned to the thermal cycler and incubated at 42°C for 15 minutes followed by 2 
minutes at 95°C to inactivate the reverse transcriptase. The resulted cDNA was then 
further diluted with 50ul RNase-free water in a 1.5mL RNase-free sterile microtubes 
and stored at -20°C until needed for real-time PCR. All reagents used were vortexed 
briefly before use to ensure thorough mixing of components. The risk of 
contamination was minimised with the use of RNase-free filter pipette tips.  
 
2.15.4 Real-time polymerase chain reaction  
Real-time PCR (RT-PCR), also known as quantitative PCR (qPCR), is a 
technique used frequently to measure relative cDNA expression levels. Briefly, 7µl of 
SYBR green mastermix (ThermoFisher, UK). was mixed with 5µl cDNA samples and 
2µl forward and reverse primer mix in a 48-well Eco™ PCR reaction plate (Illumina, 
San Diego, USA). The plates were then sealed using Eco ™adhesive seal (Illumina, 
USA) and briefly centrifuged to mix and bring all components to the bottom of the 
well and ensuring no bubbles were present. Plates were then transferred to Eco™ 
Real-Time PCR System (Illumina, USA) set with 10-minute incubation at 95°C, 
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followed by 40x cycles of 10 seconds at 95°C, 30 seconds at 60°C and 15 seconds 
at 72°C to allow for the cDNA denaturation, primers annealing, and transcript 
elongation. At the end of every cycle, data were collected corresponding to the 
relative sample fluorescence expression. The increase in the fluorescence level 
leads to a cycle threshold (Ct) value detection. Ct value is the number of PCR cycles 
needed to amplify the DNA target to a measurable level. Following PCR cycles, a 
melting curve is performed for every plate consisting of 15 seconds at 95°C, 15 
seconds at 55°C and 15 seconds at 95°C. The data generated from the melting 
temperature should give a single peak to represent no formation of secondary 
product in the reaction, including primer-dimer and non-specific misprimers forming. 
Within the same PCR reaction, all experiments were performed in duplicates.  
Standard curves were made for every primer used to measure the primer 
efficiency, using a 5-fold serial dilution of the cDNA template. The efficiency curves 
were used to measure primer efficiency using the equation: ‘Efficiency (E) = 10(-
1/slope)-1’ an efficiency value of 2 was considered 100% amplification efficiency. The 
relative level of target genes were quantified using the Pfaff mathematical model 




2.16 Proteome profiler human XL cytokine array 
The human cytokine array kit (R&D Systems, Abingdon Science Park, 
Abingdon, UK) is a sensitive tool to detect the presence of different cytokines in the 
samples. The kit can capture antibodies spotted on a nitrocellulose membrane 
(Diagram 2.9) and a give relative expression of 105 different cytokines within one 
sample (Table 2.4). Which makes it an easier tool than immunoassays. Following 
certain steps, the signal produced at the capture spot corresponds to the amount of 
protein-bound.  
 45 
Sample preparations: Conditioned media taken from eight conditions used for 
the kit (Diagram 2.10). These include (i) human CSCs plated in a 6-well plate with 
SFM, (ii) calcium alginate used with CSC following 15°C storage, encapsulated 
ASCs (iii) stored at 15°C for 72 hours only, or, followed by (iv) 48 hour storage at 
37°C, encapsulated ASCs used with scratch healing for 48-hours with either (v) post 
15°C storage, or, (vi) non-stored, non-encapsulated ASCs were also used as (vii) 
non-stored, or, (viii) following 15°C storage. The supernatant from each sample was 
centrifuged to remove all debris and diluted with the blocking buffer to a final volume 
of 1.5 mL then placed on ice to be used with the kit.  
Array procedure: The kit was used with cell culture supernatants produced 
according to the manufacturer’s instructions. Briefly; the kit contains four membranes 
that were placed inside a 4-well multi-dish and incubated with a blocking buffer for 1 
hour on a rocking platform. The prepared samples were added to the 4-well multi-
dish for overnight incubation at 4°C on a rocking platform. The membranes were 
then washed with a 1X washing buffer prepared by mixing 20mL wash buffer with 
480mL PBS for 10 minutes on a rocking platform for a total of three washes. During 
membrane washing steps, the 4-well multi-dish was also washed with tap water to 
prepare for the next steps. Detection Antibody Cocktail was prepared by diluting the 
Human XL Cytokine Detection Antibody Cocktail with 200µL PBS, followed by mixing 
30µL of the detection antibody cocktail with 1.5mL of 1X Array Buffer 4/6 that was 
prepared by mixing 4mL of Array Buffer 4 to 8mL of array buffer 6. After the wash, 
1.5mL of Detection Antibody Cocktail mixed with 1X Array Buffer 4/6 was incubated 
with each membrane in the 4-well multi-dish for 1 hour at room temperature on a 
rocking platform. Followed by washing steps and 2mL of 1X Streptavidin-HPR was 
added to the membranes for 30 minutes at room temperature on a rocking platform. 
1X Streptavidin-HPR was diluted in Array Buffer 6 in a 1:2000 dilution before use. 
Followed by washing steps, 1mL Chemi Reagent Mix was pipetted evenly onto each 
membrane and incubated for 1 minute at which point the membranes were protected 
from light. Chemi Reagent Mix was prepared by mixing Chemi reagent 1 and 2 in a 
1:1 ratio freshly before use. The membranes were protected from light and placed in 
a wash buffer until visualisation using Amersham™ Imager 600 (GE Healthcare Life 
Sciences, Buckinghamshire, UK). Using ImageJ, the produced membrane images 
were analysed for pixel intensity, choosing the same circle width to mark all captured 
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antibodies spots, under the Analyze tab, Measure plugin was used to measure the 
pixel intensity and plotted in an Excel spreadsheet and graphs processed using 
Prism 6.0.  
 




Coordinate Analyte/Control Coordinate Analyte/Control
A1	– A2 Reference	spot C1	– C2 -
A3	– A4 Adiponectin C3	– C4 ENA-78
A5	– A6 Apolipoprotein	A-I C5	– C6 Endoglin
A7	– A8 Angiopoietin C7	– C8 Fas Ligand
A9	– A10 Angiopoietin-1 C9	– C10 FGF	basic
A11	– A12 Angiopoietin-2 C11	– C12 FGF-7
A13	– A14 BAFF C13	– C14 FGF-19
A15	– A16 BDNF C15	– C16 Fit-3	ligand
A17	- A18 CC-C5/C5a C17	- C18 G-CSF
A19	– A20 CD14 C19	– C20 GDF-15
A21	– A22	 CD30 C21	– C22	 GM-CSF
A23	– A24 Reference	spot C23	– C24 -
B1	– B2 - D1	– D2 GROa
B3	– B4 CD40	 ligand D3	– D4 GH
B5	– B6 CHI3L1 D5	– D6 HGF
B7	– B8 CF	D D7	– D8 ICAM-1
B9	– B10 CRP D9	– D10 IFN-y
B11	– B12 Cripto-1 D11	– D12 IGFBP-2
B13	– B14 Cystatin C D13	– D14 IGFBP-3
B15	– B16 Dkk-1 D15	– D16 IL-1a
B17	- B18 DPPIV D17	- D18 IL-1b
B19	– B20 EGF D19	– D20 IL-1ra
B21	– B22	 Emmprin D21	– D22	 IL-2
B23	– B24 - D23	– D24 IL-3
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Coordinate Analyte/Control Coordinate Analyte/Control
E1	– E2 IL-4 G1	– G2 Leptin
E3	– E4 IL-5 G3	– G4 LIF
E5	– E6 IL-6 G5	– G6 Lipocalin-2
E7	– E8 IL-8 G7	– G8 MCP-1
E9	– E10 IL-10 G9	– G10 MCP-3	
E11	– E12 IL-11 G11	– G12 M-CSF
E13	– E14 IL12	P70 G13	– G14 MIF
E15	– E16 IL-13 G15	– G16 MIG
E17	- E18 IL-15 G17	- G18 MIP1a/MIP1b
E19	– E20 IL-16 G19	– G20 MIP-3a
E21	– E22	 IL-17A G21	– G22	 MIP-3b
E23	– E24 IL-18	Bpa G23	– G24 MMP-9
F1	– F2 IL-19 H1	– H2 Myeloperoxidase
F3	– F4 IL-22 H3	– H4 Osteopontin
F5	– F6 IL-23 H5	– H6 PDGF-AA
F7	– F8 IL-24 H7	– H8 PDGF-AB/BB
F9	– F10 IL-27 H9	– H10 Pentraxin-3
F11	– F12 IL-31 H11	– H12 PF4
F13	– F14 IL-32 H13	– H14 RAGE
F15	– F16 IL-33 H15	– H16 RANTES
F17	- F18 IL-34 H17	 - H18 RBP-4
F19	– F20 IP-10 H19	– H20 Relaxin-2
F21	– F22	 I-TAC H21	– H22	 Resistin
F23	– F24 Kallikrein 3 H23	– H24 SDF-1a
 49 
 
Table 2.4 – Human XL cytokine array coordinates.  
 
Coordinate Analyte/Control Coordinate Analyte/Control
I1	– I2 Serpin E1 J1	– J2 Reference	spot
I3	– I4 SHBG J3	– J4 -
I5	– I6 ST2 J5	– J6 Vitamin	D	BP
I7	– I8 TARC J7	– J8 CD31
I9	– I10 TFF3 J9	– J10 TIM-3
I11	– I12 TfR J11	– J12 VCAM-1
I13	– I14 TGF-a J13	– J14 -
I15	– I16 Thrombospondin-1 J15	– J16 -
I17	- I18 TNF-a J17	- J18 -
I19	– I20 uPAR J19	– J20 -
I21	– I22	 VEGF J21	– J22	 -





Diagram 2.6 – The conditions used for the Human Cytokine XL Array Kit. (i) CSC 
used with SFM, (ii) calcium alginate used with CSC following 3 days storage at 15°C, 
(iii) encapsulated ASCs stored at 15°C for 3 days, (iv) prior to storing at 37°C without 
CSC, encapsulated ASCs used with CSC (v) post storage at 15°C and (vi) 
immediately following encapsulation, non-encapsulated ASCs attached to the 
transwell insert and used with CSC (vii) post storage at 15°C and (viii) immediately 
following attachment. CSC: corneal stromal cells; SFM: Serum-free DMEM:F12; 
Calcium alginate: VLVG alginate; ASCs: adipose-derived mesenchymal stem cells. 
 
(ii) Calcium alginate stored at 15°C prior to use with CSC
(v) Encapsulated ASCs Stored at 15°C prior to use with CSC
(vi) Used following encapsulation with CSC (non-stored)
(vii) ASCs stored at 15°C prior to use with CSC
(viii) ASCs used following attachment with CSC (non-stored)
(i) SFM used with CSC
(iv) Encapsulated ASCs Stored at 15°C prior to storage at 37°C
(iii) Encapsulated ASCs Stored at 15°C only
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2.17  Statistical analysis 
Unless otherwise stated in the thesis, statistical analysis was performed using 
GraphPad Prism, Version 6.0. Data are expressed as the mean of values from at 
least three separate donors ± SEM. Statistical comparisons were made using one-
way or two-way repeated-measures ANOVA, and Tukey’s multiple comparisons 
tests, excluding comparison of two single variables for which paired two-tailed t-test 
were used. Values of p> 0.05 were considered significant (*, p < 0.05; **, p < 0.01; 
***, p< 0.001; ****, p<0.0001).  
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Chapter 3.  Stem cells bandages formation: Effect of cells encapsulated 
in alginate on in vitro corneal stromal scratch wound closure 
 
3.1 Introduction 
Corneal damage can range in severity between superficial (cellular) and deep 
stromal damage. Depending on the damage grade, the treatment method can range. 
Superficial corneal abrasions that damage the epithelial cells can be healed within a 
few days using antibiotics. Deeper abrasions may require antibiotics, steroids, and 
painkillers to help heal the eye. Severe abrasions, on the other hand, even with 
treatment, can still affect vision by forming a scar. Stem cells have been tested as 
therapeutic cells that can heal various diseases. Adipose-derived stem cells (ASCs), 
present a promising choice for corneal therapy for they can be easily obtained from 
fat tissues, are known to be environmentally responsive in wound repair, and able to 
secret paracrine factors and extracellular molecules that have immunomodulatory 
(Aggarwal and Pittenger, 2005), angiogenic (Watt et al., 2013), trophic (Roddy et al., 
2011) and anti-fibrotic activity (Dong et al., 2015). Thus, we hypothesise that stem 
cell bandages can help heal these scars and improve vision.  
 
3.2 Aims  
This chapter will explain the preliminary experiments taken to determine the 
optimal approaches in investigating the formation and effect of stem cell bandages 
containing alginate encapsulated human ASCs on in vitro human corneal cell 
cultures. Herein, we explain the steps taken in (i) determining the optimal seeding 
density of corneal cells, (ii) media used to culture cells, and (iii) methods used in 
assessing cell migration and proliferation. We also show (iv) the encapsulation 
optimisation of ASCs and (v) the types of alginate used for the encapsulation that is 
suitable for scratch assay and image analysis using time-lapse and ImageJ software. 
As well as (vi) the hypothermic procedure used to store the cells and (vii) the 
adaptability made to the model to improve reproducibility. These optimisation steps 
allowed the formation of stem cell bandages. These bandages maintained their 
viability and functional ability during hypothermic storage and in vitro wound healing. 
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HGF is an important protein responsible for cell motility, proliferation and 
morphogenesis, thus we also tested its production level  
 
3.3 Results 
3.3.1 A choice of cell migration assay and media effect on corneal stromal 
cells cultures  
To start our experiments, human corneal cells (CSCs) were isolated and 
expanded from healthy corneal donors (see isolation procedure in chapter 2 2.1). To 
measure cell migration, few adjustments were needed to optimise the scratch 
procedure. Starting with the seeding density of the cells to accommodate the wells 
and expand to near confluency, without being over confluent. Cells were seeded at a 
range of densities in a 6-well plate with 5% media for 24 hours, at which point the 
cells were in their fibroblastic active form. Followed by 72 hours of starvation via 
supplementing the cells with serum-free media (SFM) (DMEM: F12 supplemented 
with 5g/L ascorbic acid, 1% Insulin-Transferrin-Selenium and 1% penicillin-
streptomycin) to induce their in-active form. Over- or under- confluent wells were not 
used in the experiments, for they presented non-uniform scratches, and gave 
inconsistent scratch measurements across technical and biological repeats (Figure 
3.1). During the 72 hours incubation, the cells were expected to have minimal 
proliferation. To reach the optimum monolayer confluency, different seeding 
densities were measured including 5x105 cells/well (Figure 3.1 A), 1.5x105 cells/well 
(Figure 3.1 B) and 2.5x105 cells/well (Figure 3.1 C). Hence, the initial seeding 












Figure 3.1 – Effect of the seeding density on scratch uniformity presenting cell 
images of (A) over confluent (5x105 cells/well), (B) under confluent (1.5x105 
cells/well), and (C) the optimum confluency (2.5x105 cells/well) that is used in the 
subsequent experiments. Two types of microscopes are used to take images, an 
inverted microscope using Leica software (Left) and Iprasense lensless imaging 
using Horus software (Right). n = 3 repeats. Scale bars of microscope images = 
220µm, and Iprasense images = 300µm. 
 
CSC cultures were used to optimise the incubation time following scratch to 
determine the optimum time needed to allow the cells to cover the full scratch (cell-
free) area. Following 72 hours of cell starvation, scratch assays were performed on 
the cells and incubated with either SFM or 5% media for 48 hours (Figure 3.2 A). 
SFM was used with all subsequent CSC experiments, therefore, they were used as a 
negative control, while 5% media used as a positive control, where the presence of 
serum is expected to activate CSC to fibroblasts to migrate and proliferate. The 
cultured plates were imaged using Iprasense time-lapse microscopy in a 1-hour 
interval without disruption.  
As we expected, significant differences were found between the two conditions 





indicated the time it takes for the cells to cover the cell-free area; therefore, it was 
decided that 48 hours of culture (following scratch induction) mark the end of each 
experiment. Using Alamar blue assay, we determined cell density at time 48 hours 
compared to time 0 (Ctrl) (Figure 3.2 C) an increase in cell number was found with 
the 5% media (p = 0.0309). Indicating 5% media induced the cells to proliferate to 























































Figure 3.2 – Media effect on CSCs cultures. Comparing Serum-free media (SFM) 
and 5% media (DMEMF12 supplemented with 5% FBS). (A) Representing scratch 
migration assay, (B) average scratch width, (C) cell number at time 48 for SFM and 
5% media, while time 0 for Ctrl, and (D) percentage wound closure. Scale bar = 
300µm, values are expressed as means ± SEM of at least n=3, (****, p < 0.0001; ***, 
p < 0.001; **, p < 0.01).  
 
3.3.2 Formation of stem cells bandages: cell encapsulation in 3D biomaterial  
To test stem cell bandages, we tested two types of alginate sources, Sigma-
Aldrich and NovaMatrix alginate (Table 3.1). Both of the providers extracted sodium 
alginate from the brown algae cell wall and supplied it in a powder format in different 
levels of purity. While there seemed to be differences in the appearance of the 
powder, from the datasheet, the major differences were found in the viscosity, purity, 













Table 3.1 – Comparison between Sigma and NovaMatrix alginates (image adapted 
from https://pubchem.ncbi.nlm.nih.gov/compound/5102882#section=Top). 
 
We adapted Swioklo’s encapsulation method and further adjusted it to suit our 
system (encapsulation procedure is explained in detail in chapter 2. 2.6). Following 
bandage ± cell formation, we sought to determine its effect on CSC cultures. S. 
(Sigma) and N. (NovaMatrix) alginates ± 1x106 cells were used immediately 
following formation, a condition referred to as (non-stored). From the scratch images 
(Figure 3.5 A, B), the presence of bandage + ASCs (S. and N. alginates) within the 
co-culture showed an improvement in CSC area coverage compared to the bandage 
- ASCs (S. and N. alginates). This improvement showed significance at 30 and 40 
hours in S. (p = 0.023 and 0.011 respectively) and N. (p = 0.006 and 0.0009 
respectively) alginates (Figure 3.5 C). However, compared to the 0-hour cell number 
(ctrl) (Figure 3.5 D) there was no significant increase in CSCs proliferation, thus 
these cells were mostly migrating into the scratched cell-free area (as shown in our 
Sigma (S) NovaMatrix (N)
Powder appearance Off-white to light brown White to off-white
Solution appearance Light brow to yellow Colourless
Viscosity 4 – 12 mPa/s < 20 mPa/s 
pH N/A 5.5 – 8.8
Composition Primarily D-mannuronic
acid residues
Primarily Guluronic acid 
residues
Purity N/A Ultrapure
Shelf life N/A 5 years
Storage conditions 2 – 8 oC 2 – 8 oC
Alginate composition
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development experiments Figure 3.2). Upon comparing all these conditions, no 
significant differences were found between the two alginates.   
 
Figure 3.3 – Comparison of the non-stored conditions. Scratch images of the (A) S. 
(Sigma) and (B) N. (NovaMatrix) alginates at times 0, 10, 20, 30 and 40 hours. (C) 
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Time	(Hours) S. Encaps. S. Alginate N. Encaps. N. Alginate SFM
0 100 100 100 100 100
10 81.69821345 85.59131728 84.83644374 89.48036646 89.83239473
20 49.79913212 67.77276819 59.73258326 70.29389912 70.75146893
30 28.20143779 47.75834416 31.01474136 52.30109544 54.94253768
40 14.27614064 35.20327455 12.10979343 36.71236533 37.07073254
E
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Average scratch width, (D) cell number, and (E) percentage wound closure. Scale 
bar = 300µm, values are expressed as means ± SEM of at least n=3, using 2way 
ANOVA, asterisks represent significance between the N. alginate and N. Encaps 
(***, p < 0.001; **, p < 0.01), while symbols represent significant between S, alginate 
and S. Encaps. (§, p < 0.5). S. represent Sigma alginate; N. represent NovaMatrix 
alginate; ctrl represents time 0-hour cell number.  
 
3.3.3 Assessment of hypothermically stored ASCs on corneal stromal cell 
culture 
3.3.3.1 Hypothermic storage effect on viable cell recovery  
For efficient cell therapy, it is important to avoid the use of serum and for the 
stored cells to be adapted to a serum-free condition. Therefore, we encapsulated 
ASCs and stored them at 4°C and 15°C in SFM for 72 hours using both S. and N. 
alginates before counting the cells (Figure 3.4). Although no significant differences 
were found between the different alginates, there were differences when comparing 
the different temperatures within the same type of alginate. At 4°C, stored cells 
showed a significant drop in cell number yielding 54.3% ± 7.8% and 64% ±3.4% 
viable cells in both S. and N. alginates respectively, when compared to non-stored 
conditions (ASCs released following encapsulation) significant difference shown (p = 
0.0027 and 0.0041 respectively). Whereas at 15°C, cells achieved a viable cell 
recovery of 75% ± 2.4% and 77% ± 2.9% in S. and N. alginates respectively. When 
compared to the non-stored conditions, significant differences were found in the N. 
alginate (p = 0.04) but not in the S. alginate. Therefore, and corresponding to 
Swioklo et al, 15°C storage was again shown to be the optimal storage condition, 
which also corresponded with the minimum acceptable specification of cell viability 
(70% viable cells following storage) set by the FDA (Administration), and this result 
could not be achieved without alginate encapsulation. The difference in cell viability 
between our experiment and Swioklo’s is attributed to the use of growth media that 
contains 2% serum whilst our experiment did not contain serum.  
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Figure 3.4 – Storage effect on viable cell recovery. ASCs released immediately 
following encapsulation (non-stored) or stored at 4 and 15°C either encapsulated or 
non-encapsulated (Ctrl), for 72 hours before assessing percentage of viable cells 
recovered. Values are expressed as means ± SEM of n=3, asterisks represent 
significant differences between control and temperature differences with the different 
alginate type (***, p < 0.001; **, p < 0.01; *, p < 0.05) and symbols represent 
differences between temperatures of the same alginate (§, p < 0.01; &, p < 0.5).    
 
3.3.3.2 Hypothermically stored bandages effect on CSC scratches  
Following a viable cell recovery assessment, we aimed to assess the possibility 
of paracrine factors released from the bandages using scratch wound assay. We 
stored both types of alginates at 4°C (Figure 3.5) ± ASCs before assessing their 
effect on CSC culture. Surprisingly, no significant differences were found when 
comparing S. alginate ± ASCs (Figure 3.5 A, C), where both conditions showed 
similar area coverage over time. N. alginate ± ASCs showed significant differences 
at 30 and 40 hours (p = 0.0042 and 0.0148 respectively) post scratch (Figure 3.5 B, 
C). Upon comparing both alginates, significant differences were found between S. 
Encaps. and N. at 20 and 30 hours post scratch (p = 0.025 and < 0.0001 
respectively), whilst S. Alginate showed significantly faster wound coverage 
compared to N. Alginate at 30 hours (p = 0.0046) and N. Encaps. at 40 hours (p = 
0.0015). N. Encaps showed a significant increase in cell proliferation compared to N. 
































Figure 3.5 – Hypothermic storage effect at 4°C on corneal stromal culture. S. and N. 
Alginates ± ASCs. Scratch images of (A) S. and (B) N. alginates, (C) average 
scratch width, (D) cell density, and (E) percentage scratch closure. Values are 
expressed as means ± SEM of at least n=3, (**, p < 0.01; *, p < 0.05). Scale bar = 
300µm. 








































































Time	(Hours) S. Encaps. S. Alginate N. Encaps. N. Alginate SFM
0 100 100 100 100 100
10 83.5371172 84.05481802 84.56866255 90.47747724 89.83239473
20 55.78751849 65.43229828 60.38956215 74.35161473 70.75146893
30 32.92712167 42.52496771 42.25491349 61.73361512 54.94253768




Similarly, both alginates ± ASCs were stored at 15°C for 72 hours (Figure 3.6). 
Where S. Encaps. showed an enhanced wound coverage at time 30 hours (p = 
0.0463) (Figure 3.6 A, C). Unexpectedly, N. alginate showed a significant delay in 
area coverage 20, 30, and 40 hours post scratch (p < 0.0001) (Figure 3.6 B, C). This 
difference is also shown when compared to S. alginate (p < 0.0001). On the other 
hand, the presence of ASCs with the N. alginate presented an enhanced wound 
coverage, as well as a significant increase in cell proliferation (Figure 3.6 D) 
compared to S. and N. alginates, where the latter showed a small reduction in cell 
density compared to control.    
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Figure 3.6 – Hypothermic storage effect at 15°C on corneal stromal culture. S. and 
N. alginates ± ASCs stored at 15°C for three days. Shown scratch images of (A) S. 
and (B) N. alginates, (C) average scratch width, (D) cell density, and (E) percentage 
C D










































































S. Encaps. S. Alginate N. Encaps. N. Alginate
A B
Time	(Hours) S. Encaps. S. Alginate N. Encaps. N. Alginate SFM
0 100 100 100 100 100
10 77.45314883 76.67395547 78.89253634 90.6730273 89.83239473
20 42.13011347 50.70229797 47.42793869 77.57457737 70.75146893
30 18.34201136 33.38349459 25.59013208 61.72007122 54.94253768
40 9.859734452 17.09513986 13.64367217 46.73877113 37.07073254
E
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scratch closure. Values are expressed as means ± SEM of at least n=3, (****, p < 
0.0001; **, p < 0.01; *, p < 0.05), Scale bar = 300µm. 
 
From the data, differences were found at times 20 and 30 hours post-scratch in 
the bandage + ASCs condition, thus we compared these time points (Figure 3.7 A). 
Whilst no significant differences were found when comparing non-stored and storage 
at 15°C for S. and N. Encaps.  S. Encaps following 15°C storage showed a 
significant increase in wound recovery compared to S. Encaps following 4°C at times 
20 and 30 hours post scratch (p = 0.029 and 0.0217 respectively). This reduction in 
wound area suggested that 15°C storage affected ASCs and in turn affect CSC. 
culture via growth factor(s) release. Whereas N. Encaps following 4°C storage 
showed a delay in wound coverage at time point 30 hour compared to S. Encaps 
following 15°C storage (p < 0,0001), N. Encaps following 15°C storage (p = 0.0052), 
and S. Encaps non-stored (used immediate following encapsulation) (p = 0.0081), 
which could be due to the reduced ASCs cells number before starting the 
experiment. So far, S. Encaps following 15°C storage presented the best 
temperature and alginate type to be used for initiating therapy. This effect of scratch 
healing can be attributed to the alginate composition since the only difference 
between N. Encaps and S. Encaps is the type of alginate used.  
Our data suggest that Encaps. ASCs stored at 15°C for 3 days improve CSCs 
scratch wound, whereas alginate controls did not show this effect, suggesting that 
encapsulated ASCs can produce soluble factor(s). We can assume that the amount 
of these factor(s) produced is relative to the number of (live) ASCs cell number. 
Thus, we normalized the measured effect (wound closure) to the number of live 
ASCs found within the alginate at the end of the experiment. After applying this 
normalisation step we found that non-stored Encaps. (Figure 3.7 B, C) showed the 
slowest cell response compared to the other conditions.  
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Figure 3.7 – Migration speed per cell. (A) comparison of S. and N. alginates at times 
20 and 30 hours post scratch. ASCs cell number normalized to CSCs number 
following 48 hours for both (B) S. alginate, and (C) N. alginate. Values are expressed 
as means ± SEM of at least n=3, (****, p < 0.0001; **, p < 0.01; *, p < 0.05). 
 
3.3.4 Assessment of ASCs cell surface marker expression  
Following the assessment of ASCs’ effect of CSC culture, we sought to assess 
if ASCs maintained their phenotypic markers following culture with CSC. Flow 
cytometry analysis performed and compared non-stored ASCs grown in culture 
without alginate (Figure 3.8 A) to encapsulated ASCs in S. or N. alginates either 
used with CSC for 48 hours (Figure 3.8 B) or without CSC culture (Figure 3.8 C). 
ASCs were assessed for size (forward scatter) and granularity (side scatter) 
following release from encapsulation. When comparing the two types of alginates 
(Figure 3.8 B, C), a similar profile was found in cell size and granularity compared to 
normally grown ASCs. Upon assessing ASCs-associated markers (Figure 3.8 D), CD 
90 and CD73 were slightly lower in the S. (74.1% and 70.1%) alginate compared to 
the and N. alginate (76.6% and 73.2%). Of the markers that have a key role in cell 
adhesion and cell-cell interaction, CD166 were slightly less expressed in N. alginate 
(84.6%) than S. alginate (90.2%), while CD29 expression was faintly less in S. 




















































































and CD14 remained unchanged for S. alginate (1.5% and 1.9%) and N. alginate 
(1.3% and 1.4%). While human leukocyte markers (HLA) -ABC and -DR were slightly 
higher in S. alginate (56.4% and 25.2%) compared to N. alginate (50.8% and 
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Figure 3.8 – Assessment of granularity, size, and immunophenotype of encapsulated 
ASCs following culturing with CSC scratch wound. ASCs were grown in culture at 
37°C assessed for (A) size and granularity. Encapsulated ASCs in Sigma (S.) and 
NovaMatrix (N.) alginates without (B) and with (C) CSCs culture without CSCs 
culture. (D) Immunophenotype markers were assessed after use with CSCs culture. 
(E) Table represent the percentage of expression of cell surface markers from 2 
separate donors. Abbreviations: FSC, forward scatter; SSC, side scatter; HLA, 
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3.3.5 Effect of cell encapsulation in different alginate matrices on HGF and 
VEGF secretion  
The following results were compiled by a Master student’s project (Tam 
Jeewon) and included here to further test Sigma and NovaMatrix alginates in terms 
of the effect on growth factors production. To quantify the hepatocyte growth factor 
(HGF) and vascular endothelial growth factor (VEGF), Enzyme-Linked Immune-
Sorbent Assay (ELISA) was used. ELISA was performed using conditioned media 
collected from the encapsulated ASCs following 15°C storage (Figure 3.9 A). Using 
7 different types of alginate to form the bandages including Sigma, VLVG, LV, MVG, 
VLVM, LVM, and MVM. These alginates differ in viscosity and M/G monomers ratio; 
thus, they were chosen for this comparison. VLVG alginate is the NovaMatrix 
alginate we have been using in the previous experiments. VLVG, very low viscosity 
alginate with a minimum of 60% guluronate monomers; LVG, low viscosity alginate 
with a minimum of 60% guluronate monomers; MVG, medium viscosity alginate with 
a minimum of 60% guluronate monomers; VLVM, very low viscosity alginate with a 
minimum of 50% mannuronate monomers, LVM, low viscosity alginate with a 
minimum of 50% mannuronate monomers; MVM, medium viscosity alginate with a 
minimum of 50% mannuronate monomers. Sigma (S.) alginate presented the highest 
level of HGF produced on day 3 compared to adherent cells and VLVG (N.) alginate. 
Whilst VEGF levels were slightly higher in VLVG (N.) alginate than S. alginate 
(Figure 3.9 B). To determine the effect of cell number of HGF and VEGF secretion, 
data were normalised to cell number (Figure 3.9 C). Data normalisation showed that 
S. alginate produced significantly the highest level of HGF protein compared to 
adherent culture and N. alginate. Whereas VEGF levels were significantly higher in 
encapsulated cells compared to adherent cultures (Figure 3.9 D). 
 Following the previous observation, to determine the effect of S. alginate on 
cells production of HGF, ASCs culture were grown in a monolayer and alginate gels 
(Sigma, VLVG (N.) and VLVM) were placed in a transwell system (Figure 3.10) It 
was found that cells produced a high level of HGF with the S. Alginate compared to 
N. Alginate. This observation suggested that S. Alginate may contain impurities that 
increase the cells’ secretion of HGF. This may explain the increase in scratch wound 
recovery over time compared to N. Alginate. 
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Figure 3.9 – The effect of different alginate matrices on HGF and VEGF protein 
production. Encapsulated ASCs stored at 15°C were assessed for (A) HGF, and (B) 
VEGF production over 7 days’ time course. Similarly, ASCs production of (C) HGF 
and (D) VEGF represented on days 3 and 7. N =2. VLVG alginate is the NovaMatrix 
alginate we have been using in the previous experiments. Abbreviates, VLVG, very 
low viscosity alginate with 60% guluronate monomers; LVG, low viscosity alginate 
with 60% guluronate monomers; MVG, medium viscosity alginate with 60% 
guluronate monomers; VLVM, very low viscosity alginate with 50% mannuronate 
monomers, LVM, low viscosity alginate with 50% mannuronate monomers; MVM, 
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Figure 3.10 – ASCs production of HGF in proximity with cell-free gels. N = 2.  
 
HGF and VEGF levels were further measured in response to inflammatory 
stimulation. ASCs were cultured with interleukin-1 beta (IL-1ß), an inflammatory 
cytokine activated by macrophages. IL-1ß is involved in many cellular events, such 
as cell differentiation, apoptosis, and proliferation. In the cornea, IL-1ß stimulates 
neutrophil activation and inflow, which leads to corneal haze (Barbosa et al., 2010, 
Kaur et al., 2009). Our results show, upon stimulating ASCs with IL-1ß (Figure 3.14 
A), HGF levels were upregulated compared to non-stimulated cultures (p = 0.0007), 
similarly, although not significant (Figure 3.14 B), VEGF levels were also 
upregulated. 
 
Figure 3.11 – IL-1ß stimulation on ASCs increase the production of (A) HGF and (B) 
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Biomaterial selection is one of the key factors in determining the success of 
translational therapy (Mount et al., 2015). The biomaterial needs to becompatible 
with the cells encapsulated within, i.e. allowing cells survival during transportation 
(Dash et al., 2018). For the cells to survive, they need to maintain nutrients 
exchange by taking in fresh nutrients and excreting waste, for that the biomaterial 
design must allow this exchange. Biomaterials function as carriers of cells, therefore, 
regardless of delivery method, they should maintain the cells inside the barrier whilst 
allowing the cells to produce factors in response to the environment (Shen et al., 
2008). This is an important feature of a biomaterial. A key aspect of many 
approaches to stem cell therapy is the cells ability to sense the environmental cues 
and produce factors in response to these cues (Ruprecht et al., 2017). For example, 
in an injury penetrating to the corneal stroma, depending on the severity of the 
wound, the cells at the wound site would release signals whilst undergoing 
apoptosis. These signals are usually sensed by adjacent cells to start differentiating, 
migrating and proliferating to close the wound (Jester et al., 1999b). Therefore, if a 
biomaterial were to be applied to the injury site, the cells within the biomaterial must 
sense these cues and start producing growth factor(s) to aid in wound closure. 
Therefore, the biomaterial should be compatible with the cells within and the host 
tissue. To comply with this condition, a biomaterial must undergo various 
adjustments to serve in a specific application without causing any complications.  
Cell migration is essential to many biological processes, such as tissue 
remodelling, immune response and wound healing (Ridley et al., 2003). Cell 
migration requires the cells to be active and to move in a specific direction via 
sensing environmental cues (Mak et al., 2016). These cues (mechanical and 
chemical signals) can polarise and differentiate the cells to an active, motile 
morphology, thus, able to migrate in the direction of these cues (Swaney et al., 
2010). Cell polarisation is essential in defining the leading and trailing ends, via 
allocating proteins, which allow the cells to move in the right direction (Etienne-
Manneville, 2008). In vitro, cell migration is demonstrated using time-lapse 
microscopy as cells can take up to several hours to make a small movement. 
Therefore, in this study, to measure in vitro cells migration, scratch assay was 
chosen as a low-cost, easy to perform, robust albeit relatively simplistic (in terms of 
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wound healing biology) assay (Cory, 2011). A scratch assay can give an accurate 
measure of cells’ behaviour under the effect of specific and well controlled 
conditions. Taking images at the start of the experiments, following the formation of a 
scratch and then taking images at different time points (time lapse), or an image at 
the end of the experiment, results in information on the speed of cell migration (once 
proliferation is accounted for).  
Although the scratch assay is a good method to measure migration it has 
limitations. Cells not only migrate but they proliferate, and the scratch assay does not 
easily differentiate between migration and proliferation. Scratch assay also has a 
technical issue where it requires a uniform scratch across all used cells or conditions 
to give a relatively accurate measure of area closure over time (Liang et al., 2007, 
Jonkman et al., 2014). Upon in vivo cell injury, cells usually release signals that alert 
the body and are recognised by either cellular receptors to initiate a pro-inflammatory 
response or by extracellular sources to stimulate inflammatory response (Rock and 
Kono, 2008). Thus, the advantage of a scratch assay is having an injury response 
model, therefore, it is a suitable method for our research.  
Calcium alginate can be extracted from seaweed which makes it a naturally 
existent polymer. It has been used in drug delivery (Cong et al., 2017), wound 
dressings (Aderibigbe and Buyana, 2018), and protein and enzyme immobilisation 
(Gombotz, 1998). Alginate as a wound dressing material maintains a moist 
environment, reduce bacterial infection, and induce wound healing. Thus, this 
material would be best suited for the entrapment and delivery of cells. Depending on 
the cross-linker used, alginates can be controlled in releasing drug dosage inside the 
wound, which makes them appealing for pharmaceutical applications (Lee and 
Mooney, 2012). For this, alginate hydrogels can be used to deliver cells into the 
injury site to induce the resident cells in regenerating the tissue. Alginate hydrogels 
have been used in cultivating corneal endothelial and limbal stem cells, where it 
suggested that alginate can aid in corneal regeneration (Wright et al., 2012, Liang et 
al., 2011).  It has also been found that alginate maintains ASCs viability and 
functional ability during short-term hypothermic storage (Swioklo and Connon, 2016, 
Swioklo et al., 2016). This ability of alginate is a key feature in the formation of stem 
cells bandages. As such, alginate was used to encapsulate cells in a 3D 
environment in all subsequent experiments.   
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Although calcium alginate is a suitable biomaterial for the formation of stem cell 
bandage, it is still important to determine the source of alginate (Sanchez et al., 
2013). The structure is dependent on the guluronic and mannuronic acid formation, 
which is also dependent on the source (Augst et al., 2006). Therefore, we tested two 
types of alginate sources, the first was purchased from Sigma-Aldrich (extracted 
from Macrocystis pyrifera, referred to as S.) a low molecular weight, non-purified, 
high M acid content. The second is NovaMatrix ultrapure, low molecular weight, and 
high G acid content alginate purchased from FMC Biopolymer (extracted from 
Laminaria hyperborea, referred to as N.). Both of the providers extracted sodium 
alginate from the brown algae cell wall and supplied it in a powder format in different 
levels of purity. While there seemed to be differences in the appearance of the 
powder, from the datasheet, the major differences were found in the viscosity, purity, 
and composition of the G and M acid block copolymers ratio.  
We then sought to determine the cell encapsulation method. In our lab, Swioklo 
et al encapsulated 1x106 adipose-derived stem cells (ASCs) in 0.5mL alginate 
hydrogel discs (Swioklo et al., 2016). The authors crosslinked alginate gels with 
102mM calcium chloride, to produce a gelled disc that contains cells. The formed 
disks were transferred inside a 2ml cryovials with growth medium. The growth 
medium is a reduced serum growth medium (MesenPro RS) supplemented with 
2mM GlutaMAX and 1% v/v antibiotic-antimycotic. 
The two alginate materials were found here to preserve ASCs viability when 
used with a secondary cell population, shown by the cell number counted upon 
release. In our system, the encapsulated cells were separated from the CSCs culture 
by using a transwell system, which serves as a physical barrier that prevents direct 
contact between CSCs and alginate (Rohrschneider et al., 2015). Additionally, we 
used serum-free media, with three days’ serum starvation prior to starting the 
experiment, this would induce the cells to deactivate to an inactive form (Foster et 
al., 2015). Previously, it was shown that serum absence from culture media induce 
partial retrieval of the native keratocyte phenotype from corneal fibroblasts. This 
upturn was expressed by the increase of keratocyte markers such as kertocan, 
lumican, and SLRPs (Beales et al., 1999, Brown et al., 1999, Foster et al., 2015). 
SFM incubation with CSCs fibroblasts was shown to allow the cells to partially return 
to their keratocytes phenotype, thus, allowing the cells to return to their inactive form 
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(West-Mays and Dwivedi, 2006), at which point, the cells were about 90% confluent. 
This was evident when comparing the average time it took for the cell to cover the 
cell-free area when compared to cells cultured with serum media, as such, serum-
free cultured cells showed a slower area coverage. Thus, the beneficial effect seen 
is from having ASCs in culture.  
One of the key aspects of successful stem cell therapy is the scaffolds’ ability to 
maintain cell viability and ability to release growth factors (Ashimova et al., 2019, 
Nicodemus and Bryant, 2008). Another important condition is the transportation of 
therapeutic cells, from the manufacturing site to the clinic where it can take from 
days to weeks (Swioklo and Connon, 2016). Therefore, we sought to test alginate 
ability in maintaining cell survivability during storage. Swioklo et al investigated 
alginate ability to maintain ASCs viability and morphology during three days of 
storage at temperatures ranging from 4°C to 23°C (Swioklo et al., 2016). Upon 
comparing the various temperatures, 15°C storage marked the best temperature in 
maintaining cell survivability when compared to non-encapsulated cells. Upon cell 
release, our results correspond to the results found by Swioklo, therefore, we used it 
with CSCs culture. Data suggested that storing cells at 15°C prior to using with 
CSCs culture to enhance area coverage over time when compared to 4°C and non-
stored conditions in both alginate types. In support of this, we assessed ASCs-
associated surface markers by flow cytometry, where they were maintained during 
encapsulation in both types of alginates following culture with CSCs. These results 
showed Sigma and NovaMatrix alginate to maintain ASCs’ size and granularity. 
ASCs’ surface marker expression profile was mostly similar between cells 
encapsulated in Sigma and NovaMatrix alginates following culture with CSCs 
(Mildmay-White and Khan, 2017). In which cells expressed CD29, CD44, CD73, 
CD90, and MHC class I but not MHC class II, CD14, and CD45. Thus, support our 
belief that alginate can be used as a bandage to immobilise the cells without 
affecting their function. 
 To treat corneal opacity, MSCs were previously tested for the production of 
HGF and VEGF, where it was found that MSCs produce HGF in response to 
inflammatory cytokine IL-1ß (Weng J, 1997b, Weng J, 1997a). It was also found that 
the addition of HGF to a corneal wound can restore corneal transparency by 
inhibiting myofibroblastogenesis (Miyagi et al., 2018). Authors also found that HGF 
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decreases inflammatory cytokines level in a corneal epithelial injury model whilst 
promoting cell proliferation (Torricelli et al., 2016). Therefore, evidence suggests that 
high HGF levels in the cornea can restore corneal transparency while reducing 
inflammatory cytokines. In our results, there was no change in VEGF levels, 
however, the increase in HGF level was associated with the presence of Sigma 
alginate and not the ASCs themselves. HGF levels were also higher in response to 
IL-Iß stimulation compared to non-stimulated cells. Therefore, this effect was 
considered as undesirable in stem cell therapy, since the focus of the therapy is the 
ASCs’ ability to produce growth factors in response to the environmental cues.  
In conclusion, this chapter tested the possibility of using ASCs in corneal 
therapy focusing on comparing two types of alginates Sigma and NovaMatrix 
alginates. We show the importance of using alginate biomaterial to encapsulate and 
store ASCs before use in therapy, where they maintain ASCs viability and functional 
ability during storage. ASCs were also able to maintain the immune surface markers 
in both alginates. Sigma alginate showed superiority over NovaMatrix alginate in 
improving CSCs scratch wound closure. This ability was also shown following 
storage at 4°C and 15°C for 72 hours. Upon further testing this, Sigma alginates 
were found to induce ASCs secretion of HGF and VEGF, which may explain the 
effect we have presented in the Sigma alginate condition. Although it is important to 
have HGF in corneal wound healing, having HGF secreted via the effect of alginate 
would defy the purpose of safe cell therapy. Alginate offer cells cytoprotection during 
storage by reducing cellular edema and osmotic shock while having involvement in 
solute and ion diffusion throughout the matrix (Golmohamadi and Wilkinson, 2013). 
As a material, it demonstrated biocompatibility, reproducibility, and importance in cell 
therapy. As such, our model of NovaMatrix alginate bandages presented a promising 
method of therapy. 
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Chapter 4. Hypothermically stored alginate encapsulated ASCs enhance 
corneal stromal cells scratch wound closure via release of paracrine 
factors 
 
4.1 Introduction  
A considerable body of evidence suggests that mesenchymal stem cells 
(MSCs), have a beneficial effect on corneal injury (Arnalich-Montiel et al., 2008, 
Espandar et al., 2012, Alio del Barrio et al., 2015), especially through their ability to 
produce paracrine factors (Ratajczak et al., 2012, Al-Jaibaji et al., 2019). Adipose-
derived mesenchymal stem cells (ASCs) have been shown to produce various 
cytoprotective and angiogenic factors that aid in cell therapy including vascular 
endothelial growth factor (VEGF) (Kinnaird et al., 2004, Rehman et al., 2004), 
insulin-like growth factor (IGF-1) (Togel et al., 2007), monocyte chemoattractant 
protein (MCP-1) (Kwon et al., 2014), transforming growth factor- B (TGF-ß) 
(Boomsma and Geenen, 2012), hepatocyte growth factor (HGF) (Rehman et al., 
2004), and interleukin-6 (IL-6) (Kwon et al., 2014). It has been shown that MSCs 
reduce inflammation in alkali burn corneas via reducing CD68+ cells of macrophage 
and monocyte lineages and downregulating VEGF, tumor necrosis factor-a (TNF-a) 
and macrophage inflammatory protein -1a (MIP-1a) (Yao et al., 2012). Moreover, 
MSCs growing on the nanofiber scaffold transferred onto alkali-induced oxidative 
injury showed a reduction in neovascularization and inflammatory cell infiltration 
(Cejkova et al., 2013). Tumor necrosis factor-a stimulated gene-6 (TSG-6) secretion 
by MSCs was shown to promote corneal epithelial wound recovery in diabetic mice 
via the activation of local epithelial cells (Di et al., 2017). These studies suggest that 
MSCs produce various paracrine factors that would benefit specific treatments and 
may be used for specific cell therapy.  
 
4.2 Aims 
Our findings in the previous chapter suggest that alginate preserves cells 
functional state during hypothermic storage. Hypothermically stored ASCs bandages 
were shown to have a favorable effect on corneal stromal cells (CSC) and so we are 
closer to the formation of stem cell bandages. However, many more tests are 
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required to evaluate and improve the construction of stem cell bandages. We sought 
to assess different conditions using scratch assay including (i) ASCs ability in healing 
CSCs without the bandage, (ii) encapsulation of different densities of ASCs, (iii) 
conditioned media (CM) production from the bandages, (iv) effect of CM + 
bandages, (v) effect of ASCs lysis (death) and lysate (formed CM during cell lysis), 
(vi) effect of different cell bandages including human dermal fibroblasts (hDF) 
corneal stromal-mesenchymal stem cells (CSF) and keratoconus cells (KC) 
compared to ASCs bandages. Followed by assessment of (vii) CSC and ASCs key 
markers using qPCR, (viii) protein production using Bradford assay, (viiii) collagen 
production using Sirius red, and lastly (x) the paracrine factors produced by ASCs 
bandages using human XL cytokine array kit. Our presented results in this chapter 
elucidate the beneficial effect of ASCs bandages in healing CSC in vitro via the 
production of paracrine factors including HGF, TSG-6, IL8, MCP-1, thrombospondin-
1, among other factors that regulate inflammation and wound healing.  
 
4.3 Results 
4.3.1 ASCs improves corneal stromal cells scratch closure in an indirect co-
culture 
As we want to form bandages, we require a scaffold to maintain the viability 
and function of the cells. However, even without a scaffold, it is known that ASCs do 
indeed improve wound recovery, which has been shown in many in vitro and in vivo 
studies (Almaliotis et al., 2015, Aluri et al., 2017, Arnalich-Montiel et al., 2008). 
Therefore, it is indispensable to measure ASCs’ effect on CSCs without the use of a 
scaffold. To do that, we plated ASCs on a transwell insert either without storage 
(non-stored) or following 72-hours storage at 4°C and 15°C. The cells were left to 
attach to the membrane for 2-hours at 37°C and 5% CO2 with SFM. Two hours 
following incubation, the transwells were carefully washed to remove dead cells and 
incubated with fresh SFM before placing with scratched CSCs cultures (as described 
in chapter 2 2.5). Since the cells were plated on the transwell membrane, we were 
unable to use Iprasense holographic time-lapse microscopy to follow cell 
movements. Instead, we used Leica light microscopy, with images were manually 
taken at 0-, 24-, and 48-hours following scratch.  
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The presence of ASCs improved area coverage (Figure 4.1 A, B), storage 
seemed to play an important aspect in this. Following 15°C storage, at 24 hours, an 
increase in area coverage was found compared to non-stored and 4°C stored cells 
(p = 0.0001 and p > 0.0001 respectively). This difference continued to 48 hours 
when compared to non-stored (p = 0.0157). No difference was found upon 
comparing CSC cell density at 48-hour post scratch (Figure 4.1 C). Interestingly, this 
disparity was seen despite the fact that 15°C stored ASCs density were far less than 
non-stored cells. At 48-hours, 15°C stored ASCs were counted to be 1.89x105 
cells/mL (37.8%) compared to non-stored ASCs 3.96x105 cells/mL (79.2%) and to 
4°C stored ASCs 0.86x105 cells/mL (17.2%). Upon normalizing ASCs number to 
CSCs scratch wound percentage (Figure 4.1 D), significant differences were found 
between non-stored and 15°C at times 24 and 48 hours (p = 0.0479 and <0.0001) 
and to 4°C stored (<0.0001). This suggests that although storage has a certain effect 
on cells in improving their production of paracrine factors, ASCs cell number present 




Figure 4.1 – Wound closure analysis of non-encapsulated ASCs. ASCs were used 
immediately following plating on a transwell membrane or following 72-hours storage 
at 4°C and 15°C. (A) Scratch images taken using light microscopy at times 0-, 24-, 
and 48 –hours. (B) Wound closure percentage over time. (C) CSCs cell density at 
48-hours. (D) ASCs cell number normalized to CSCs scratch area. Values are 
presented as mean ± SEM from three separate keratocytes donors, asterisks 
represent significance between non-stored and 15°C stored conditions (****, p < 













































































0.0001; ***, p < 0.001; *, p < 0.05), while symbols represent significance between 
15°C and 4°C stored ASCs (§§§§, p < 0.0001) and 4°C and non-stored (^^^^, p < 
0.0001). Scale bar = 220µm for the non-stored and 4°C stored and 110µm for the 
15°C stored. Non-stored and 4°C stored images taken using 4x magnification, while 
15°C images taken using 10x magnification.           
 
4.3.2 Encapsulated ASCs density determines area coverage speed  
Although in the previous chapter we encapsulated the same number of ASCs 
(1x106 cells), we still needed to measure the effect of cell density on CSCs. We 
expect with more ASCs in culture the faster the area will be covered by CSCs i.e. 
dose-response. Thus, we encapsulated a range of ASCs densities (10,000 cells, 
100,000, cells and 500,000 cells) in alginate and used that with scratched CSCs 
(Figure 4.2 A). ASCs were used immediately following encapsulation (i.e. without 
storage). In agreement with our speculations (Figure 4.2 B), the more cells 
encapsulated, the faster the area covered by CSCs, where encapsulating 1x106 cells 
showed significant improvement in area coverage compared to all other densities at 
24 hours (p > 0.0001). This significance persisted to 48 hours when compared to 
0.01x106 cells encapsulated (p = 0.0004). Significant increase in CSCs cell number 
with the 1x106 cells ASCs following scratch healing compared to 0.01x106 cells and 
0.1x106 cells (p = 0.0355 and 0.0365 respectively), which supports our theory of the 




Figure 4.2 – Wound closure analysis of ASCs cell dilution. ASCs were used 
immediately following encapsulation. (A) Scratch images taken using light 
microscopy at times 0-, 24-, and 48 –hours. (B) Wound closure percentage over 
time. (C) CSCs density at 48 hours. Values are presented as mean ± SEM from 
three separate keratocytes donors, asterisks represent significance between 1x10^6 
cells and 0.01x10^6 cells (****, p < 0.0001; *, p < 0.05). Scale bar = 220µm. The 
difference in images is due to technical issues.  
 
4.3.3 Conditioned media enhances area coverage  
 In our system, to determine ASCs’ suitability as a bandage, we need to test the 
release of therapeutic soluble factors. It is expected that encapsulated ASCs secrete 
a cocktail of factors into the media, thus, we needed to know the storage effect on 





























































because they are environmentally responsive, we sought to test the conditioned 
media (CM) produced from the encapsulated ASCs. ASCs were encapsulated and 
stored at 4°C and 15°C for 72-hours with SFM without disruption, at which point, the 
media were collected and considered as CM (explained in chapter 2 2.9). This CM 
was taken from the encapsulated cells and the alginate controls. Two concentrations 
were used with CSC scratches, 50% CM diluted in 50% SFM, and 100% CM. These 
two concentrations were used with the assumption that ASCs produce paracrine 
factors during storage and so the more CM used the greater the effect on CSC 
scratch closure will be seen.  
CM taken from 4°C stored ASCs bandages showed a significant increase in 
area coverage compared to alginate only CM (Figure 4.3 A, B, C). 20-hours following 
scratch induction, CSC incubated with CM taken from 50% Encaps. showed a 
significant increase in area coverage compared to CM taken from 50% alginate (p = 
0.0297), similarly, 100% Encaps. showed a significant decrease in the cell-free area 
compared to 100% alginate (p > 0.0001). This significance persisted at times 30- 
and 40-hours post scratch for both 50% CM (p = 0.0001) and 100% conditioned 
media (p < 0.0001 and 0.0001 respectively). Upon comparing 50% and 100% CM 
taken from ASCs bandages, differences were shown at times 20- and 30-hour post 
scratch (p = 0.0010 and 0.0282 respectively). These results suggest that the CM 
taken from stored ASCs bandages to contains factors released from the cells that 
can aid in wound recovery. 
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Figure 4.3 – Wound closure analysis of conditioned media taken from 4°C stored 
alginate +/- ASCs. Condition media were either diluted with SFM or used without 
dilution. (A) Scratch images taken using Iprasense at times 0-, 20-, and 40 –hours. 
(B) Average scratch width (C) Percentage wound closure. Values are presented as 
mean ± SEM from three separate keratocytes donors, asterisks represent 
significance 100% Encaps. and 100% alginate (****, p < 0.0001; ***, p < 0.001), 
while (^) symbol represent significance between 50% Encaps. and 50% alginate 
(^^^, p < 0.001; ^, p < 0.05). The (§) symbol represents significance between 100% 
Encaps. and 50% Encaps. (§§, p < 0.01; §, p < 0.5). Scale bar = 300µm. Alginate, 
bandage – ASCs; Encaps, bandage + ASCs. 
 
 
CM taken form 15°C stored alginate encapsulated ASCs also showed 
significant improvement in wound coverage (Figure 4.4 A, B, C). 50% conditioned 
media showed a significant increase in area coverage compared to conditioned 
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media taken from alginate controls at times 30- and 40-hours post scratch (p = 
0.0079 and 0.0145 respectively). Whereas 100% conditioned media taken from 
encapsulated cells also showed significant difference at times 20-, 30-, and 40-hours 
post scratch (p = 0.0015, 0.0002 and 0.0085 respectively). Whilst 50% and 100% 
conditioned media taken from encapsulated cells showed significant difference at 
time 20 hours post scratch (p = 0.0114). From the graph, although not significant, 
there seems to still be a difference between the two conditions.  
 
 
Figure 4.4 – Wound closure analysis of conditioned media taken from 15°C stored 
alginate +/- ASCs. Condition media were either diluted with SFM or used without 
dilution. (A) Scratch images taken using Iprasense at times 0-, 20-, and 40 –hours. 
(B) Average scratch width. (C) Percentage wound closure. Values are presented as 
mean ± SEM from three separate keratocytes donors, asterisks represent 
significance 100% Encaps. and 100% alginate (***, p < 0.001; **, p < 0.01), while (^) 
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symbol represent significance between 50% Encaps. and 50% alginate (^^, p < 0.01; 
^, p < 0.5). The (§) symbol represents significance between 100% Encaps. and 50% 
Encaps. (§, p < 0.05). Scale bar = 300µm. Alginate, bandage – ASCs; Encaps, 
bandage + ASCs. 
 
To determine which storage temperature improves cell production of growth 
factor, we compared 50% and 100% CM taken from 4°C and 15°C. However, no 
significant differences were found between the conditions. Next, we sought to 
determine the possibility of using double-conditioned CM. It was interesting to test 
whether the co-culture used up all the beneficial factors within the CM during scratch 
healing. If so, then it is expected to see no effect on CSC or a reverse effect because 
the double-conditioned CM will contain the waste produced from the co-cultured cells 
during scratch healing.   
Following the use of 100% CM with CSCs healing, we collected that media and 
used it again with another population of scratched CSC. Double-conditioned CM 
should contain all the growth factors released from ASCs bandages during storage, 
adding to that, the growth factors released during scratch recovery. The downside of 
this is that this Double-conditioned CM contains all the factors produced by the two 
cell populations, and we have not explored the effect of CSC CM alone.  
We used 15°C storage 100% CM with CSC for 48-hours, followed by another 
48 hours of scratch healing with another CSC scratch culture (Figure 4.5 A). 
Interestingly, significant differences were found between the Double-conditioned CM 
from bandages ± ASCs (Figure 4.5 B &C). At 20-hours post-scratch, a significant 
increase in wound coverage was seen over time (p = 0.0203) which persisted to 
times 30-, and 40-hours post scratch (p = 0.0017 and 0.0005 respectively). This, 
however, when compared to 100% CM showed the disadvantage of using double-
conditioned CM, where the latter showed a significant delay on area coverage at 
times 20-, 30-, and 40-hours post scratch (p = 0.0006, 0.0020 and 0.0105 
respectively). This may suggest that the most active factors are from the ASCs 
rather than CSC since ASCs’ growth factors would have been used during culture 
with first CSCs. 
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Figure 4.5 – Wound closure analysis of double conditioned media taken from 15°C 
stored alginate +/- ASCs. A) Scratch images taken using IPRASENS at times 0-, 20-, 
and 40 –hours. B) Average scratch width. (C) Percentage wound closure. Values are 
presented as mean ± SEM from three separate keratocytes donors, asterisks 
represent significance between conditions (***, p < 0.001; **, p < 0.01; *, p < 0.05). 
Scale bar = 300µm. 
 
4.3.4 Combination of 15°C stored encapsulated ASCs conditioned medium 
with ASCs bandages have improved effect on corneal scratch wounds 
Following CM assessment, and determining the effect of 100% CM, we wanted 
to assess whether this CM caused an additive effect. ASCs bandages stored at 15°C 
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bandages plus their formed CM with CSC scratch wound, the combinative effect was 
seen on CSC scratch closure (Figure 4.6 A). Comparing the combination of ASCs 
bandages with CM (Encaps.Combi) and the ASCs - bandage with their CM 
(Alginate.Combi) (Figure 4.6 B &C), significant differences were seen at times 20, 30 
and 40 hours post scratch (p = 0.0121, 0.0032 and 0.0058 respectively). Upon 
comparing Encaps.Combi to ASCs bandages and to CM only, no significant 
differences were found. This experiment, however, was made using only 2 technical 
repeats and the results would need to be further validated. 
  
Figure 4.6 – Wound closure analysis of combined conditioned media and alginate +/- 
ACs following 15°C stored. (A) Scratch images taken using Iprasense at times 0-, 
20-, and 40 –hours. (B) Average scratch width. (C) Percentage wound closure. 
Values are presented as mean ± SEM from three separate keratocytes donors, 
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asterisks represent significance between conditions (**, p < 0.01; *, p < 0.05), scale 
bar = 300µm. 
 
4.3.5 Cell lysis within alginate slightly improves wound area coverage  
Having the cells alive inside the gel means they can respond to the 
environmental cues. However, we wanted to assess whether growth factors are 
released from the encapsulated ASCs during culture with CSCs (in response to co-
culture, i.e. active response to injury) or during storage (passage response) but are 
suppressed inside the gel then released over time upon return to normal therma. 
And so, we sought to assess the cell lysis effect within the scaffold using the freeze-
thaw cycle, assuming that this would release all GF from within the ASCs).  
Following 72-hour storage at 4°C and 15°C, encapsulated ASCs were 
incubated at -80°C for 2-hours followed by 30 minutes incubation at room 
temperature, to allow the gels to thaw at room temperature before using with CSC 
culture. At which point, the cells were released and incubated with live/dead staining 
to assess cell survival where the cells showed an average of 98% dead cells. For the 
freezing process, the encapsulated cells were washed and incubated with fresh SFM 
to remove any possible growth factors present and released during storage. The 
formed SFM following freezing were considered as lysate for they contain all the 
contents of the lysed cells. Thus, we compared gels containing cells that had been 
frozen (cell lysis) plus media (lysate) to gels containing cells that had been frozen 
without media (Figure 4.7 and 4.8).  
At 4°C storage (Figure 4.7 A, B &C), a significant difference was found between 
the two conditions, where the presence of lysate (ASCs lysis plus lysate) in culture 
presented improvement in wound coverage significantly shown at times 20-, 30-, and 
40-hours post scratch (p = 0.005, 0.0032 and 0.0268 respectively). Upon comparing 
it with live cells, cell lysis plus lysate showed improvement of wound coverage 
significantly shown at times 20- and 30-hours post scratch (p = 0.0253 and 0.0227 
respectively). Interestingly, live cells showed a similar effect to lysed cells (without 
lysate), which can be explained by (i) the number of live cells inside the gel before 
use with CSCs being low, (ii) growth factors within gel released during storage to be 
the main source and not from the cells during culture with CSCs, or (iii) ASCs require 
time to adjust upon return to normal therma to start releasing growth factors.  
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Following 15°C storage (Figure 4.8 A, B &C), no significant differences were 
found upon comparing ASCs lysis plus lysate to ASCs lysis without lysate. However, 
from the graph, there seems to be a slight difference between the two conditions. 
Where ASCs lysis plus lysate showed improvement in CSCs scratch wound closure 
compared to ASCs lysis without lysate. Upon comparing ASCs lysate plus lysis and 
ASCs lysate without lysis to encapsulated ASCs, the latter still presented an 
improved wound recovery. This could be attributed to the cells themselves being 
able to release growth factors in response to the environment. 
 
Figure 4.7 – Wound closure analysis of In-scaffold lysis, taken from 4°C stored 
encapsulated ASCs. Encapsulated ASCs were incubated at -80°C for two hours 
before thawing at room temperature and incubating with scratch wound. (A) Scratch 
images taken using Iprasense at times 0-, 20-, and 40 –hours. (B) Average scratch 
width. (C) Percentage wound closure. Values are presented as mean ± SEM from 
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conditions (**, p < 0.01; *, p < 0.05). Scale bar = 300µm. ASCsLysis, following 
thawing, encapsulated ASCs incubated with fresh SFM before placing with scratch 
wounds; ASCLysis + Lysate, following thawing, encapsulated ASCs and their formed 
lysate incubated with scratch wounds. 
 
Figure 4.8 – Wound closure analysis of In-scaffold lysis, taken from 15°C stored 
encapsulated ASCs. Encapsulated ASCs were incubated at -80°C for two hours 
before thawing at room temperature and incubating with scratch wound. (A) Scratch 
images taken using Iprasense at times 0-, 20-, and 40 –hours. (B) Average scratch 
width. (C) Percentage wound closure. Values are presented as mean ± SEM from 
three separate keratocytes donors, Scale bar = 300µm. ASCsLysis, following 
thawing, encapsulated ASCs incubated with fresh SFM before placing with scratch 
wounds; ASCLysis + Lysate, following thawing, encapsulated ASCs and their formed 
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4.3.6 Assessment of ASCs specificity  
The following part will discuss the possibility of encapsulating different types of 
cells and assessing them in healing CSC scratch wounds.  
4.3.7 Encapsulated human dermal fibroblasts bandages used as a negative 
control for CSCs scratch wound healing 
For stem cell bandages, we assessed the possibility of using ASCs in healing 
scratch wounds because of their well-known regenerative properties, however, other 
cell types have also been used in wound recovery. Human dermal fibroblasts (hDF) 
are normally responsible for skin wound healing (Froget et al., 2003, Tracy et al., 
2016), thus, we wanted to assess their use in corneal recovery. 
Alginate encapsulated hDF were used either immediately following 
encapsulation (non-stored) or 3 days storage at 4°C and 15°C with CSCs scratch 
wounds. Although hDF are usually used in healing skin wounds, in our system 
encapsulated hDF slowed CSCs scratch wound closure (Figure 4.9 A, B &C). Where 
there seemed to be a similar delay in corneal cell migration into the cell-free area in 
all used conditions (non-stored, 4°C and 15°C stored encapsulate hDF). Upon 
comparing encapsulated hDF to alginate only controls there was no significant 
difference in scratch wound healing, however, encapsulated hDF still presented a 
delay in wound closure. Whereas encapsulated ASCs presented significant 
improvement compared to encapsulated hDF. Comparing non-stored encapsulated 
hDF to non-stored encapsulated ASCs significant differences were found at times 
30- and 40-hour post scratch (p = 0.0146 and <0.0001 respectively), similarly, when 
comparing 4°C stored cells (p = 0.0331 and <0.0001), and 15°C stored cells (p= 
0.0090 and 0.0039 respectively). These results suggested the importance of using 
ASCs with corneal injuries. Looking at Alginate alone results we see there is an 
effect from Alginate alone on CSC scratch wound, from this experiment however, 
there is no significant difference which can indicate hDF to promote CSC, this 
however could not be confirmed due to the lack of appropriate experiment of hDF 
only control.   
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Figure 4.9 - Wound closure analysis of encapsulated human dermal fibroblasts 
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storage at 4°C and 15°C. (A) Scratch images taken using Iprasense at times 0-, 20-, 
and 40 –hours. (B) Average scratch width. (C) Percentage wound closure. Values 
are presented as mean ± SEM from three separate keratocytes donors asterisks 
represent significance between bandages (****, p < 0.0001; ***, p < 0.001, **, p < 
0.01). Scale bar = 300µm.  
 
4.3.8 Encapsulated corneal-derived mesenchymal-like stromal cells bandages 
improves corneal scratch area closure 
It has been suggested that corneal stromal fibroblast (CSF) are in fact 
mesenchymal-like stem cells (Eslani et al., 2017, Vereb et al., 2016, Branch et al., 
2012, Pinnamaneni and Funderburgh, 2012). Thus, we wanted to determine the 
possibility of using these cells in CSCs scratch healing. Hence, we encapsulated 
CSF and used them either immediately following encapsulation (non-stored) or 
following 72 hours storage at 15°C (Figure 4.10 A, B &C) with our standard scratch 
assay. Although the presence of these cells did improve wound closure, there was 
no difference when compared to alginate only controls. No differences were found 
upon comparing encapsulated CSF to encapsulated ASCs in the non-stored 
condition and the 15°C stored cells. However, there was a slight improvement of 
area closure in the 15°C stored encapsulated ASCs compared to encapsulated CSF.   
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Figure 4.10 – Wound closure analysis of encapsulated corneal stromal fibroblasts 
(CSF). CSF were used immediately following encapsulation or following 72 hours 
storage at 15°C. (A) Scratch images taken using Lica microscopy for the non-stored 
and Iprasense holographic microscopy at times 0-, 20-, and 40 –hours. (B) Average 


















0 100 100 100 100 100
10 82.72314343 78.13118194 86.90368731 72.53508148 89.83239473
20 61.83004392 50.31418161 62.50073856 37.012002 70.75146893
30 43.37750084 30.18385353 38.22205016 11.90677761 54.94253768
40 9.411863258 9.279878252 13.40905716 6.245047377 37.07073254





















































from three separate keratocytes donors. Scale bar = 110µm for the non-stored and 
300µm for the 15°C stored. 
 
4.3.9 Human keratoconus bandages for CSC scratch wounds 
Keratoconus (KC) is a progressive eye disease where the cornea loses its 
typical curved shape and thins to a cone-like shape (McMonnies, 2009). KC cells are 
extracted from the corneal stromal layer for they lack healthy keratocytes (McKay et 
al., 2017b). Therefore, we thought it interesting to assess the effect of diseased cells 
on healthy cells. As before, we compared two conditions, non-stored and 15°C 
stored KC bandages (Figure 4.11 A, B &C). In both conditions, a decrease in wound 
area were found, at approximately 30-hours post scratch however, the wound area 
increased in size, where there seemed to be a change in healthy cells morphology 
and more cells dying and detaching. Although this was not detected in other 
experiments, this result suggested that there could be factors released from the 
diseased cells that have a negative effect on the healthy cells, or, the lack of fresh 
media affected both cultures. seeing as we did not add fresh media to the duration of 
the incubation time, we expect that there was a competition between the two cell 
types for the nutrients in the media and so there was a decrease in healthy cells. 
Although the presence of KC improved cell coverage when compared to alginate 
only control, significantly shown at time 30-hour (p = 0.0185), they were still slower 
than ASCs. Upon comparing non-stored encapsulated KF to non-stored 
encapsulated ASCs, differences were found at time 40-hour post scratch (p = 
0.0106), whereas 15°C stored ASCs showed significant improvement in scratch 
closure at times 30- and 40-hour (p = 0.0058 and 0.0012 respectively).   
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Figure 4.11 – Wound closure analysis of KC bandages. KC were used immediately 
following encapsulation or following 72 hours storage at 15°C. A) Scratch images 
taken using light microscopy at times 0-, 20-, and 40 –hours. B) Wound closure 
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from three separate keratocytes donors asterisks represent significance between 
bandages (***, p < 0.001; *, p < 0.05). Scale bar = 220µm. 
4.4 Cells expression markers  
Following the experiments with Encapsulated ASCs, CSCs markers were 
analyzed at the gene transcription level and compared to the serum-free controls. 
Primer efficiency was calculated from the efficiency curves using ‘Efficiency =10(-
1/slope) -1’equation. The efficiency value of 2 represents 100% efficiency. Primer 
efficiency values for the genes used with CSCs (Figure 4.12 A-G) and ASCs (Figure 
4.13 A-H) showed a good correlation coefficient.   
 
 
Figure 4.12 – Primer efficiency curves for (A) DCN, (B) LUM, (C) VIM, (D) aSMA, (E) 
ALDH3A1, (F) GAPDH. 5-fold dilutions were performed on cDNA pooled from all 
samples. Log cDNA concentrations plotted against Ct values and efficiency 
calculated (G). Data expressed as mean of duplicated values form a single 
experiment.  
 





























































































































































Figure 4.13 – Primer efficiency curves for (A) TSG-6, (B) HGF, (C) VEGF, (D) 
HIF1A, (E) IGF, (F) REX1, (G) GAPDH. 5-fold dilutions were performed on cDNA 
pooled from samples. Log cDNA concentrations plotted against Ct values and 
efficiency calculated (H). Data expressed as mean of duplicated values form a single 
experiment. 
 
 CSC gene expression data were normalised to scratched cells incubated with 
SFM (Ctrl) (Figure 4.14). Results showed a clear decrease in CSCs gene expression 
levels (DCN, LUM, VIM, and aSMA) when cultured with encapsulated ASCs. 
Particularly, the following storage, where DCN expression was significantly reduced 
following exposure to ASCs previously-stored at 4°C and 15°C (p = 0.0005 and 
0.0286 respectively). Whereas corneal crystalline gene expression ALDH3A1 was 
significantly enhanced following exposure at 15°C stored ASCs compared to the 
control, non-stored, and 4°C stored Encaps (p = 0.0049, 0.0060 and 0.0337 

































































































respectively). As such, encapsulated ASCs seemed to be affected by storage to 
produce paracrine factors that reduce corneal cell gene levels.  
 
Figure 4.14 – Corneal stromal cells marker expression at the gene transcription 
level. Key corneal stromal markers, Decorin (DCN) (A), lumican (LUM) (B), vimentin 
(VIM) (C), aSMA (D) and ALDH3A1 (E) expressions were assessed. Values are 
presented as mean ± SEM of three separate donors, asterisks represent significance 
between conditions and control sample (***, p < 0.001; **, p < 0.01; *, p < 0.05), 
symbols represent difference between 15°C storage and other conditions (^^, p < 
0.01; ^, p < 0.5). 
 
Furthermore, ASCs markers were analyzed at the gene transcription level and 
normalised to normal ASC culture controls. (Figure 4.15). Comparing ASCs 
bandages following storage to following scratch healing. Results showed that 
storage decreased anti-inflammatory gene coding TSG-6 and HGF gene expression 
while increasing VEGF, aSMA (p = 0.0374, and 0.0172), IGF, and HIF1A gene 
expressions. Whereas, healing increase TSG-6 (p = 0.0441) and HGF gene 
expression, whilst reducing VEGF, HIF1A, aSMA, and IGF gene expression. ASCs 
also expressed high levels of REX1 gene responsible for stem cell phenotype (p = 




































































































































































































active role in wound repair and that these cells may be affected by CSC presence in 
a bidirectional signaling pathway.  
 
Figure 4.15 – Adipose derived stem cells marker expression at the gene transcription 
level. Key ASCs markers, TNF-stimulate gene-6 (TSG-6) (A), hepatocyte growth 
factor (HGF) (B), vascular endothelial growth factor (VEGF) (C), hypoxia inducible 
factor 1 subunit alpha (HIF1A) (D), insulin like growth factor (IGF) (E), and REX1 (F) 
expressions were assessed. Values are presented as mean ± SEM of three separate 
donors. ( **, p < 0.01;*, p < 0.05). 
 
4.5 Assessment of soluble protein concertation within the media 
Bradford assay was performed on conditioned media produced following each 
experiment to determine soluble protein concentrations produced. The experiments 
were made in the presence of CSC except for 15°C Encaps-storage and 4°C 











































































































































































Results were plotted against a standard curve made of bovine serum albumin (BSA) 
protein standard provided by the manufacturer (Figure 4.16 A).  
To start with (Figure 4.16 B), CSC cultured with SFM had a 6 ± 2.6-fold 
increase in protein concentration over 48-hours culture. whereas 15°C and 4°C 
Encaps-storage had 7.4 ± 4.5- and 12.9 ± 3-fold increase in protein concentration 
over 48-hour culture. Upon comparing the encapsulated ASCs to alginate controls 
stored at 15°C and 4°C, 8.5 ± 5.1- and 13. 5 ± 1.5-fold increase in protein 
concentration was found. This increase implies that ASCs had an effect on CSC 
cultures via the production of paracrine factors and this production of factors was 
enhanced upon culturing with CSC. We also measured the protein concentrations of 
the encapsulated ASCs dilution (10,000, 100,000 and 500,000 cells), non-
encapsulated Non-stored (Non-stored, 15°C and 4°C stored NE) ASCs, and the 
ASCs + CM at 48-hour culture with CSC scratch wound (Figure 4.16 C). Although no 
significant differences were found between the conditions and the SFM controls, 
there seems to be a trend in protein concentration in relation to the increase in ASCs 
number. Non-encapsulated ASCs also had a similar effect, where non-stored and 
15°C stored ASCs had an increase in protein concentration compared to 4°C stored. 
This can be attributed to ASCs cell number as mentioned before (section 4.3.1) 
being lower in the 4°C stored. This suggests that cell number play a vital role in 
paracrine factors production.  
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Figure 4.16 – Soluble protein concentrations. (A) Values plotted against standard 
curve made of bovine serum albumin. Comparing (B) the media taken following 72h 
storage and protein concentration at time 48h, (C) media taken from ASCs dilution, 
and non-encapsulated (NE) ASCs following 48 hours incubation of non-stored and 
following 4°C and 15°C storage. Values are presented as mean ± SEM of three 
separate keratocytes donors, asterisks represent significance (*, p < 0.05). Ctrl, 
serum-free media at time 48 hours taken following CSCs scratch wound healing.  
 
4.6 Assessment of collagen production  
Sirius red assay was performed on CSCs cultures following scratch healing. 
The stained materials were imaged and absorbance measured at 490nm and 
compared to SFM control samples. Absorbance results were plotted against a Rat 
Tail Collagen I (First Link Ltd, UK) standard curve made at different concentrations 
(Figure 4.17 A). In general, results suggested a trend between different conditions. A 
5.9 ± 0.7 mg increase in collagen amount produced from the CSCs when cultured in 
the presence of non-stored encapsulated ASCs compared with the amount of 
collagen produced from SFM control group (Figure 4.17 B, Bi). Moreover, 11.9 ± 9.7 


























































































































































































































































































































































and 17 ± 6.2 mg increase in collagen amount from the CSCs found when cultured in 
the presence of 15°C and 4°C stored encapsulated ASCs. However, upon 
comparing the alginate only groups to the SFM control we see similar increases in 
collagen production i.e. a 1.0 ± 0.7 mg increase in collagen amount with the non-
stored alginate alone, 13.1 ± 10 mg fold increase with the 15°C stored alginate alone 
and 13.9 ± 10.5 mg increase with the 4°C stored alginate alone. Interestingly, when 
comparing the Encapsulated ASCs to the alginate control conditions, we found an 
increase in collagen amount in the non-stored and the 4°C stored by 4.8 ± 0.0 mg 
and 3.0 ± 4.3 mg and a decrease in the 15°C stored by 1.1 ± 0.5 mg. Upon 
normalizing collagen amount to cell number, alginate only showed an increase in 
collagen production compared to ASCs encapsulated groups, which can indicate that 
alginate can have an effect on cell production on collagen. This effect may be driven 
by alginate ability to sequester ions from the media and so CSC becomes non-motile 
thus produce collagen (Figure 4.17 C). 
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Figure 4.17 – Assessment of collagen amount. (A) Values plotted against standard 
curve made of Rat Tail Collagen I, (B) total collagen amount of each condition, (Bi) 
representative images of collagen stained CSCs cultures taken at 48 hours. (C) 
Collagen amount normalised to cell number. Values are presented as mean ± SEM 
of three separate keratocytes donors, Scale bar = 100µm. Ctrl, serum-free cultures.  
 
4.7 Proteome profiler human XL cytokine array 
To assess which factors were produced by the ASCs, a Human XL Cytokine 
Array (R&D Systems, Abingdon Science Park, Abingdon, UK) was used to detect 
109 different soluble growth factors, cytokines, chemokines and other soluble 


































































































































































proteins within the 8 different conditioned media (Diagram 4.1). The detected protein 
levels were expressed relative to an internal (by the manufacturer) positive control 
for each sample, which allowed for a direct semi-quantitative comparison between 
samples. Cells were treated with SFM labeled as ‘CSC’, plus alginate only, labeled 
as ‘CSC + alginate’, non-encapsulated ASCs either non-stored or stored at 15°C in 
the presence of CSCs, labeled as ‘Non-Stored Non Encaps’ and ‘15°C Non-Encaps’, 
non-stored or 15°C stored encapsulated ASCs, labeled as ‘Non-Stored Encaps’ and 
‘15°C Encaps’. Lastly, conditioned media were taken from encapsulated ASCs 
following 15°C storage for 72 hours, labeled as ‘15°C Storage’, and double stored 
encapsulated ASCs (encapsulated ASCs stored at 15°C for 72 hours followed by 
storage at 37°C for 48 hours), labeled as ‘2x Storage’, which represented the 
storage effect on ASCs (Figure 4.18).  
Cultured CM was generated for each condition. 0.5mL CM was taken following 
each experiment and analysed with the array kit, ImageJ used to quantify the dot 
blots. Of the 109 soluble factors on the array, 30 were detected. Most of the tested 
angiogenic factors, including angiogenin, VEGF, and MCP-1 were detected in the 
CSC, CSC + alginate (Figure 4.18 and 4.19), and 15°C Encaps conditioned media. 
Furthermore, these conditions produced significantly high levels of chemotactic 
factor growth-related oncogene (GROa) and stromal cell-derived factor-1 (SDF-1). 
Whilst most of the IL family proteins were not detected, except for IL-6 and IL-8 and 
a small amount of IL-17A and IL-18 Bpa. Most of the detected factors were 
upregulated in the 2x storage condition when compared to the 15°C storage, which 
may indicate that encapsulated ASCs produce more factors upon return to culture 
condition. However, for technical issues 15°C storage CM were used following a 
cycle of freeze-thawing at -80°C, thus, the shown result for this condition is 
unreliable. On the other hand, non-encapsulated ASCs conditioned media showed 











(ii) Calcium alginate stored at 15°C prior to use with CSC
(v) Encapsulated ASCs Stored at 15°C prior to use with CSC
(vi) Used following encapsulation with CSC (non-stored)
(vii) ASCs stored at 15°C prior to use with CSC
(viii) ASCs used following attachment with CSC (non-stored)
(i) SFM used with CSC
(iv) Encapsulated ASCs Stored at 15°C prior to storage at 37°C
(iii) Encapsulated ASCs Stored at 15°C only
CSC
CSC	+	Alginate












































































































Figure 4.18 – Cells production of paracrine factors. A Human XL Cytokine Array kit 
was used to measure the relative number of paracrine factors produced by the 
encapsulated cells at 48 hours in (A, Ai) the CSC and CSC+ alginate, (B, Bi) 15°C 
stored ASCs and 15°C+37°C stored ASCs, (C, Ci) Non-stored and 15°C stored non-
encapsulated ASCs, and (D, Di)non-stored and 15°C stored ASCs used with 
CSCcultures. Values are presented as mean ± SEM of two technical repeats, 












































































































































































































































































































































































































































































































































































































Figure 4.19 – Spider Radar plot of all 30 markers showing the difference in marker 









































































































































































































































































4.8 Discussion  
This chapter explored the effect of ASCs bandages on in vitro primary CSC 
cultures. Cell transplantation is becoming an important concept for the modern 
pharmaceutical industry. ASCs, although they have limitless potential in medicine, 
they still hold major concerns in clinical settings. Testing the functional activity of the 
cells is the first step in producing pharmaceutical therapy. Therefore, measuring 
ASCs’ affect and their production of paracrine factors, i.e HGF, IGF, VEGF, IL, and 
many other factors that could affect wound closure has been used to investigate the 
effect of this potential therapy. The search for the best conditions/parameters to 
store ASC for optimum clinical effect is still ongoing (Patrikoski et al., 2019). For 
example, storage temperature and duration, cell condition, number, and type must 
be adjusted to produce a product. 
We tested ASCs’ ability to ‘heal’ corneal scratch wounds. ASCs were either 
stored (at 4°C or 15°C) for 72 hours or non-stored (used following normal culture at 
37°C). 15°C storage showed significant improvement in wound closure compared to 
non-stored and 4°C stored cells. These are encouraging results similar to the 
previous chapter where 15°C storage enhanced the cells to produce paracrine 
factors. Thus, we suggest storage to be a hypoxic condition. Hypoxia induces ASCs 
to enhance their potential in producing factors (Zachar et al., 2011, Chung et al., 
2009, Riis et al., 2017). Literature showed cells to retain or enhance their ability 
following storage in hypoxic conditions using different wound models (Riis et al., 
2017, Schive et al., 2017, Chung et al., 2009). However, we needed to further 
validate this theory in terms of stem cell bandages.  
Cell number is an important factor for stem cells bandage formation (Bohari et 
al., 2011). We assumed that cell numbers play a role in the observed rate of wound 
healing, where the more cells we have the more paracrine factors produced and the 
faster the closure of the scratch wound. To test this, we encapsulated and compared 
a range of ASCs cell numbers (10,000, 100,000, 500,000 and 1,000,000 cells). 
Storage can lead to cell loss (Angel et al., 2016), thus, cells were used immediately 
following gel formation. Our data suggest ASCs ability to produce paracrine factors 
to be in proportion to their number. This, however, was only done with normal culture 
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(i.e. non-stored cells), the question arises whether we see the same effect following 
storage. Storage at 15°C does enhance the cells to become more active and to 
enhance their ability to affect wound closure, as was seen in the previous chapter. 
Hence, we expect to see an additive effect of storage and cell number; however, we 
did not further test this theory.  
Cell-free therapy is gaining much interest in therapy. CM contains all the 
elements produced by the cells during storage such as cytokines, chemokines, and 
growth factors (Dowling and Clynes, 2011). It has been investigated in various 
wound models including heat shock (Mahat and Lis, 2017), cell differentiation (Yang 
et al., 2014), and regenerative medicine (Pawitan, 2014) where they found it to be an 
effective treatment. CM that contains the factors produced by ASCs were tested and 
used in the healing of various diseases (Shan et al., 2018, Lee et al., 2014, Lee et 
al., 2016, Yang et al., 2010). Therefore, CM as a therapeutic tool has become 
popular in recent years. CM produced from our ASCs bandages were shown to 
improve CSC wound healing. Double CM, a condition we used to test whether 
beneficial factors produced during wound healing remain when used again with 
different cultures showed a reduction in wound healing. This reduction can be due to 
the waste materials present in the media or the beneficial factors present used 
during the first wound healing, both of which can show the importance of using fresh 
CM (Mahat and Lis, 2017).  
Since CM showed improvement in wound closure, the next question we asked 
whether this CM coupled with the bandages can present us with better wound 
coverage. Interestingly, no differences were observed compared to using bandages 
on its own. In vitro studies of ASCs-derived CM showed enhanced wound closure 
and fibroblast migration (Stojanovic and Najman, 2019, Ong et al., 2017). Our data 
support other published data in that ASCs bandages and CM improve wound 
healing, however, to our knowledge, no other investigations have been done on 
using both bandages + CM in wound healing. Although we show no significant 
difference in combining the two conditions, this would need to be further 
investigated. Also, we did not generate CM from cells during normal culture, which 
limits our data interpretation and should be added in future experiments.  
To test whether ASCs have an active effect on wounds rather than a passive effect, 
we induced cell death within the bandages.  
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According to our knowledge, no published data were found aimed at assessing 
the effect of dead ASCs bandages on wound healing. Many in vitro and in vivo 
studies focused on finding new cell-free ASCs based therapies, utilizing cell 
secretome where they found it to promote wound healing (Stojanovic and Najman, 
2019, Kober et al., 2016, Park et al., 2018, Lombardi et al., 2019). In our experiment, 
dead-ASCs bandages + their CM (lysate) improved scratch wound closure, this, 
however, fell short when compared to having live cells in cultures. Thus, support our 
hypothesis that ASCs able to actively release paracrine factors in response to the 
signals present in the culture. This is also supported by the gene expression data 
showing that CSCs can influence ASCs’ behavior.  
We then sought to assess the role of ASCs and whether we can replace them 
with an alternative cell type. We tested hDF, CSF, and KC bandages in healing CSC 
wounds. When compared to ASCs, hDF presented a major delay in wound healing, 
while CSF and KC presented a delay in wound recovery. Interestingly, KC bandages 
impeded wound closure following 30 hours which merits further investigation.   
Stored encapsulated ASCs modulate the expressions of keratocytes-
characteristic ECM components (decorin, lumican) corneal myofibroblasts marker 
(vimentin, aSMA) and corneal crystalline (ALDH3A1) expressions. Decorin and 
lumican belong to small leucine-rich proteoglycan family (SLRPs) which mainly aid in 
collagen fibrillogenesis and tissue hydration. The binding of SLRPs to collagen fibrils 
affects collagen matrix assembly and in turn, can affect corneal transparency. The 
significant increase in ALDH3A1 is particularly interesting in the 15°C stored group 
since ALDH3A1 maintains corneal transparency (Jester J.V.  et al., 1999) and 
protects the cornea from harmful UV-induced lipid peroxidation. It has been shown in 
vivo and in vitro that ALDH is mainly produced by inactive keratocytes rather than 
their activated, fibroblastic phenotype (Stagos et al., 2010, Pei et al., 2006). As was 
seen in the previous chapter, 15°C stored ASCs cultured with CSC were found to 
increase cell proliferation, evident by CSC cell number following scratch healing. As 
such, ASCs seem to maintain corneal cells inactive keratocyte phenotype while 
aiding in therapy.  
At the same time, ASC markers were analyzed following 15°C storage and 
culturing with CSC. ASCs phenotypic marker REXI showed an increase in 
expression following incubation with CSCs. Similarly, TSG-6 and HGF markers that 
are usually produced in response to injury showed upregulation in expression during 
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incubation with CSC. Whereas, hypoxia presenting markers VEGF, HIF1A, and 
aSMA were upregulated during storage. Which suggest that storage is a hypoxic 
environment that induces the cells to become highly active, this also corresponds to 
the literature (Lakatos et al., 2016, Liu et al., 2017, Han et al., 2016) Thus, our data 
indicated that the cells used after storage can exhibit an augmented wound healing 
compared to non-stored cells. 
Soluble protein concentration can give a good indication of the amount of 
protein present in the culture at a specific time point. Interestingly, ASCs bandages 
showed a significant increase insoluble protein production following 72-hour storage 
at 15°C. This production in soluble factors indicates that at 15°C, the cells remain 
active within the gel compared to 4°C storage where the cells are in a relatively 
dormant state. May also explain the reason why we found more viable cells following 
15°C storage compared to 4°C storage. At 15°C cells are actively producing factors 
that aid in maintaining viability compared to the dormant state the cells are in during 
4°C storage. Interestingly, the cells remained in their activated state following return 
to normal culture condition and incubation with a secondary population, similar to 
what was found before (Hung et al., 2007).  
An important structural protein is collagen, CSCs predominately secret collagen 
type I and V, which are the main collagen fibrils in the cornea. Collagen fibrils run 
parallel with one another, this arrangement along with their uniform diameter is the 
main reason for corneal transparency (Meek and Boote, 2004). Our data suggest 
that storage affects CSCs collagen production, although not significant. Upon 
normalizing the data to cell number, CSCs with alginate only were shown to produce 
marginally more collagen than all the other conditions. It is suggested that CSCs 
increase collagen production in non-motile cultures when incubated with retinoic acid 
(Gouveia and Connon, 2013). Which suggests that CSC incubated with alginate 
remain in-active, hence, explaining the delay found in the scratch wound healing of 
this condition. We suggest that CSC produce collagen while delaying cells migration 
and proliferation in closing the wound. This however, need to be further investigated 
in future experiments.  
It has been shown that ASCs produce many paracrine factors in response to 
injury in ocular and nonocular cell types (Alio Del Barrio et al., 2017, Chung et al., 
2009, Lee et al., 2014, Shan et al., 2018, Yang et al., 2010). These factors able to 
promote epithelialization while reducing neovascularization, scarring, and 
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inflammation (Bray et al., 2014, Song et al., 2018, Eslani et al., 2018). This cocktail 
of factors, however, is not fully understood. Research is lacking in the limits of the 
different factors produced by the ASCs in response to injury. Therefore, in an 
attempt to explore these factors, we decided to test a random set of growth factors, 
cytokines, and chemokines. Whilst this may present a good indication of what the 
cells produce, it does not give a definitive answer to all the factors produced by the 
cells.   
Pre-conditioning MSCs by subjecting them to hypoxia have been found to 
induce the heart to be more resistant to lethal ischemic attacks, which is found in an 
ischemic myocardium module (Murry et al., 1986). This method was adapted into cell 
therapy with the aim of increasing cell viability (Dzobo et al., 2018). Various other 
studies showed that pre-conditioning MSCs in hypoxic situations induces MSCs 
expression of proangiogenic and pro-survival factors, such as angiopoietin-1, VEGF 
and hypoxia-inducible factor-1 (HIF-1) (Mirotsou et al., 2011, Rehman et al., 2004, 
Thangarajah et al., 2009, Hsiao et al., 2013).  
It has been shown that ASCs produce many inflammatory cytokines and 
chemokines including MCP-1, IL-6, and IL-8 (Pourgholaminejad et al., 2016, 
Kyurkchiev et al., 2014) that aid in corneal wound healing (Roddy et al., 2011, Ma et 
al., 2006b). It has been shown that IL-6 and IL-8 regulate immune cell infiltration 
during wound healing whilst inducing fibroblasts and keratocytes migration (Oh et al., 
2009, Oh et al., 2008). Our data show upregulation in IL-8 in all conditions and 
significantly in the 15°C Encaps. Whereas IL-6 levels were upregulated in the 15°C 
Encaps and the 2x Storage conditions. When compared to 2x conditions, data 
suggest that ASCs do indeed produce IL-6 and IL-8. MCP-1 is an important 
chemokine that regulates macrophage recruitment (Yu et al., 2016). Our data show 
significantly high expression of these proteins in the 15°C Encaps condition 
compared to the non-stored condition. Interestingly, epithelial neutrophil-activating 
protein 78 (ENA-78) a chemoattractant of neutrophil function (Fillmore et al., 2003), 
extracellular matrix metalloproteinase inducer (EMMPRIN) a protein that stimulates 
fibroblasts to synthesize matrix metalloproteinase (Huet et al., 2011) were highly 
expressed in the 15°C Encaps treatment.  
An antiangiogenic factor, Thrombospondin-1 (TSP-1) was found to be 
produced by corneal epithelium (Sekiyama et al., 2006). TSP-1 was also found to be 
produced underneath the corneal epithelium (Schlotzer-Schrehardt et al., 2007, 
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Chen et al., 2012). In our experiment, TSP-1 was produced in all conditions, 
however, it was upregulated in the 15°C Encaps, which suggest that ASCs highly 
expressed the antiangiogenic factor to induce corneal wound healing. An angiogenic 
factor, VEGF, usually increases endothelial growth, migration, proliferation, 
differentiation, and vascular permeability (Ma et al., 2006a, Hui-Kang et al., 2009). 
VEGF key role in inflammation is determined by promoting B-cell and monocyte 
chemotaxis production and vascular leakage (Ferrara et al., 2003). VEGF is 
undesirable in corneal therapy, research found the use of anti-VEGF antibodies to 
show therapeutic success (Chang et al., 2012, Devarajan et al., 2019). Although not 
favourable, we found VEGF, to be produced at 15°C Encaps, 2x storage, which can 
indicate that ASCS produce VEGF. However, we also found VEGF produced in the 
CSC+Alginate group, which can indicate that VEGF is produced in the effect of 
alginate. Whereas, there was no production of VEGF in the non-stored group, which 
lead to the assumption of VEGF production to be related to storage. The key 
mediator of hypoxia is hypoxia-inducible factor (HIF), which can regulate various 
genes, including VEGF (Ramakrishnan et al., 2014). Thus, support our hypothesis 
that storage is hypoxia-inducible situation.  
Serpine e1 level expresses the rate at which the cornea heals (Sun et al., 2015, 
Deng et al., 2006). Serpine e1 key role is suggested to be in modulating cell 
migration and matrix reconstruction. We found serpine e1 to be activated in all 
conditions except CSC+ alginate. Serpine e1 expression is TGFß1 mediated 
(Samarakoon et al., 2009, Johnsen et al., 2002), which in turn is expressed in the 
wounded cornea, thus we can expect it to be produced in wound healing. However, 
we found Serpine e1 expressed in the 2x storage group, which was not a wound 
healing group. Hence, further study is warranted to investigate the effect of Serpine 
e1 during wound healing.   
 In conclusion, our findings so far elucidate the effect of hypothermically stored 
ASCs bandages in CSC wound healing by the production of paracrine factors that 
aid in wound recovery whilst maintaining normal keratocytes phenotype. Such 
effects of ASCs bandages may not be limited to healthy CSC. Considering that 
ASCs bandages and their production of paracrine factors are important for other 
diseases, such as keratoconus and deep corneal injuries/scratches. Thus, these 
data suggest the possible beneficial use of ASCs bandages for the in vivo corneal 
wound healing. 
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Chapter 5. Effect of stem cells bandages on keratoconus fibroblasts 
scratch-wounds 
 
5.1 Introduction  
Keratoconus (KC) is a bilateral and asymmetrical corneal disorder 
characterized by thinning of corneal stroma, which results in the corneal protrusion 
that leads to myopic shift and astigmatism (Romero-Jimenez et al., 2010, Zadnik et 
al., 1996, Zadnik et al., 2002). Presently, it is considered a multifactorial disorder 
caused by environmental and genetic factors (Bawazeer et al., 2000, Wachtmeister 
et al., 2009, Fabre et al., 2009). Although KC is considered as a non-inflammatory 
disease, inflammatory factors including interleukins and matrix metalloproteinases 
have a role in KC development (Balasubramanian et al., 2012, Lema et al., 2009, 
Kaiserman and Sella, 2019). KC treatment depends on the severity of the disease, 
ranging from spectacles and contact lenses to keratoplasty. The shortage of corneal 
donors is the main issue in treating KC.  
To solve this, cell therapy is used. KC usually produces a thinner irregular 
extracellular matrix (ECM) that contains collagen type3 and pro-fibrotic marker 
compared to the healthy stromal cells (McKay et al., 2015, Sharif et al., 2019). KC 
also changes the cellular metabolism that correlates to an increase in oxidative 
stress (McKay et al., 2017a). Thus, the cornea appears thin and opaque. ASCs 
bandages are a developing treatment that aims to improve the cornea, however, 
there still insufficient evidence to determine its benefits in KC treatment.   
Although a great amount of research is being conducted into the use of 
mesenchymal stem cells (MSCs) in KC treatment, it is still insufficient. MSCs ability 
to release growth factors in response to the environment is one of the key 
therapeutic features of these cells. It has been shown that MSCs release hepatocyte 
growth factor (HGF), transforming growth factor beta 1 (TGF-ß1), platelet-derived 
growth factor (PDGF), among many others (Boomsma and Geenen, 2012, Lee et al., 
2011, Lee et al., 2015) to improve various diseases. These factors although not fully 
understood, were found to promote cell migration, proliferation, and extracellular 
matrix protein production (Jiang et al., 2017). There is still insufficient evidence in the 
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use of ASCs in KC treatment. Thus, our ASCs bandages can help advance the 
treatment of KC in vitro and possibly in the clinic.  
 
5.2 Aims 
In the present chapter, we investigate the effect of adipose-derived 
mesenchymal stem cells (ASCs), as a stem cell bandage, on the corneal KC wound 
healing model. Diseased cells behave differently to healthy/normal cells, including 
their production of paracrine factors. Thus, investigating our bandages’ ability to 
affect their KC will provide us with an in-depth understanding of the usage and 
limitation of our bandages. Using in vitro model of human-derived KC, our previously 
described scratch wound assay was used to measure the effect of hypothermically 
stored ASCs bandages on (i) KC cell migration/proliferation, (ii) soluble protein 
concertation and (iii) collagen deposition. We show that ASCs bandages the ability to 
secret paracrine factors regardless of storage temperature, which improved KC 
wound closure. In addition, stored cells stimulated KC survival compared to non-
stored cells, which lead to an improvement in wound closure. Our findings in this 
chapter elucidate the beneficial effect of ASCs bandages in healing KC in vitro via 
the production of paracrine factors. Although we did not test the factors produced, 
from the previous finding, we expect factors including HGF, TSG-6, IL8, MCP-1, 
thrombospondin-1, to improve wound healing. 
  
5.3 Results 
5.3.1 ASCs bandages effect on keratoconus cultures  
To explore ASCs bandages' effect on KC cultures, we cultured ASCs bandages 
immediately the following formation and compared that with serum-free DMEM:F12 
(SFM) and alginate only controls (Figure 5.1 A &B). As shown in the figure, ASCs 
bandages showed increase in wound closure at times 20, 30 and 40-hours post 
scratch when compared to SFM (p <0.0001, 0.0001, and 0.0009 respectively) and 
when compared to alginate (p <0.0001, 0.0001, and 0.0074 respectively) cultures. 
We also assessed the effect of hypothermically stored ASCs bandages on KC 
culture. As we found in the previous chapter, 15°C is the optimum temperature for 
cells survival and for enhancing cells functional ability, we assessed this on KC 
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scratch wounds (Figure 5.1 A &C). Similar to the previous observation, ASCs 
bandages improved cells scratch wound closure significantly shown at times 20, 30, 
and 40-hours post scratch when compared to SFM (p = 0.0005, <0.0001, and 0.0001 




Figure 5.1 – Keratoconus wound closure. (A) Wound closure images taken using 
Iprasense lensless holographic microscope at times 0-, 20-, and 40-hours post 
scratch. (B) Scratch wound closure percentage of non-stored bandages, (C) scratch 
































































0 100 100 100 100
10 89.83239473 79.81871667 75.81346667 72.18942
20 70.75146893 64.18318 34.06266 42.05753
30 54.94253768 51.25793333 18.79689333 20.886708
40 37.07073254 33.25612333 15.30699833 9.881723
D
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wound closure percentage of 15C stored bandages, and (D) wound closure valuse. 
Wound closure percentage measured by dividing the scratch area at time 0 hour with 
scratch area at subsequent times and multiplied by 100. Values are presented as 
mean ± SEM from three separate Keratoconus donors, asterisks represent 
significance between bandages and SFM (****, p < 0.0001; ***, p < 0.001), while 
symbols represent significance between bandages and Alginate (^^^^, p < 0.0001; 
^^^, p < 0.001; ^^, p < 0.01).  Scale bar = 300µm. SFM, serum free DMEM:F12; 
Alginate, bandages without cells; non-stored and 15C stored bandages, bandages + 
ASCs either used immedicably following formation or following 3 days storage.  
 
5.3.2 ASCs bandages conditioned medium effect on keratoconus cultures 
SFM cultured with 15°C stored bandages with and without ASCs was used to 
generate conditioned media (CM) as before (Chapter 4). 100% CM was used with 
KC scratch cultures (Figure 5.2). CM taken from encapsulated cells showed 
significant improvements in scratch closure compared to gel only CM significantly 
shown at times 10, 20-, 30-, and 40-hours post scratch (p = 0.0149, 0.0222, 0.0033, 
and 0.0319 respectively).  
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Figure 5.2 – Conditioned media effect on Keratoconus cultures. CM taken from 15°C 
stored alginate with and without cells following 3 days storage. (A) Images taken 
using light microscopy at times 0-, 20-, and 40-hour post scratch. (B) Wound closure 
percentage and (C) values measured by dividing the scratch area at time 0 hour with 
scratch area at subsequent times and multiplied by 100. Values are presented as 
mean ± SEM from three separate Keratoconus donors, asterisks represent 
significance between conditions (****, p < 0.0001; ***, p < 0.001). Scale bar = 
220µm. SFM, serum free media; CM-Alginate, CM taken from gel only cultures; CM-
bandage, CM taken from ASCs bandages.  
 
5.3.3 Combination of ASCs bandages and their generated conditioned 
medium effect on keratoconus cultures 
Upon comparing the CM scratch coverage to ASCs bandages scratches 
coverage, no significant differences were found between the two conditions. 
Nonetheless, from the graph (Figure 5.3), we see faster wound coverage with the 


































0 100 100 100
10 89.83239473 78.33333333 65.33333333
20 70.75146893 66.90096 54.79672
30 54.94253768 53.66666667 37





Figure 5.3 – Comparison of encapsulated ASCs and the conditioned media used 
with Keratoconus scratch wounds.  
 
Thus, we sought to investigate the combined effect of encapsulated ASCs and 
their generated CM (Figure 5.4). Comparing ASCs+CM with alginate+CM, significant 
difference was found at time 30-hour post scratch (p = 0.0271). When compared to 
encapsulated ASCs without CM however, no differences were found between the 
cultures.  
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0 100 100 100
10 89.83239473 69.10272 60.68065
20 70.75146893 51.49863333 41.70049333
30 54.94253768 45.94838 16.66148333




Figure 5.4 – comparison between Combi-Encaps. (ASCs bandage + CM) and 
Combi-Alginate (alginate + CM) used with Keratocoic cells scratch wounds. (A) 
Images taken using light microscopy at times 0-, 20-, and 40-hour post scratch. (B) 
Wound closure percentage and (C) values measured by dividing the scratch area at 
time 0 hour with scratch area at subsequent times and multiplied by 100. Values are 
presented as mean ± SEM from three separate Keratoconus donors, asterisks 
represent significance between conditions (*, p < 0.05). Scale bar = 220µm. Combi-
Alginate, gel conditioned media used with alginate; Combi-Encaps, encapsulated 
ASCs conditioned media used with encapsulated ASCs cultures.  
 
5.3.4 Corneal stromal cells bandages effect on keratoconus cultures 
Next, we sought to investigate corneal stromal cells (CSCs) bandages effect of 
KC cultures (Figure 5.5). Comparing non-stored and 15°C stored encapsulated 
CSCs, a significant difference was shown at time 40-hour post scratch (p = 0.0459).   
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Figure 5.5 – Corneal stromal cells effect of Keratoconus cultures used either 
immediately following encapsulation (Non-stored) or 3 days following 15°C storage 
(15°C stored). Images taken using Iprasense lensless holographic microscope at 
times 0-, 20-, and 40-hours post scratch. Wound closure percentage measured by 
dividing the scratch area at time 0 hour with scratch area at subsequent times and 
multiplied by 100. Values are presented as mean ± SEM from three separate 
Keratoconus donors, asterisks represent significance between conditions (*, p < 
0.05). Scale bar = 300µm.  
 
5.3.5 Human keratoconus bandages effect on keratoconus cultures 
We then assessed the effect of KC bandages on another KC culture either 
































0 100 100 100
10 89.83239473 74.90689667 79.17277667
20 70.75146893 41.98093333 46.37986
30 54.94253768 31.83298 23.42231667




Surprisingly, the negative effect was seen from the non-stored KC conditions when 
compared to 15°C storage where it showed improvement in wound closure at times 
30- and 40-hours post scratch (p = 0.0017 and 0.0003 respectively). This suggests 
that non-stored KC are in a way defected but when stored they are modified or 
corrected by the storage temperature.  
  
Figure 5.6 – Encapsulated Keratoconic cells effect on Keratoconus cultures used 
either immediately following encapsulation (Non-stored) or 3 days following 15°C 
storage (15°C stored). (A) Images taken using light microscopy for the non-stored 
condition and Iprasense lensless holographic microscope for the 15°C stored at 
times 0-, 20-, and 40-hours post scratch. (B) Wound closure percentage and (C) 
values measured by dividing the scratch area at time 0 hour with scratch area at 
subsequent times and multiplied by 100. Values are presented as mean ± SEM from 
three separate Keratoconus donors, asterisks represent significance between 



































0 100 100 100
10 89.83239473 77.95188 79.17277667
20 70.75146893 75.51181667 46.37986
30 54.94253768 78.97641667 23.42231667




5.3.6 Total protein production assessment 
Next, we sought to assess the soluble protein concentration within the culture 
following scratch healing (Figure 5.7). Comparing 15°C stored ASCs bandages with 
bandage +CM and SFM cultures. A significant difference was found between the ctrl 
and bandage +CM cultures (p = 0.0427).  
 
Figure 5.7 – Soluble protein concentration taken using following scratch healing 
using Bradford protein assay. Values are presented as mean ± SEM from three 
separate repeats, asterisks represent significance between conditions (*, p < 0.05). 
 
5.3.7 Collagen production  
Subsequently, we assessed collagen production using Sirius Red staining on 
the KC cultures following scratch healing of the SFM, alginate, only and ASCs 
bandages (Figure 5.8 A, Ai). No differences were found between the conditions. We 
then measured the KC cell number (Figure 5.8 B), similarly, no differences were 
found between conditions. Upon normalizing CSC cell number to collagen amount 
(Figure 5.8 C), although no differences were found between cultures, from the graph, 
alginate cultures showed an increase in collagen amount compared to SFM and 

























Figure 5.8 – Assessment of Keratoconus collagen amount (A, Ai), cell number (B), 
and normalized collagen amount to cell number (C). Scale bar = 100µm. 
 
5.4 Discussion 
MSCs have been used in the treatment of many diseases as therapeutic cells 
due to their ability to secret immunomodulatory molecules, influence endogenous 
production of extracellular matrix proteins, and enhance endogenous cell 
proliferation (Pinnamaneni and Funderburgh, 2012). In corneal therapy, MSCs have 
also been shown to improve corneal transparency via the production of paracrine 
factors (Mittal et al., 2016, Basu et al., 2014). Several studies suggested MSCs and 
ASCs can promote corneal wound healing via their ability to release paracrine 
factors (Kern et al., 2006, Gnecchi et al., 2005, Zeppieri et al., 2017). Such factors 
have been seen to promote corneal stromal cells migration, proliferation, and 









































































visual parameters of patients with advanced KC (Alio Del Barrio and Alio, 2018). This 
chapter entails the use of ASCs bandages on diseased cultures whereas the 
previous chapter discussed the use of ASCs bandages on healthy cultures. 
Diseased cells behave differently than normal/healthy cells, including their 
production of different paracrine factors. Thus, showing our bandages effect on 
these cells provide us with an in-depth understanding of what our bandages can be 
used for. Our results showed ASCs bandages promoting KC wound healing via the 
release of paracrine factors. This ability of ASCs was present following storage at 
15°C. Upon testing collagen deposition, no differences were found between the 
conditions, this could be attributed to the culture period of our scratch being too 
short. These results correspond to our findings in the previous chapters.  
ASCs CM was previously shown to promote cell migration, proliferation, and 
wound healing (Yoon et al., 2010, Watson et al., 2010). Moreover, in a corneal injury 
mouse model, MSCs CM was found to improve corneal epithelium regeneration 
(Jiang et al., 2017). Thus, we tested CM taken following 3 days of storage at 15°C, 
where it showed an improvement in wound closure. We also found that combining 
encapsulated ASCs with their CM enhanced wound closure, in contrast, to stand-
alone CM that contains growth factors released during storage. Soluble protein 
levels were enhanced within the media following scratch healing of bandage +CM. 
compared to control samples. This difference is minor when compared to ASCs 
bandages. The similarity found between these conditions suggests that ASCs 
actively respond to the injury via sensing signals produced by KC and react by 
producing paracrine factors that aid in wound healing. These factors can include but 
are not limited to HGF, IGF, TGF-ß, and KGF.   
Studies demonstrated that mesenchymal-like stem cells are present in the 
human limbus area (Polisetty et al., 2008, Hertsenberg and Funderburgh, 2015). 
These corneal mesenchymal stromal cells (CSC) were shown to have decrease 
antiangiogenic properties in vivo and to reduce corneal neovascularization (Eslani et 
al., 2017). Therefore, we assessed CSC bandage ability in improving KC scratch 
wound with and without storage. Our result showed no difference between non-
stored and stored CSC bandages, where both conditions enhanced KC wound 
closure. When compared to ASCs, no difference was found between the two cell 
types. This corresponds to research by Holan et al, where authors compared MSCs, 
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ASCs, and limbal stem cells in a rabbit alkali injured eye (Holan et al., 2015). They 
found all cell types were able to reduce neovascularization, improve re-epithelization 
while suppressing inflammation.  
Although KC is diseased cells, we sought to investigate their effect on another KC 
population. Since both cell populations were diseased, we expected to see no effect 
on wound closure or a negative effect. Similar to our expectation, non-stored KC 
bandages showed a negative effect on wound closure, where there was no change 
in the scratch size. Surprisingly, however, 15°C stored KC bandage showed 
improvement in wound closure comparable to the use of ASCs. It has been 
suggested that storage stimulates ASCs ability to express enhanced levels of growth 
factors (Kaita et al., 2019). Moreover, we showed cells stored at 15°C prior to using 
with a scratch assay to improve cells’ ability to produce growth factors. Thus, it would 
seem that storage also enhanced KC to produce beneficial growth factors that aid in 
wound closure. We also expect that storage affected KC gene expression which 
reduced their ability to produce harmful factors, this, however, needs further testing 
and understanding.  
It has been suggested that cryopreservation affects the cell cycle (following 
thaw). Devine et al suggested that cryopreserved marrow and leukemia cell lines 
maintain these alterations in the cell cycle following 48-hours after return to normal 
temperature (Devine et al., 2018). In another study, authors stored a retinal pigment 
epithelial cell line at 4°C, 16°C and 37°C for 7 days (Pasovic et al., 2017). Cells 
stored at 4°C showed minimal changes in gene expression comparable to non-
stored cells, whereas cells stored at 16°C and 37°C showed larger changes in gene 
expression. Interestingly, changes in hypoxic markers were shown at 16°C and 37°C 
storage. This suggests that hypothermic storage at 15°C also affects cell cycle and 
in turn their gene expression and so increases their value in therapy. We suggest 
that storage affected cells cycle, thus, presented us with improved wound recovery. 
However, our data suggested that the improvement seen following 15°C storage is 
comparable to non-stored cells. This can be attributed to the recovered cell number, 
where a reduction in ASCs cell number was seen following storage. Hence, we 
suggest two main factors affect ASCs’ ability in wound healing, these being their 
number and storage temperature.  
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In conclusion, this chapter suggests that our bandages can be used in future 
therapies of KC diseases, and this would benefit the patient when there is a limited 
supply of corneal donors. 15°C stored encapsulated ASCs improved KC wound 
healing comparable to the non-stored cells. This improvement can be attributed to 
the storage effect on cell cycle and gene expression, where the cells showed 
improvement in the production of paracrine factors. ASCs’ production of paracrine 
factors attributed to their ability to sensing environmental cues. These factors 
including but not limited to HGF, IGF, KGF, and TGF-ß that improve adherent cells’ 
ability in migration and proliferation to close the wound. Thus, ASCs bandages 
provide great potential in KC wound treatment.  
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Chapter 6. Multipotent adult progenitor cell bandages for corneal 
stromal cell scratch-wounds 
 
6.1 Introduction  
Multipotent adult progenitor cells (MAPCs) have been investigated in various 
diseases, including bone repair and myelodysplasia (Martens et al., 2017, 
Roobrouck et al., 2017, Plessers et al., 2016), graft vs host disease (Maziarz et al., 
2015), ischaemic stroke (Hess et al., 2017), and acute myocardial infarction (Penn et 
al., 2012). However, it has not been tested on the ocular surface or the cornea, 
hence, we sought to test MAPCs bandages on corneal recovery. It is suggested that 
the immnunomodulatory effects produced by MAPCs are released in response to 
wounding (Ravanidis et al., 2015, Reading et al., 2013). This effect is postulated to 
be driven by the cells’ ability to produce growth factors, such as hepatocytes growth 
factors (HGF), tumor necrosis factor-inducible gene 6 (TSG-6), and transforming 
growth factors-ß1 (TGF-ß1). There is still not enough evidence to support the use of 
MAPCs, thus, we aimed to assess their effect on corneal wounds to give us an idea 
of their future therapeutic value.  
 
6.2 aims 
This chapter discusses the possible use of commercial MAPCs® as bandages. 
We assessed (i) their expansion and morphology, (ii) viability following hypothermic 
storage at 4°C and 15°C, followed by (iii) effect on in vitro corneal stromal cells 
(CSC) scratch wound, and their (iv) collagen levels using Sirius red staining. To our 
knowledge, this is the first report that shows MAPCs favorable effect on corneal 
wounds. The results obtained showed the benefit of incorporating MAPCs into future 
corneal therapy.  
 
6.3 Results 
6.3.1 MAPCs expansion and morphology assessment 
As described in Methods Section (Chapter 2. 1.5) the received frozen MAPCs® 
vials (ReGenesys, Belgium) were thawed and seeded in a cell-binding flask, in a 
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2000 cell/cm2 density, which was recommended by the supplier, and cultured at 
37°C for 72 hours with XF media. XF (Xenobiotic-free) media were also 
recommended by the supplier to be the optimum media that can be used in growing 
the cells, whilst maintaining their stem cell phenotypic morphology. Prior to this 
study, MAPCs properties were tested by Crabbè et al  (Crabbè et al., 2016) and 
compared to MSCs cultures, where both cell types were isolated from three shared 
donors. The authors found that compared to MSCs, MAPCs show faster doubling 
potential with smaller fibroblastic-like cells.  
Following 72 hours of culture, MAPCs showed high proliferative potential with 
80% confluency. At which point, cells were assessed for their morphology using 
phase-contrast microscopy, where the cells showed small, spindle-shaped 
fibroblastic-like morphology (Figure 6.1). This shape is similar to what was found by 
the supplier in a previous study (LoGuidice et al., 2016, Reyes and Verfaillie, 2001), 
therefore, no further validations were required in regards to morphology, stem cells 
markers and differentiation potential. Following 3 days in culture, cell viability was 
tested with live/dead staining and showed an average of 95 ± 1% of viable cells.  
 
 
Figure 6.1 – Bright field images of MAPCs morphology. Images taken 72 hours 
following seeding, showing spindle shaped fibroblastic-like cells. This morphology 
was seen an all MAPCs expansion cultures (n=3), and, in correspondence with the 
literature, is considered normal MAPC morphology, therefore, no further validations 
were taken in terms of phenotyping. Scale bar = 200µm.   
 
6.3.2 Alginate encapsulation effect on MAPCs viability  
Calcium alginate was used to form MAPCs bandages and measure the 
hypothermic storage effect on cell function and viability. 1 x 106 cells were 
encapsulated in 1.2% w/v VLVG alginate in ring shape molds (encapsulation and 
Day 1 Day 2 Day 3
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storage procedure explained in detail in chapter 2. 2.6) and stored at 4°C and 15°C 
in XF media for 72 hours. Encapsulated cell recovery was compared to non-
encapsulated cells stored and treated in the same manner to eliminate any possible 
differences between the conditions.  
MAPCs bandages stored at 15°C showed similar viable cell yield to cells stored 
at 4°C (~ 66%), whilst the non-encapsulated cells stored at 4°C showed reduced cell 
viability (~40%) compared to non-encapsulated cells stored at 15°C, where the latter 
showed similar viability to encapsulated cells (Figure 6.2 A). Following cell viability 
assessment, cells were tested for attachment efficiency, via culturing the released 
cells at 37°C for 24 hours and stained with Alamar blue. Following cell reattachment, 
significant differences were seen when comparing the previously encapsulated cells 
to non-encapsulated cells, suggesting encapsulation preserves cell functionality 
(Figure 6.2 B). Further normalisation was taken to measure overall cell functionality 
by multiplying cell viability values by cells’ attachment efficiency. This showed 
significant differences between the encapsulated cells and non-encapsulated cells, 
further suggesting the importance of alginate in maintaining cell function (Figure 6.2 
C) following storage. Although not significant, storing encapsulated cells at 15°C 
showed a better cell function than 4°C, whilst significant differences were shown 
between non-encapsulated cells stored at 4°C and 15°C. Cell morphology was also 
examined using light microscopy, were the cells adopted a spindle-shaped 
fibroblastic-like morphology, indistinguishable to non-stored cells (Figure 6.2 D). 
They also displayed high proliferative potential following 24 hours of culture.  
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Figure 6.2 – Alginate encapsulation effect on MAPCs. MAPCs encapsulated in 
alginate (Encaps.) were compared to non-encapsulated MAPC (Ctrl.) following 72 
hours of hypothermic storage at 4°C and 15°C. (A) Cells were released from 
encapsulation following 72 hours of storage before measuring viable recovery, and 
(B) attachment efficiency. (C) MAPCs functional cells number was also calculated 
via dividing viable cell recovery by the attachment efficiency. (D) MAPCs morphology 
was also assessed upon release and return to culture following 42 hours. Values are 
expressed as means ± SEM from n=3 with asterisks indicating significance from 
control values (***p < 0.001; **p < 0.01; * < 0.05), scale bar = 200µm. 
 
6.3.3 Encapsulated MAPCs effect on in vitro corneal scratch-wound 
regeneration  
Encapsulated MAPCs effect was tested on corneal stromal cells (CSCs) using 
the scratch-wound assay. CSC monolayers were serum-starved for 72-hours prior to 
scratching with 1mL pipette tip, at which point, the cells were grown in a confluent 
monolayer. The scratched cells were incubated with the following conditions; serum-
free medium (SFM), alginate only (Alginate), and MAPCs bandages (Figure 6.3). 
Time-lapse images were taken for the duration of 48-hours following the scratch with 































































































































0, 10, 20, 30, and 40 hours post-scratch. Experiments were repeated with 3 separate 
biological donors of CSCs and two technical repeats for each, whilst, three vials of 
MAPCs were received from the collaborator, each vial was used for a separate CSC 
donor. 
The effect of MAPCs bandages on CSC was examined directly following their 
formation (non-stored). From the graphs, Non-stored MAPCs bandages had an 
augmented scratch closure compared to Alginate and SFM only (Figure 6.3 A&B). 20 
hours post-scratch, CSC showed significant decrease in scratch width with the effect 
of MAPCs bandages compared to Alginate (p = 0.0002), this effect persisted 
following 30 and 40 hours post-scratch (p < 0.0001 and < 0.0001 respectively). 
Meanwhile, SFM showed a significant difference to Alginate at time points 20, 30, 
and 40 hours (p = 0.0012, 0.0036, and 0.0025 respectively) where it had faster-
wound closure. SFM also displayed slower scratch-wound recovery compared to 
MAPCs bandages at time points 30 and 40 hours (p = 0.0393 and 0.0117 
respectively).  
Hypothermic storage of the MAPCs bandages was tested following 4°C storage 
for 72 hours (Fig 6.3 A&C). MAPCs bandages showed significant scratch closure at 
time points 20, 30, and 40 hours when compared to Alginate (p = 0.0373, 0.0021 
and 0.0007 respectively). Surprisingly, however, no significant differences were 
found when compared to SFM. Whereas storage at 15°C for 72 hours (Fig 6.3 A&D) 
showed a significant wound closure at time points 20, 30 and 40 hours when 
compared to Alginate (p = 0.0004, <0.0001 and <0.0001 respectively), Interestingly 
significant differences were found between SFM and MAPCs bandages at time point 
30 hours (p= 0.0288). Thus, storing MAPCs at 15°C prior to using with CSC did 




Figure 6.3 – Effect of non-stored and hypothermically stored at 4°C and 15°C 
MAPCs bandages on CSC cultures. (A) Representative images of the scratch taken 
using Iprasense time-laps holographic microscope at time points 0, 20, and 40 hours 
post-scratch. Comparison of the scratch wound closure over time of (B) non-stored, 
(C) 4°C stored, and (D) 15°C stored bandages, and (E) scratch percentage values. 
Significant differences presented for the comparison of Alginate and Encaps in each 
graph. SFM, serum-free DMEM:F12; Alginate, VLVG alginate; Non-stored, MAPCs 
bandages used following formation; 4°C and 15°C stored, MAPCs bandages used 
following 72 hours of hypothermic storage. Values are expressed as means ± SEM 
from n=3, (****p < 0.0001; ***p < 0.001; **p< 0.01), Scale bar = 300µm.  
 



































































































































































































































Time	(Hours) SFM Alginate Non-stored 4oC storage 15oC storage
0 100 100 100 100 100
10 89.83239473 90.2468741 84.77022011 83.19104675 82.1769285
20 70.75146893 74.28158858 56.40275556 64.61386277 56.26766769
30 54.94253768 58.4928743 31.80806083 37.71729114 27.74437148
40 37.07073254 37.1387765 15.58263046 13.98659725 9.347396422
E
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Although CSCs were all shown to have improved wound healing when co-
cultured with MAPCs bandages (rather than Alginate alone), there are also 
differences when compared together (Figure 6.4). For example, 20- and 30-hours 
post scratch, significant wound closure was seen in the presence of the 15°C stored 
bandages when compared to non-stored bandages (p = 0.0427 and 0.0091 
respectively). At 40-hour post scratch, differences were found when compared with 
4°C stored bandages (p = 0.0471). These results suggest that 15°C storage 
increases the amount of soluble factors available to the CSC as measured by 
scratch-wound closure, which supports our previous chapters. 
 
Figure 6.4 – Comparison of MAPCs bandages following use in CSCs scratch-
recovery of the non-stored, 4°C and 15°C storage. (**p < 0.01; * < 0.05). 
 
 Following scratch closure, we counted the MAPCs cell number using live/dead 
staining and subsequently used to normalise the scratch closure data (Figure 6.5). 
Average scratch width values were divided by the total remaining MAPCs cell 
number for every condition and subtracted from time 0 values, to the present rate of 
which individual MAPCs effect CSC wound closure. From the graph, significant 
differences were found between the non-stored and 4°C stored at times 20, 30, and 
40 hours post scratch (p = 0.0312, 0.0035, and 0.0368 respectively) with speed of 
migration of 0.0000019, 0.0000029, and 0.0000033 µm/cell/hour respectively. Whilst 
15°C seems to be slower at time 20 hours 0.0000016 µm/cell/hour, 30 hours 
0.0000024 µm/cell/hour, and 40 hours 0.0000021 µm/cell/hour. This is an indication 
that although there are less average cells alive after 4°C storage (5x10^5 ± 0.89 
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cells), they can show similar healing potential on a per-cell basis to those stored at 
15°C prior to incubation with scratch 7.4 x 10^5 ±0.69 cells and non-stored 7.6 x 
10^5 ±0.87 cells. This supports our previous suggestion that hypothermic storage 
can influence cells to produce a greater amount or more potent factors that affect 
CSCs culture within the scratch assay.  
 
 
Figure 6.5 – Normalisation of the recovered MAPCs cell number following scratch 
recovery to CSC scratch healing over time, the graph represents the speed which 
MAPC cell affect CSC scratch-wound closure.  
 
6.3.4 Corneal stromal cell proliferation and collagen production following 
scratch wound recovery in presence of bandages 
CSC cell number was measured following scratch closure; the cells were lifted 
and stained with Trypan blue and counted using Countess FL automated cell counter 
(Figure 6.6 A). CSC cell number was counted for all conditions stated previously to 
determine whether the cells migrated or proliferated. From the initial seeding density 
2 x 10^5 cells/well, CSC cultured with SFM showed a slight increase in cell number 
(2.1 x10^5 ± 0.17 cells/well), while there was a decrease in cell number in the 
Alginate condition (1.4 x10^5 ± 0.32 cells/well), whilst a sharp increase in cell 
number was noticed in the MAPC bandages condition when they were 
hypothermically stored prior to co-culture at 4°C and 15°C (2.95 x10^5 ± 0.23 and 
4.17 x10^5 ± 0.5 cells/well respectively), compared to non-stored (2.1 x10^5 ± 0.42 
cells/well). Thus, CSCs showed an approximate doubling in proliferation when co-






















cultured with 15°C stored bandages. following scratch wound healing compared with 
non-stored. 
72-hours post-scratch wound, the plates with CSC were stained with Picro-
Sirius red staining to measure collagen deposition (Figure 6.6 B). Total collagen 
amount measured in the SFM condition was found to be 48.2mg ± 3.0, whereas 
CSC cultured with 5% media (5% FBS added to the media) were found to be 84.0mg 
± 8.5. CSC cultured with 15°C stored MAPC bandages showed an increase in 
collagen deposition to 62.5mg ±19.4, similar to 4°C 61.0mg ±13.1 and higher than 
non-stored 56.3mg ±15.4. In comparison, Alginate condition showed an even higher 
collagen deposition amount to 67.2mg ±15.6 in the non-stored condition and 63.9mg 
±21 in the 4°C storage and 57.1mg ±24.4 when stored at 15°C prior to using. 
However, no significant differences were found among all the groups.  
The total collagen amount was normalized to CSC cell number, to measure 
single-cell collagen deposition by dividing total collagen amount to final cell number 
(Figure 6.6 C). From the graph, significant differences were found among the 
treatment groups when compared to Alginate (different to what was found in Chapter 
4, which can be attributed to the difference in the type of plate used for the 
experiments), while there was a drop-in collagen amount produced by cells in the 
15°C stored bandages and the 5% media.  
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Figure 6.6 – (A) CSC Cell density, and (B) total collagen amount taken following 
scratch recovery, and (C) collagen amount normalized to cell number to represent 
the amount of collagen produced per cell. 5% media, 5% FBS DMEM:F12. Values 
are expressed as means ± SEM from n=3, (***p < 0.001; **p < 0.01; * < 0.05). 
 
6.4 Discussion  
MAPCs therapeutic value appears to be dependent upon the method of 
delivery that allows for optimal retention of the functional viability whilst maintaining 
their ability in producing supposed paracrine factors (i.e. HGF, PDGF, TGFß, etc.). 
So far, MAPCs have shown significant value in the clinical treatment of multiple 
sclerosis (Singh et al., 2017), acute ischemic stroke (Hess et al., 2017), hind limb 
ischemia (Aranguren et al., 2011), bone repair (LoGuidice et al., 2016), and 
myelodysplastic syndrome (Roobrouck et al., 2017). MAPCs therapeutic abilities 
were shown to be driven by their immunoregulatory effectors and their secretion of 
paracrine factors (Kovacsovics-Bankowski et al., 2015). Although MAPCs are similar 






























































































































We investigated the ability of alginate in maintaining MAPCs viability and 
function following hypothermic storage at 4°C and 15°C. Previously, we and others 
showed that alginate preserves MSCs viability and functional recovery following 
ambient and hypothermic storage, it was also found that changes in temperature can 
affect cell viability (Cesselli et al., 2009, Weissman et al., 2001). Here, we found 
alginate to preserve MAPCs during 72 hours of hypothermic storage at 4°C and 
15°C. Alginate also maintained MAPCs phenotype when returned to normal culture 
conditions, where they presented spindle-shaped fibroblastic like cells with high 
proliferative potential, this was indeed in agreement with the literature (Reading et 
al., 2013, Boozer et al., 2009, Crabbè et al., 2016).  
Although many studies were conducted on MAPCs they were not researched 
on corneal injuries. Thus, we tested the MAPCs bandages’ effect on CSC scratch 
wound healing. From the data, we found that MAPCs bandages produce some (as of 
yet) undefined factors that significantly improved scratch closure. Storage at 15°C 
prior to using in co-culture presents a faster scratch closure. An intriguing 
observation is the 4°C storage, which showed an enhanced wound closure potential 
following normalization to cell number. Although we note a decrease in MAPCs cell 
number following 72-hour storage at 4°C, the cells, however, appear to display high 
activity in producing paracrine factors and so are able to speed the scratch wound 
closure.  
 As has been shown in chapter 3 and 4, alginate presence in the culture seems 
to attenuate the wound recovery rate while increasing collagen amount produced by 
the CSC. We expect this to be attributed to the ion exchange reaction between the 
alginate and the SFM. Alginate contains calcium ions that may react with the sodium 
ions from the media, thus, effecting CSC proliferation (Tong et al., 2017, Lee and 
Mooney, 2012). The increase in ion absorption may have caused the alginate to 
swell and slowly dissolve in the media, which might explain the negative effect seen 
with the alginate only treatment used with CSC culture. It is also suggested that the 
subsequent increase in calcium ions may influence cell migration and proliferation 
(Lee et al., 2018). 
Collagen is one of the main components of the cornea, which is also produced 
by the corneal fibroblasts in response to wound recovery. Depending on the wound 
severity, collagen deposition can be delayed (Ljubimov et al., 1998, Nakayasu et al., 
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1986). Within the present system, collagen deposition is delayed across the 
conditions that showed high cell proliferation, it is suggested that alginate improves 
collagen deposition in damage site (Wang et al., 2015, Lee et al., 2009). Although no 
significant difference was found between alginate and MAPCs bandages in regards 
to collagen amount, normalisaing data to cell number gave a significant increase in 
alginate condition compared to all other conditions, this delay can prove useful in 
wound healing. Considering in corneal wound healing, we usually want the cells to 
heal the injury without causing scar formation, therefore, if there was high collagen 
production at the injury site without having partial or almost full recovery can cause 
the formation of scars and loss of corneal transparency. As detailed alginate alone 
decreases cell proliferation, it has been observed that non-motile corneal stromal 
cells are associated with high collagen amounts (Gouveia and Connon, 2013). This 
may explain the increased collagen production in the presence of alginate 
In conclusion, these results provide compelling evidence that alginate can 
preserve MAPCs during hypothermic storage without losing their viability and 
functional recovery. Also, our initial data support the potential of using MAPC therapy 
in corneal wounds. However, it is still unknown the exact mechanism in which MAPC 
affects the corneal cells. Therefore, further work needs to validate and test the 
growth factors produced by MAPC and their importance in wound healing.  
  
 143 
Chapter 7. Summary of wound healing data  
 
The effect of different bandages formation was investigated on the wound 
healing of the human corneal stromal cells (CSC). Conditions were either with non-
stored (Figure 7.1) or stored for 72-hour at 4°C (Figure 7.2) and 15°C (Figure 7.3). 
The storage was made in tightly sealed plates at 4°C and 15°C with serum-free 
media (SFM) and to prevent direct contact we used a Transwell® system.  
We compared two types of alginates, Sigma and NovaMatrix alginates. Sigma 
alginate showed improvement in scratch wound closure in all conditions, however, it 
was shown to induce ASCs to produce hepatocyte growth factor (HGF) and ascular 
endothelial growth factor (VEGF), thus, for the safety of cell therapy we decided to 
use NovaMatrix alginate in all experiments.  
Many conditions were evaluated and compared to ASCs bandages in healing 
CSC scratch wounds, including conditioned media (CM) taken from the bandages 
stored at 4°C and 15°C, other conditions including CSC bandages, human dermal 
fibroblast (hDF) bandages, keratoconus (KC) bandages, and MAPC bandages. We 
also measured ASCs lysis (cell death within bandage) effect and their formed lysate, 
and the combination of ASCs bandages +CM. Compared to all those conditions, 


















































































    
 
Figure 7.1 – Non-stored conditions used in wound healing. Represented at times (A) 
20-, (B) 30-, and (C) 40- hours post scratch. Values are presented as mean ± SEM 
from three separate keratocytes donors, asterisks represent significance between 
NovaMatrix Encaps. and all other conditions (****, p < 0.0001; **, p < 0.01; *, p < 
0.5), while symbols represent significance between Non-Encaps and all other 































































































































































































































































































































































































































































































Figure 7.2 – 4°C stored conditions used in wound healing. Represented at times (A) 
20-, (B) 30-, and (C) 40- hours post scratch. Values are presented as mean ± SEM 
from three separate keratocytes donors, asterisks represent significance between 
NovaMatrix Encaps. and all other conditions (****, p < 0.0001; ***, p < 0.001; **, p < 
0.01; *, p < 0.5), while symbols represent significance between Non-Encaps and all 
other conditions (^^^^, p < 0.0001; ^^^, p < 0.001; ^^, p < 0.01; ^, p < 0.5). 









































































































































































































































































































Figure 7.3 – 15°C stored conditions used in wound healing. Represented at times 
(A) 20-, (B) 30-, and (C) 40- hours post scratch. Values are presented as mean ± 
SEM from three separate keratocytes donors, asterisks represent significance 
between NovaMatrix Encaps. and all other conditions (****, p < 0.0001; ***, p < 
0.001; **, p < 0.01; *, p < 0.5), while symbols represent significance between Non-
Encaps and all other conditions (^^^^, p < 0.0001; ^^^, p < 0.001; ^^, p < 0.01; ^, p < 
0.5). NovaMatrix Encaps., ASCs bandages. 
 
The combined treatment of hypothermically stored ASCs bandages with CSC 
scratch wound has been shown to increase paracrine factors release to a level that 
is not achievable when ASCs used without alginate or without storage. In addition, 
this activity appeared to be enhanced when ASCs in the presence of a secondary 
population. Supportive effects between ASCs and CSCs have not been previously 
reported in regards to hypothermic storage and alginate, thus, these studies highlight 
a significant consideration to make for the potential of combined efficiency of 
hypothermic storage and alginate in stem cells bandages.  
Within the groundwork examination of encapsulated ASCs, we found their 
importance as bandages for in vitro corneal wound healing. This healing ability was 
mainly driven by their ability to produce a cocktail of growth factors, such as HGF, 
TGF-ß1, and IGF among many others. Thus, we then wanted to measure their effect 

















































































































































Chapter 8. Proof of concept: Delivery of hypothermically stored ASCs 
bandages to the ocular surface 
 
8.1 Introduction  
Chemical injuries (including acid and alkali burns) are one of the common eye 
injuries affecting many people. These injuries vary in severity from minor, affecting 
the corneal surface to major that penetrate deep into the corneal layers and lead to 
inflammation, scarring, and blindness (Wagoner, 1997). Therefore, they are 
considered an emergency that requires immediate assessment and treatment (Singh 
et al., 2013). Treatments aim to restore corneal epithelium, reduce inflammation, 
ease pain, and prevent bacterial infection (Salzman and O'Malley, 2007, Fish and 
Davidson, 2010). The treatment method depends on the severity of the injury.  
Amniotic membrane (AM) can be transplanted to the injured cornea for grade I, III, 
and IV injuries (Clare et al., 2012). It can act as a bandage contact lens or a 
basement membrane for re-epithelialisation and corneal healing (Shimmura et al., 
2001, Bouchard and John, 2004). For the most severe injuries limbal stem cell (LSC) 
transplantation can be used to improve the reconstruction of the ocular surface 
(Liang et al., 2009, Kim et al., 2003). Corneal transplantation to treat severe thinning, 
neovascularisation, corneal perforation, or descemetocele (ulcers) (Baradaran-Rafii 
et al., 2013, Alio et al., 2002). Thus, we found it interesting to investigate our 
adipose-derived mesenchymal stem cells (ASCs) bandages’ ability in healing 
corneal chemical burns. As a bandage, ASCs can be placed as a contact lens on the 
eye and release paracrine factors in response to the environmental cues. 
 
8.2 Aims 
So far, we have shown that alginate bandages are effective in preserving ASCs 
during storage. ASCs bandages were able to deliver therapeutic factors to a 
secondary population in vitro, without direct contact with the cells. Therefore, we 
sought to investigate these bandages as a therapeutic contact lens for the delivery of 
therapeutic factors to the ocular surface in vivo.  
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8.3 Material and methods 
8.3.1 ASCs encapsulation, storage and assessment of viable cells recovery 
This study was performed in collaboration with Dr. Stephen Swioklo, Atelerix 
Ltd. and Dr. Alex Shortt, UCL. Dr. Swioklo designed the experiment and prepared 
the materials. Dr. Shortt performed the animal study. I was responsible for analysing 
the corneas post mortem and interpretation of the results. 
Human ASCs derived from adipose tissue of healthy donors, were 
encapsulated in 1.2% w/v calcium alginate. ASCs bandages were stored at 15°C for 
3 days in a sealed cryovial with a growth medium. Viable cell recovery was assessed 
using live-dead staining to count the number of viable cells. Attachment efficiency 
was measured using methylene blue staining after 24 hours of cells return to culture. 
While functional recovery was measured by multiplying attachment efficiency by 
viable cell recovery.  
 
8.3.2 Delivery of stored, encapsulated ASCs to the ocular surface  
Human ASCs (as described in chapter 2 2.3) were encapsulated in 1.2% (w/v) 
calcium alginate discs (as described in chapter 2 2.3) containing 20 x 106 cells/mL 
and stored at 15°C for 3 days in serum-free medium (SFM). Bandages were 
transported within an insulated box under temperature-monitored conditions. At UCL 
the bandages were cut down to a diameter of 3.5mm (1 mm thickness) using a 
biopsy punch to form a therapeutic contact lens, which resulted in approximately 
60,000 cells transferred to the eye. 
12 Adult male NSG (NOD/SCID/Gamma) mice aged 8 to 12 weeks were 
divided into two groups, those receiving an ASCs bandage, and those receiving a 
bandage without cells. Under combined topical and general anesthesia, the left 
cornea and limbus were treated with 20% ethanol for 3 minutes before debridement 
of the corneal and limbal epithelium. Eyes were washed with HBSS. An 8-0 proline 
tarsorrhaphy suture were pre-placed then a 3.5mm diameter gel were placed over 
the cornea and limbus, the lids were shut and suture tied. The suture was removed 
after 4 days and the lids opened, at which point, the bandages were found degraded 
and fragments could be seen on the cornea. Seven days following injury, eyes were 
imaged under terminal anesthesia before sacrificing the animals and eyes 
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enucleated. Eyes were fixed in 4% (w/v) paraformaldehyde and mounted in OCT. 
15μm sections were cut for subsequent H&E staining and immunohistochemistry 
studies. Animal care and handling were in-line with ARVO Statement for Use of 
Animals in Ophthalmic and Vision Research.  
 
8.3.3 Hematoxylin and Eosin staining 
Hematoxylin is a deep blue-purple stain that stains the cells nucleic acid, while, 
Eosin is a pink stain that stains cytoplasm and extracellular matrix. Which makes this 
an optimal stain to visualise animal tissue sections (Fischer et al., 2008). 
Hematoxylin can stain the tissue when combined with metal cations, which will be 
positively charged cations and so, will bind to negatively charged nucleic acids, thus, 
stain blue. Eosin, on the other hand, is negatively charged anionic and react with 
amino groups in the cytoplasm, thus, stain pink.  
H&E staining procedure was performed as described by Fischer et al, briefly, 
15µm frozen cryosections of the enucleated eyes were dehydrated at room 
temperature before washing with 95% and 70% EtOH for 2 minutes and marking the 
edge of the slide with ImmEdge™ hydrophobic barrier pen (Vector laboratories LTD, 
Peterborough, UK). Sections were stained with hematoxylin stain (Sigma-Aldrich, 
UK) for 2.5 minutes followed by a wash and 2 dips in acid alcohol solution, a 
differentiation solution made by mixing 1% HCI (Fluka analytical, Bucharest, 
Romania) with 70% EtOH. Ammonia water solution, a blueing solution, made by 
mixing 0.2% ammonium hydroxide solution (Sigma-Aldrich, UK) in distilled water, 
was added to the section tissues following a wash for 60 seconds. The sections were 
then washed with 95% EtOH for 30 seconds before adding Eosin Y solution (Sigma-
Aldrich, UK) counterstain for 60 seconds followed by two washes with 95% and 
100% EtOH for 5 minutes. The section slides were then cleared and mounted with 
DPx mountant solution for histology (Sigma-Aldrich, UK) to preserve the stain, and 
covered with glass coverslip 24 x 50mm (Menzel Gläser, VWR, UK). Images were 
then taken using Nikon ECLIPSE TS100 (Nikon Instruments Europe BV, Tripolis100, 
Amsterdam, Netherlands) inverted microscopy using 20x, 10x and 5x magnification 
using ProgRes® CapturePro (V2.8.8) (Jenoptik, Jena, state of Thuringia, Germany) 
image analysis software.  
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8.3.4 Immunocytochemistry  
Immunocytochemistry is a semi-automated, rapid technique for determining 
lymphoid cell phenotype via examining cell surface antigen expression. This 
technique can define the population of lymphocytes in terms of lineage either T or B 
cells, monoclonal or polyclonal cells.  
The R&D systems protocol was used for staining the frozen cryo-sectioned 
samples, briefly, the frozen cryosections were allowed to thaw at room temperature 
before washing with a wash buffer (1X PBS) for 10 minutes to rehydrate the 
samples. Hydrophobic barrier pen (Vector laboratories LTD, UK) was used to 
surround the tissue sections before incubating with blocking/incubation buffer 
containing 2% bovine serum albumin (First link Ltd, Wolverhampton, UK) and 0.1% 
Triton® X-100 (ThermoFisher Scientific, UK) in PBS for 30 minutes to block non-
specific staining between the tissue and primary antibody. Up to 8 sections of each 
sample were then incubated with primary antibody anti-neutrophil (NIMP-R14) – rat 
anti-mouse (Abcam, Cambridge, UK) overnight at 4°C in a humidified container to 
avoid sample dryness. This incubation allows specific binding of the antibody to the 
tissue whilst reducing non-specific background staining. Sections were washed 3 
times for 15 minutes before incubating with IgG anti-rat secondary antibody (1 in 
1000 dilution) (Vector Laboratories, Peterborough, UK) and Hoescht 33342 solution 
(1 in 2000 dilution) (ThermoFisher Scientific, UK) for 60 minutes at room 
temperature. This was followed by 3 washes with washing buffer for 15 minutes, at 
which point, the sections were protected from light and mounted in Prolong® 
Diamond Antifade Mountant (ThermoFisher Scientific, UK) and sections covered with 
a glass 24 x 50mm coverslip. A Zeiss AxioImager (with Apotome) fluorescence 
microscope was used to image the cryosections. Negative controls were included in 
every staining; these were used as described above but without the addition of 
primary antibody. Neutrophil numbers in the central and corneal periphery were 




8.4 Results  
8.4.1 Alginate encapsulation preserves cells during hypothermic storage  
Alginate encapsulation preserved cells during hypothermic storage where it 
showed a significant cytoprotective effect following 72-hours of storage at 15°C. 
Following 3 days of storage, cells yielded a viable recovery of 86 ± 6% and a 
functional recovery of 80 ± 3% (Figure 8.1 A). This increase is significantly observed 
when compared to the control samples where there was a 1,8 ± 0.2-fold increase. 
Similarly, following 7 days storage, cells presented viable recovery of 68 ± 5% and 
functional recovery of 63 ± 2.3%, upon comparing to the control samples, a 2.3 ± 
0.5-fold increase was detected (Figure 8.1 B).  
 
Figure 8.1 – Alginate encapsulation preserves ASCs during hypothermic storage and 
transport from Newcastle to London. Human ASCs were entrapped in calcium 
alginate (Encaps.) or in suspension (Ctrl.) for either 3 days (A) or 7 days (B) at 15°C. 
Data expressed as mean ± SEM of three independent repeats, asterisks represent 
significance between conditions (***, p < 0.001; **, p <0.01; *, p < 0.5). Viable 
recovery, viable cells % following release; functional recovery, attachment efficiency 
x viable recovery. These results were compiled by Dr Stephen Swioklo, Atelerix Ltd.  
 
8.4.2 Encapsulated ASCs suppress ocular inflammation and promote 
epithelial wound healing in a mouse chemical injury model  
To determine the effect of encapsulated ASCs treatment on corneal chemical 
burn in vivo, we used a NSG (NOD/SCID/Gamma) mice model. Corneal limbal and 
A B
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epithelial were debrided of cells via treating with 20% EtOH for 3 minutes, and either 
treated with gel + ASCs containing 20 x 10^6 cells/ mL (treated) or gel – ASCs 
(untreated control) (Figure 8.2). The corneal injury was induced on the mice’s left 
corneas, while the right corneas served as normal controls. Corneas were harvested 
on day 7 following injury and were used to assess corneal epithelial layer recovery.  
Corneal images taken before enucleation suggested a reduction in corneal 
haze measured by clinical scoring from microscopy image, in the treated group 
compared to the untreated groups (Figure 8.3 A). H&E staining presented a 
reduction in the inflammatory cells infiltration in the corneal stroma in the treated 
group compared to the untreated group (Figures 8.3B, 8.5, 8.6, and 8.7). 
Immunohistochemistry staining of anti-neutrophil antibody (NIMP-R14) supported 
this observation where it showed a decrease in the number of neutrophils infiltrated 
the cornea in the cell-treated groups (Figure 8.4A, 8.5, 8.6, and 8.7). Moreover, data 
suggested that the number of neutrophils shown (measured manually via calculating 
the number of stained neutrophils in the central and peripheral corneas) was higher 
in the central cornea of the untreated group compared to the treated corneas (Figure 
8.4 B). Additionally, aSMA staining showed upregulation in the untreated samples 
compared to the ASCs treated groups (Figure 8.8). These data suggest that ASCs 




Figure 8.2 – Human ASCs bandages delivery to the ocular surface. 20 x 106 cells/mL 
were encapsulated in alginate (in an approximately 1mm thickness) and stored at 
15°C for 3 days. After transport, gels were punched in a 3.5mm diameter (left) and 
placed directly on the ocular surface (middle) following thorough epithelial 




Figure 8.3 – Histological analysis of the cornea. (A) Corneal haze, and (B) H&E 
staining of the mouse cornea demonstrating corneal inflammation in the untreated 
(bandages without ASCs) mice compared to the normal (un-injured) and treated 
(ASCs bandages). N = 7, with 4 treated, 2 untreated and 1 normal samples. S, 











































































Figure 8.4 – Immunohistochemistry staining for neutrophil. (A) Images revealed 
intense neutrophil infiltration (arrows) in the untreated groups (bandages without 
cells) compared to the treated group (ASCs bandages). (B) Neutrophil number 
counted from the images. S, corneal stromal layer; E, corneal epithelial layer. 

















































                              
Figure 8.5 - Normal non-injured animal cornea. Data collected and processed in 
collaboration Dr Stephen Swioklo, Atelerix Ltd. 
  
Figure 8.6 –Untreated samples, where bandages were transferred to the cornea. (A) 
sever injured cornea that were excluded from the study, (B) sample used for the final 








Figure 8.7 – Summary of ASCs bandages treatment. Showing 4 samples that are 
used in the study. Data collected and processed in collaboration Dr Stephen 









Figure 8.8 – Images showing the type of inflammatory cells infiltrating the cornea as 
well as a-SMA staining. (a) eosinophil, (b)basophil, (c) neutrophil, and (d) 
monocytes. Data collected and processed in collaboration Dr Stephen Swioklo, 
Atelerix Ltd. 
 
8.5 Discussion  
Insufficient corneal wound healing can lead to corneal haze, loss in 
transparency, and vision loss. Various growth factors have been shown to have an 
important role in corneal epithelial wound healing (Yu et al., 2010). In this study, we 
show that hypothermically stored, ASCs bandages to reduced inflammatory cells 
activation and infiltration, following a chemical burn, as evidenced by the higher 
number of neutrophils in the untreated group. While inflammation is important for 
normal wound repair processes, persistent and excessive inflammation could lead to 
complications in corneal healing (Wilson et al., 2001). The increased expression of 





































apoptosis whilst metalloproteinase expression increases by the keratocytes, which 
leads to degradation of extracellular matrix (ECM) in the wounded cornea (Wilson et 
al., 1996, Girard et al., 1991, Ljubimov and Saghizadeh, 2015).  
HGF is an important mitogen and motility growth factor that is expressed by 
corneal epithelial cells, keratocytes, and endothelial cells (Saghizadeh et al., 2005, 
Weng J, 1997a). Despite the important function of HGF wound healing, its full 
potential in corneal repair is yet to be fully understood. It has been shown that HGF 
not only can affect epithelial cells proliferation but also reverse the IL-1ß anti-
proliferative effect in vitro (Omoto et al., 2017). This suggests that HGF suppresses 
inflammation in the cornea. Our previous results in chapter 4, showed HGF 
expression to increase during storage and wound healing in vitro. Accordingly, we 
expect HGF to be one of the main factors in suppressing inflammatory cell infiltration 
in the injured cornea. Other factors, including IGF, TGF-ß, IL-8, and KGF can also be 
responsible for suppressing inflammation while improving healing (Lee et al., 2015, 
Li and Zhao, 2016, Milner and Day, 2003). 
In conclusion, the present study despite its limited power (only 4 mice studied 
for the treated group, 1 for the untreated and 1 for the normal group) shows that 
application of hypothermically stored ASCs bandages has the potential to be a 
therapeutic contact lens for the treatment of corneal chemical burns. These 
preliminary results clearly show corneal wound healing via inflammatory cell 
reduction. Thus, these data provide new insight into the use of ASCs as a 
therapeutic contact lens, which could serve as a framework in the development of 
future cell-based therapies for corneal injuries. Moreover, that such cell-based 
therapies can be driven exclusively by paracrine factors and that the therapeutic 
cells need not be in direct contact with the wound but can be entrapped within a 
hydrogel such as alginate and remain active. 
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Chapter 9. Conclusion and future directions 
 
9.1 Conclusion  
This thesis covers two distinct forms of work in cell therapy, focused on adipose-
derived stem cells (ASCs) bandages formation and its effect on a secondary 
population. The first part of this research focused on the establishment of stem cell 
bandages comparing two types of alginates, Sigma and NovaMatrix alginates. This 
important development step with alginate type is a further step towards the goal of 
stem cell bandage formation. Combined with bandage formation methodology to 
establish stable bandage that maintains cell viability and functional ability, these 
bandages were further tested to encompass different types of cells. NovaMatrix 
alginate displayed stability to encompass these cells while maintaining their viability 
and functional ability. ASCs bandages, when used in wound healing presented an 
augmented therapy in vitro. When comparing ASCs bandages to conditioned media 
(CM) therapy, although no significant differences were found between the two, the 
bandages showed superiority in wound healing. Following this, different cell types 
were formed as bandages, such as human dermal fibroblasts (hDF), human corneal 
stromal fibroblasts (CSF), human keratoconus fibroblasts (KC), and multipotent adult 
progenitor stem cells (MAPC), of which, ASCs bandages presented its superiority. 
Additionally, hypothermic storage at 15°C displayed the best-tested temperature to 
store bandages. Storage is a hypoxic environment that can affect the cells positively 
by making them actively produce paracrine factors. These hypoxic-induced ASCs 
bandages were also found to reduce immune infiltration when used in an in 
vivo animal model. Thus, supporting the thesis hypothesis.  
The second part concerns the testing of proteins and genes produced by the 
ASCs bandages following scratch healing. This was investigated on the gene level 
using qPCR and protein level using XL human cytokine array kit. On the gene 
transcription level, the bandages were shown to increase HGF and TGF-6 levels 
following healing, which are responsible for wound healing while reducing VEGF, 
IGF, aSMA, and HIF1A gene levels that are representative of hypoxia. Thus, 
supporting the hypothesis of storage is a hypoxic induced environment. As for the 
protein level, 30 different cytokines were found upregulated following wound healing 
of hypoxia-induced ASCs bandage. These cytokines have a different effect, such as 
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inflammatory cytokine IL-6, anti-inflammatory cytokine IL-8, macrophage recruitment 
regulator MCP-1, neutrophil chemoattractant ENA-75, extracellular matrix 
metalloproteinase inducer EMMPRIN, antiangiogenic factor TSP-1, etc. These 
factors complement each other with the aim of healing injuries. Thus, ASCs 
bandages improved scratch wound healing via the production of paracrine factors. 
These factors were shown to induce the secondary population to migrate and 
proliferate to close the wound area. It is hoped that some of the unanswered 
questions of ASCs production of paracrine factors are revealed through the use of a 
random cytokine array kit. Although only preliminary screening results of one repeat 
of each condition is described in here, experiments will be going towards the 
completion of more experimental repeats. 
The final section of this thesis highlights the use of hypoxia-induced ASCs 
bandages on a chemical injury of rat cornea. The bandages were found to reduce 
neutrophil infiltration, however, for the lack of proper repeats and the small size of 
this study, no conclusive evidence could be drawn from this. It did, however, indicate 
that the bandages can be used as therapy if further developed and tested. To our 
knowledge, this combination of alginate, hypothermic storage, and ASCs has first 
described in this work thus it added to the literature knowledge of a possible 
therapeutic bandage. 
 
9.2 Future directions  
Few interesting questions were raised from this work that opened up several 
directions that this work can be guided to. Firstly, alginate improvement; various 
ways can be used to strengthen the alginate by coupling it with peptide for example, 
or the use of different materials, such as collagen since the cornea is mainly formed 
of collagen. The identification of a better material can open up further investigations 
into the effect and function of the material on cell encapsulation and on a secondary 
population.  
Secondly, there are still many tests to be made on the hypothermic storage. 
Although hypoxia was attributed to the enhanced beneficial effect seen from the 
bandages, it was not explicitly tested. Thus, testing hypoxia-induced conditions, such 
as manipulation of oxygen levels, gene and proteins testing such as hypoxia 
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inducible factor-1 (HIF-1), and hypoxia response element (HRE), fibroblast growth 
factor 2 (FGF2), etc. will give a better indication on its effect on the bandages. It is 
also important to determine the effect of storage or cell recovery at different 
temperatures on the cells. Thus, testing cell number whilst still inside the bandages 
would need to be considered for future experiments using live/dead staining.  
Thirdly, the future investigation into the effect of bandages on a secondary 
population using different types of experimental approaches, such as proliferation 
assay, cell staining for co-culture approach, 3D system, investigating the metabolic 
interactions, etc.  Moreover, an interesting observation in the keratoconus (KC) data 
is the behavior of the cells following a certain time point where the cells started 
losing their morphology and detaching from the culture plate. This should be further 
assessed as to why cells behave this way.  
Fourthly, for the animal experiments, for technical issues, only two untreated 
corneas were included in the results, which were vastly lacking to conclude. Thus, a 
better experimental design needed following further bandage development. 
Moreover, the bandages were not tested for the effect of transportation on cells' 
health and function, which can affect cell viability, thus, would need to be 
investigated. When ASC-therapy goes into the clinic, various points must be taken 
into considerations, such as MSCs source, until now there are many different 
sources which may ultimately give different results; type of material used in bandage 
formation, where synthetic materials are different from natural materials, also, the 
FDA must approve the use of hydrogel, which is a taxing and long process; technical 
challenges, method/technique used to form ASCs bandages; scale up the bandages 
production; regulatory challenges; clinical challenges and requirements; 
development cost and time consumed in production. All of these are the key stages 
in developing ASCs therapy and would be taken under consideration for future 
bandage improvement.  
Finally, although data presented a promising therapy that would be effective 
for the patient, it would need various regulations to be translated to the clinic. Clinical 
trials are being conducted on the use of allogenic and autologous MSCs to cure a 
range of corneal diseases that are considered untreatable by conventional methods. 
In that regard, numerous in vivo studies have demonstrated great promise and 
potential of MSC-therapy in ocular disorders. This thesis aimed to investigate the 
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potential of ASCs bandages on corneal cells following hypothermic storage. this 
research adds to the understanding of literature the benefit of ASCs bandages and 
the benefit of storage in enhancing cell expression of paracrine factors. ASCs 
bandages forward testing can potentially lead to healing other diseases such as skin 
injures. Thus, with more investigations, ASCs bandages can present us with a 
unique future therapy. ASC-based therapy presents a unique treatment in initiating 
the healing process of injured tissues. This ability is directed by a succession of 
complex interactions between the adhesion molecules, growth factors, ECM 
proteins, and cytokines that are released and expressed by the ASCs. This study 
contributes to understanding the possible potential of ASCs stem cell bandages in 
corneal wound healing. Which could have direct application in the development of 
stem cell bandages for future clinical studies. The results shown in this thesis 
support the hypothesis that ASCs can be used as bandages and their beneficial 
effects driven by a paracrine factor mechanism generated from the immobilized cells.   
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